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Cultured keratinocytes have been used extensively in clinical and research 
applications. Current standard culture conditions rely on specific culture medium 
formulations and atmospheric oxygen levels that are widely accepted as giving 
optimal cell growth of early passage cultures. However keratinocytes are readily 
triggered to differentiate and become post-mitotic, reducing the rate at which cells can 
be amplified for further use. Theoretically this can be overcome by accelerating their 
proliferation using growth factor additives, or delaying differentiation, or by 
increasing the number of progenitor cells in the culture.   
The first part of this work investigates the phenotypic stability of cell model lines, 
using the well-established basal keratinocyte biomarker, keratin 14 (K14) expression. 
Experiments show that epidermal growth factor (EGF), a potent and commonly used 
keratinocyte culture component, is associated with progressive epigenetic silencing of 
this major basal keratinocyte protein in an immortalised keratinocyte cell line, NEB-1. 
It was found that EGF has a hitherto unknown role in accelerating DNA re-
methylation in the K14 regulatory region.  
The second part focuses on improving current primary keratinocyte growth by 
altering the oxygen level. The clinical applicability of cultured primary keratinocytes 
is limited by the time required to expand the cells. The in vivo oxygen level of skin 
has been reported to be lower than the atmosphere, so the hypothesis was proposed 
that lowering the culture oxygen level would improve cell yield. It was shown that a 
lower culture oxygen level not only improves the growth potential of primary 
keratinocytes isolated directly from skin, but also results in an extended culture 
lifespan as assessed by cumulative population doublings in serially passaged 
 viii 
keratinocytes. To identify mechanisms responsible for this improved cell yield in low 
oxygen, global transcriptome profiling was carried out on human primary 
keratinocytes. Increased differentiation and oxidative stress were identified as two 
major processes preventing keratinocyte growth in atmospheric conditions.  
This work appears to be the first comprehensive study of the effect of low oxygen on 
growth of primary keratinocytes. The finding that low oxygen inhibits differentiation 
and lowers culture-induced stress has immediate clinical implications, particularly 
when large amounts of keratinocytes are cultured from a limited biopsy, such as in the 
construction of cultured epithelial autografts for third-degree burn victims, or 
genetically corrected autografts for patients suffering from hereditary skin blistering 
disorders.  
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Introduction to skin 
The basic function of skin is as a two-way barrier. It keeps pathogens out, 
prevents excessive water and electrolyte loss and protects against UV 
irradiation. It is also important as a temperature regulator, allowing release of 
excess body heat through sweating and vasodilation. There are two main types 
of skin in humans: non-hair-bearing (glabrous) and hair-bearing skin. 
Glabrous skin is found on the palms and soles and has a series of alternating 
grooves and ridges, giving rise to a unique pattern of dermatoglyphics 
(fingerprints).  Hair-bearing skin make up the major skin type and hair follicle 
density and size can vary greatly from the large follicles extending into the 
subcutaneous fat in the scalp to the fine sebum-producing ones on the forehead. 
Skin consists of two basic parts: an upper stratified epithelial layer called the 
epidermis, and an underlying dermis of connective tissue. A thin, cell-free 
interface known as the basement membrane zone separates the two layers. 
 
1.1 The tissue organization of skin 
1.1.1. Epidermis 
In humans the epidermis is usually about 6-cell layer thick of which the major 
(95%) cell type is the keratinocyte (reviewed in Mcgrath & Uitto, 2010). Other 
resident cells in the epidermis include antigen-presenting cells such as 
Langerhans cells and other dendritic cells; melanocytes, which produce 
pigment (melanin); and Merkel cells, which are innervated cells important for 
touch sensation. Based simply on morphology, the epidermis can be 
subdivided into 4 layers: stratum basale (basal layer), stratum spinosum 
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(spinous layer), stratum granulosum (granular layer) and stratum corneum 
(cornified layer). The basal layer of the epidermis comprise of a single layer of 
proliferating keratinocytes. Basal cells are small (10 -14 μm) and cuboidal 
with large nuclei and dense cytoplasm. They are held to the basement 
membrane by integrin-containing hemidesmosomes and focal adhesion 
complexes. This is the layer that houses the interfollicular epidermal stem cells 
and is responsible for the renewing capacity of the skin. There are currently 
two models proposed to explain how epidermal stem cells in the basal layer 
maintain a multi-layered differentiated epidermis. In the first model, a small 
population of slow-cycling cells divides to give rise to transiently amplifying 
(TA) cells. The TA cells divide rapidly, forming hexagonal units known as 
epidermal proliferative units in the basal layer. After a limited number of 
divisions, TA cells lose expression of surface integrins. This results in a loss 
of adherence to the basement membrane and the cells are pushed towards 
terminal differentiation in the upper layers of the epidermis (Potten, 1974; 
Jones et al., 1995). In the second more recent model, specific 
microenvironment signals trigger basal cells to polarise and partition key 
regulatory proteins into cortical regions (Lechler & Fuchs, 2005). This process 
may result in asymmetric division, with a daughter cell retaining the stem cell 
properties and the other daughter cell committed to terminal differentiation. 
Currently it is unclear if commitment to differentiation occurs before or after 
the daughter cell detaches from the basement membrane. 
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Keratinocytes that leave the basal layer enter the spinous layer. This layer is so 
named because the numerous intracellular connections give rise to a prickly 
appearance by histology. Spinous cells are held together by desmosomes that 
link to keratin filaments in the cytoplasm. Cells in the upper spinous and 
granular layer also accumulate lamellar bodies. The lipid contents (including 
sphingolipids, ceramides and cholesterol) within the lamellar bodies are 
discharged into the intercellular spaces where they play important roles in 
moisturization and barrier formation. The granular layer lies directly above the 
spinous layer, and is named after the keratohyalin granules that are present 
within the cells. The filament-aggregating protein (filaggrin) contained in 
these granules promotes aggregation and cross-linking of the keratin filaments 
(Manabe et al., 1991). Beyond this layer, the cells lose their nuclei and 
cytoplasmic organelles and form a dead flattened sheet of corneocytes packed 
in a protein-rich matrix called the cornified envelope. The matrix mainly 
consists of highly cross-linked components of involucrin, loricrin, keratins, 
filaggrin and small proline-rich proteins (SPRRs) linked together by 
disulphide and isopeptide bonds catalysed by a class of proteins known as 
transglutaminases (reviewed in Proksch et al., 2008). The epidermal 
differentiation complex (EDC) located on human chromosome 1q21 and 
encodes for many of the proteins present in the cornified envelope such as the 
SPRRs, late cornified envelope (LCE) and S100A proteins, involucrin, 
filaggrin and loricrin (reviewed in Kypriotou et al., 2012). The SPRRs and 
LCE proteins were found to be upregulated in response to a variety of 
stressors including UV irradiation and 12-O-tetradecanoylphorbol-13-acetate 
(TPA) application (Kartasova et al., 1988; Gibbs et al., 1990; Jackson et al., 
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2005). It is believed these proteins modulate the biomechanical properties of 
the epidermal barrier in the presence of environmental insults (Steinert, 1998; 
Marshall et al., 2001). In humans, the journey from basal to cornified layer 
takes 2 to 4 weeks. 
 
Keratinocytes get their name from the predominant protein in the 
cytoskeleton: keratins. Filamentous cytoskeleton is made up of three different 
networks: actin, microtubules and intermediate filaments (of which keratins 
are part of). Actin filaments being 7 nm in diameter are the smallest, while 
microtubules at 20-25 nm in diameter are the largest. Intermediate filaments, 
as the name suggests, are between 7-10 nm. There are six types of 
intermediate filaments and the expression of each type is specific to the cell 
type. Keratins belong to types I and II intermediate filaments. In a fully 
differentiated keratinocyte, up to 85% of the structural network is made up of 
keratins (Fuchs, 1995). Keratins are classified as either acidic (type I) or basic 
(type II) and are obligate heterodimers: a type I keratin pairs with a type II 
keratin and this forms the building block of the intermediate filament. The 
expression of specific keratins depends on its location and differentiation state. 
The keratin network in basal keratinocytes is predominantly made up of 
keratins (K) 5 and 14. As keratinocytes enter the spinous layer, keratin 
expression changes to K1 and K10. Further up the epidermis, cells start 
expressing K2. Some keratins are localised to specific body site; for instance, 
K9 is expressed in the suprabasal layer of the palms and feet. K6 and K16 are 
stress-associated keratins and are usually expressed in wound sites. The exact 
 6 
functional significance of the multiplicity of keratins is still unclear. Different 
intermediate filament networks resulting from different types I and II dimers 
could differ in tensile strength and pliability, allowing the keratinocyte to 




Figure 1. 1 Histological section of human skin 
Haematoxylin and eosin (H & E) staining of a section of human skin showing the 
epidermis and dermis. Keratinocytes proliferate in the basal layer and start to 
differentiate as they move upwards through the different epidermal layers. The 





The dermis is a supporting matrix of proteins and polysaccharides containing 
two major kinds of protein fibres: collagen, which has a high tensile strength 
and is the major component of the dermis, and elastic fibres, which gives skin 
a degree of stretchability. Unlike the epidermis, the dermis is largely acellular, 
with fibroblasts interspersed in the matrix. A primary role of the fibroblast is 
to synthesize the matrix components. There are at least three different 
subpopulations of fibroblasts in the dermis: 1) the papillary fibroblasts in the 
superficial papillary dermis, 2) the reticular fibroblasts residing in the deep 
dermis, and 3) the follicular fibroblasts associated with hair follicles (Sorrell & 
Caplan, 2004; Driskell et al., 2013). The different fibroblasts give rise to 
differences in matrix composition. The papillary dermis consists of thin, 
poorly organized type I collagen fibres, while the reticular dermis contains 
thick, well-organized fibre bundles of type I and type III collagen. Follicular-
associated fibroblasts are responsible for hair induction and their ablation has 
been shown to stall hair follicles in telogen (Jahoda et al., 1984; Rompolas et 
al., 2012; Chi et al., 2013). The dermis is also well vascularized, although no 
blood vessels pass into the epidermis. Hair follicles, sebaceous glands and 
sweat glands are all epidermally-derived appendages that grow down into the 
dermis during their development; in the case of the hair follicle, this involves 
repeated cycles of growth and regression throughout life.  
 
Between the epidermis and the dermis is a thin, cell-free zone called the 
basement membrane zone (BMZ). This area provides an important platform 
 9 
for anchorage of the basal cells in the epidermis to the underlying dermis. 
Hemidesmosomes and integrin-containing focal adhesions from the basal 
keratinocytes serve as “rivets” which ultimately link to collagen fibres in the 
dermis. Apart from its structural properties, the BMZ also functions as a gate 
keeper, controlling the binding and release of cytokines and growth factors in 
both directions (Breitkreutz et al., 2013).   
 
The epidermis and dermis not only serve structural functions; they participate 
in epithelial-mesenchymal interactions that help regulate their growth and 
differentiation. Keratinocytes are known to produce a variety of cytokines and 
growth factors such as interleukin (IL)-1, IL-6, IL-8 and transforming growth 
factors α and β that act via autocrine and paracrine modes (Luger & Schwarz, 
1990; Schröder, 1995).  Keratinocyte-expressed IL-1 was able to induce c-Jun 
mediated expression of keratinocyte growth factor (KGF) and granulocyte 
macrophage colony stimulating factor (GM-CSF) in co-cultured mouse 
fibroblasts. These growth factors in turn stimulated growth of the 
keratinocytes (Szabowski et al., 2000).  
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1.2. Skin culture: moving from in vivo to in vitro 
The possibility of removing part of an organ and expanding it for both 
therapeutic (clinical) and research use is an attractive one. Skin is the most 
accessible organ and would be a natural choice as it is minimally invasive to 
the donor.  
 
1.2.1. Cultured keratinocytes: A valuable tool in research and therapy 
There are many potential downstream applications of cultured skin. For 
instance, the ability to construct skin grafts would provide coverage of large 
wound areas. Many commercial companies offer off-the-shelf skin equivalents 
such as Dermagraft® (a polyglactin scaffold with neonatal fibroblasts), 
Apligraf® (neonatal keratinocytes and fibroblasts in a bovine collagen gel) and 
Stratagraft® (immortalised keratinocyte NIKS (normal immortal keratinocytes) 
cell line and primary fibroblasts embedded in collagen) for immediate grafting. 
With the ability to genetically modify keratinocytes in culture, genetically 
corrected skin autografts can be transplanted back to patients suffering from 
inherited skin disorders (Mavilio et al., 2006). Cultured skin or keratinocytes 
would also be a valuable research tool as they form useful models for studying 
individual genes or elucidating biochemical pathways. Bridging the areas of 
research and therapy, cultured cells can act as “factories”, producing clinically 
useful recombinant proteins, or as platforms for drug screening and assay 
development. This not only provides a relatively cheaper alternative to animal 
work, it also potentially bypasses ethical and safety issues related to the latter 
use. 
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In order for cultured cells to be useful models, it is necessary that they retain 
structural, physiologic and functional features of the tissue from which they 
were derived.  Elucidating the role of a protein or biochemical pathway in a 
cultured keratinocyte would not be very meaningful if the protein or pathway 
studied is not normally present in the keratinocyte in vivo. In the case of 
keratinocytes cultured for therapeutic use, it is important that the culture 
conditions encourage cells to retain their identity, particularly when they are 
transplanted into the recipient. Thus the ideal culture condition would need to 
mimic the in vivo environment as closely as possible. 
 
1.2.2. History of skin culture 
The idea of growing skin ex vivo for therapeutic purposes dates back more 
than 100 years ago, as researchers discovered that skin fragments maintained 
in an appropriate medium could produce outgrowths of epithelial and 
connective cells. The culture media used in these pioneering explant 
experiments were often glucose-supplemented saline enriched with serum or 
ascitic liquid (Carrel & Burrows, 1910). However, it was realised that 
although keratinocytes can be made to grow around the original skin fragment, 
the growth was limited and the cells could not be propagated by subculture. 
Another problem was getting pure populations of keratinocytes; the culture 
methods used resulted in an overgrowth of fibroblasts (Parshley & Simms, 
1950). These issues limited the use of primary keratinocytes to research 
purposes only.  
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The breakthrough in keratinocyte culture came when it was shown that 
enzymatically dissociated keratinocytes from rabbits remained viable and 
could be seeded directly onto prepared wound beds (Billingham & Reynolds, 
1952). It was later shown that trypsin-dissociated keratinocytes cultured on 
collagen gels proliferated well and could be subcultured two or three times 
(Karasek & Charlton, 1971). This suggested that a dermal component was 
necessary for successful propagation of keratinocytes after trypsin incubation. 
This paved the way for Rheinwald and Green when they published a 
successful method of serially passaging keratinocytes on a bed of lethally 
irradiated Swiss 3T3-J2 mouse embryonic fibroblasts (Rheinwald & Green, 
1975a). 
 
1.2.3. Keratinocyte cell models 
There are numerous keratinocyte models available, and they can generally be 
classified as either primary keratinocytes (cells isolated directly from patients 
or animals) or immortalised cell lines.  
 
1.2.3.1. Primary keratinocyte as cell models  
Since the publication of the Rheinwald and Green method of keratinocyte 
culture in 1975, the culture protocol has remained much the same in the last 
four decades. The initial method established by Rheinwald and Green is still 
considered the gold standard today. In this method, whole skin (containing 
both the epidermis and dermis) is first trimmed of excess dermis, minced with 
surgical scissors and trypsinized. Keratinocytes (and some dermal fibroblasts) 
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released from the trypsin mixture is filtered and plated onto lethally irradiated 
3T3-J2 mouse embryonic fibroblasts. The cFAD (complemented F12 adenine 
DMEM) media, together with the presence of the mouse feeder layer 
suppresses the growth of dermal fibroblasts and allows the keratinocytes to 
establish colonies.  
 
In Singapore, the Burns Centre in the Singapore General Hospital (SGH) 
follows the media formulation and feeder preparation as specified by 
Rheinwald and Green. However, their method of keratinocyte isolation is 
tailored for extraction from Asian skin (Wong et al., 2012). “Asian” in a 
Singapore context refers to predominantly Chinese, and sometimes Malay or 
Indian skin. Asian dermis generally contains more collagen than their 
Caucasian counterparts. Thus, trypsin incubation of the minced epidermis and 
dermis from Asian skin samples gives rise to a more viscous mixture as more 
collagen is released into the trypsin solution. Keratinocytes released from the 
epidermis by trypsin would thus be trapped within the viscous collagen 
mixture, and this reduces the overall yield of keratinocytes. In the protocol 
adopted by the SGH Burns Centre and the Institute of Medical Biology (IMB) 
skin bank, the cleaned skin is cut into cubes (0.5 x 0.5 mm) and incubated 
epidermis side down in dispase II or trypsin-EDTA overnight at 4°C. The next 
day, the epidermis is peeled from the dermis, minced and dissociated with 
trypsin-EDTA (if dispase incubation was done) and filtered to obtain a single 
cell suspension. Overnight incubation with either trypsin-EDTA or Dispase 
would separate the epidermis from the dermis. However, the mode of action is 
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different: trypsin is a serine protease that hydrolyses the C-terminal end of 
lysine and arginine, unless this is followed by a proline residue, while dispase 
is a neutral protease that cleaves leucine-phenylalanine bonds (which are 
found in higher frequency in fibronectin and Type IV collagen) (Stenn et al., 
1989). In practice, incubation with trypsin results in an overall digestion of the 
epidermis and the dermis, yielding an epidermis with a “softer” consistency 
(since the enzyme also digests cell-cell contacts in the epidermis) that can be 
scraped off the next day. Dispase incubation results in an epidermis that is 
firmer since it does not digest within the epidermis but releases it as a sheet, 
which can be peeled off the next day. Both methods are comparable in terms 
of keratinocyte yield. This isolation method adopted in Singapore (i.e., peeling 
of the epidermis from the dermis) results in a relatively purer population of 
keratinocytes as compared to the Rheinwald and Green method. All primary 
keratinocytes described in this work were isolated using the Singapore 
protocol. 
 
Although primary cells are considered the closest cell model physiologically, 
they are not always readily available. Not only is their source limited by the 
frequency of donation, particularly for human skin where donation rates in 
Singapore are low (Chua et al., 2007; Vasko, 2011), primary cells have an 
intrinsic mitotic limit and cannot be propagated indefinitely in culture. 
Telomeres are repetitive nucleotide sequences that protect the ends of all 
chromosomes from damage or fusion with neighbouring chromosomes. With 
each successive round of mitotic division, telomeres are shortened as the DNA 
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polymerase cannot duplicate all the way to the end of the chromosome. When 
telomeres shorten to a critical point, they trigger a DNA damage response, 
preventing the cell from re-entering the cell cycle. Stem cells (and some 
cancer cells) can bypass this mitotic block by expressing telomerase, the 
enzyme that elongates telomeres by adding more telomeric repeats at the end 
of the chromosome. However, most somatic cells lack expression of this 
enzyme, resulting in a loss of proliferation often termed “culture-induced 
senescence”. Whether telomere shortening is a true reflection of senescence in 
vivo is still a matter of debate, although it has been shown by RNA in situ 
hybridization using telomeric probes in skin, that cells associated with the 
epidermal stem cell compartment (i.e., the basal layer and bulge region of the 
hair follicle) show longer telomeres compared to their terminally differentiated 
counterparts in the suprabasal layers (Flores et al., 2008). 
 
Another challenge of using primary keratinocytes is their inherent 
heterogeneity: both genetically (between different individuals) and within cell 
populations (for cells isolated from the same individual). Primary cells from 
laboratory animals may show higher genetic homogeneity due to extensive in-
breeding. However, primary cells from human donors would not show such a 
trait. This makes primary cells an unsuitable model where consistency is key, 
for example, when comparing drug efficacy in different experimental cohorts. 
Not withstanding this, there are instances where the genetic heterogeneity in 
primary cells can be an advantage. Reproducibility of a phenotype or 
biological interaction across primary cells from different individuals provides 
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affirmation that an initial experimental observation is not a one-off event. In 
the case of heterogeneity of cell populations from a single donor, isolation and 
culture techniques can be refined to encourage the enrichment of the cell type 
of interest. For example in epidermal keratinocyte isolation, the skin can be 
enzymatically treated to allow peeling of the epidermis from the dermis, thus 
minimizing fibroblast contamination.  
 
1.2.3.2. Immortalised keratinocytes as cell models 
Immortalised cell lines offer an alternative source to primary keratinocytes. In 
contrast to the limited lifespan of primary cells, “immortal” cell lines show 
unlimited growth. They can be derived from tumour cells or generated in vitro. 
Most cells isolated from tumours do not exhibit unlimited growth in vitro, but 
they spontaneously immortalise at a higher rate than normal cells and are often 
characterised by genetic aberrations (Damia & D’Incalci, 2010; Heng et al., 
2013; Castro-Gamero et al., 2013; Stevens et al., 2013). Immortalisation is 
one of the essential processes that leads to carcinogenic transformation 
(Hanahan & Weinberg, 2000); cells can achieve immortalisation without full 
carcinogenic transformation. Transformed cells must not only show 
anchorage-independent growth in vitro, they must be able to form tumours 
when transplanted into immunocompromised mice. 
 
Cell immortalization can be induced spontaneously by continuous passage, 
treatment with certain carcinogens, or the introduction of genes that interfere 
with cell cycle control (Katakura et al., 1998). Rodent cells are particularly 
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susceptible to spontaneous immortalization by continuous passaging. For 
instance, the 3T3-J2 feeder cell line used in the experiments described here 
was derived from a continuous passage protocol; the “3T3 protocol” which 
stands for “3 day Transfer, inoculum 3 x 105 cells” (Todaro et al., 1963). 
Every 3 days, fibroblasts were passaged (transferred) into a new 20 cm2 dish at 
a seeding density of 3 x 105 cells / dish. The constant passaging resulted in an 
accumulation of random genetic and epigenetic changes that confer a growth 
advantage (Hanahan & Weinberg, 2000). Introduction of specific viral genes 
is another method of immortalizing cells. Common viral genes used for 
keratinocyte immortalization include the simian virus (SV) 40 large T antigen, 
c-myc, and the human papillomavirus (HPV) E6 and E7. These viral genes 
encode for proteins that interfere with key cell cycle regulatory proteins such 
as p53 and the retinoblastoma protein (Rb). Both E6 and E7 have been shown 
to target p53 and Rb respectively for degradation, thus allowing the cell to 
bypass the G1/S phase checkpoint (Boyer et al., 1996; Yim & Park, 2005). A 
significant discovery in the field of immortalization was that introduction of 
the catalytic domain of human telomerase (hTert) was sufficient to extend the 
lifespan of retinal epithelial and foreskin fibroblasts in culture (Bodnar et al., 
1998).  
 
The common keratinocyte cell lines in our lab were established from each of 
the three methods discussed above. HaCaT is a spontaneously immortalised 
line (Boukamp et al., 1988), NEB-1 is derived from a healthy individual and 
immortalised by the introduction of HPV16 E6^E7 (Morley et al., 2003). 
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N/TERT-1 was immortalised by the introduction of the catalytic domain of 
human telomerase, and was subsequently found to lack functional p16 
(Dickson et al., 2000).  
 
Although established cell lines offer a potentially unlimited source of cells, the 
conclusions drawn from experiments using these cells should be taken in the 
light of the prior immortalization technique used to generate them. A major 
consideration is the inadvertent disruption of the genome and the interference 
of the immortalization process with the normal physiology of the cell. Also, 
due to the superior growth ability of these established cell lines, there is a 
tendency to “over passage” them, resulting in further accumulation of genetic 
and epigenetic alterations and a loss of their original phenotype. 
 
An ideal keratinocyte cell model should exhibit genomic integrity, infinite 
growth potential in vitro, and still retain the full spectrum of biological 
functions as that of a cell in vivo. Current culture systems still fall short of 
maintaining cells that fit all of these criteria. Since in vitro culture is an 
indispensible part of research and therapy development, the decision to use 
immortalised cell lines or primary cells should depend on the specific 
application and biological question to be answered. 
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1.3. Keratinocyte culture considerations 
Once a cell model is chosen, the next consideration is the type of culture 
protocol to use. In order to generate enough cells for research and therapeutic 
use, the culture system should provide an environment that is conducive for 
cell proliferation, but at the same time, it should also mimic the in vivo 
environment. These two aims are not always congruent, since cells in vivo are 
in a state of homeostasis, and for instance in the epidermis, terminally 
differentiated cells in the suprabasal layer do not proliferate. Depending on the 
application, there are a number of factors to consider. 
 
1.3.1 2-dimensional versus 3-dimensional culture 
When cells are isolated and placed in culture, there is a change in the niche; 
cells are removed from a 3-dimensional (3D) environment and frequently 
placed in a 2D culture system. Along with this change in dimensionality is the 
loss of contact with the extracellular matrix (ECM) and loss of cell-cell 
interaction. This results in a change in the microenvironment cues. Attempts 
have been made to address this, particularly in the area of stem cell (SC) 
culture. An example of this is the expansion of mesenchymal stromal cells 
(MSCs). These adult stem cells can be isolated from multiple body sites 
including dental pulp, skeletal muscle, adipose tissue and synovial membrane 
(Gronthos et al., 2000; Zuk et al., 2001; Sakaguchi et al., 2005). The relative 
ease of isolation and culture of these cells make them an attractive candidate 
for cell therapy. However, the low frequency of these cells in vivo means that 
isolated cells have to be extensively expanded in vitro. This is frequently done 
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in a 2D system, but it has been reported that the extended culture alters the 
phenotype of these cells, resulting in reduced growth ability and 
multipotentiality (Bruder et al., 1997; Banfi et al., 2000; Boquest et al., 2005). 
Attempts at 3D culture of these cells include growing them in a 3D matrix or 
as cellular spheroids. This has resulted in cells with improved therapeutic 
properties including a greater anti-inflammatory effect, increased ECM 
secretion and enhanced osteogenic and adipogenic differentiation potential 
(Tapp et al., 2008; Bartosh et al., 2010; Frith et al., 2010).  
 
In the case of keratinocyte culture, 3D organotypic reconstruction is 
commonly done using an air-liquid protocol. At its simplest, a high density of 
keratinocytes on a bed of matrix-embedded fibroblasts are lifted to air liquid 
interface with a concomitant withdrawal of epidermal growth factor from the 
culture medium to trigger the keratinocytes to undergo terminal differentiation 
(Oh et al., 2013). A wide variety of matrix and scaffolds are available to alter 
the extracellular matrix interaction and biomechanical properties of the 
organotypics (reviewed in Griffith & Swartz, 2006). This protocol results in a 
fully stratified epidermis in two to three weeks exhibiting the typical proteins 
associated with epidermal differentiation including keratins 1 and 10, 
involucrin, loricrin and filaggrin. Although organotypics are very useful tools 
to study differentiation, there are limitations; their microenvironment is 
simpler and they lack the full repertoire of cell types (such as melanocytes and 
Langerhans cells) found in native skin. They also lack the signalling cues 
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coming from systemic sources, making them unsuitable for studies of 
inflammatory reactions on wound healing for instance. 
 
3D reconstruction of skin also inadvertently causes keratinocytes to exit the 
cell cycle in favour of differentiation. As such, 2D models are still useful for 
maintaining the proliferative potential of keratinocytes. Mitomycin C-treated 
or γ-irradiated feeders are often used in a co-culture system with primary 
keratinocytes. This has been shown to mutually induce growth factor gene 
expression in both keratinocytes and fibroblasts (Smola et al., 1993; Maas-
Szabowski et al., 1999). 2D co-culture of melanocytes and keratinocytes has 
also been useful as a model to screen for regulators of pigmentation (Lei et al., 
2002). 
 
1.3.2 Culture media  
A second consideration involves the media components. Since the publication 
of the Rheinwald and Green protocol for keratinocyte cultivation (Rheinwald 
& Green, 1975b), many attempts have been made to improve the media 
formulation or the feeder system. Defined media offer the advantage of a 
reproducible animal-free system. Safety concerns such as potential 
contamination of bovine serum with bovine spongiform encephalopathy 
highlights serum-containing media as an additional risk factor, particularly in 
cells cultured for therapeutic use. In an effort to reduce the reliance on animal 
products, many commercially available serum-free keratinocyte culture media 
are now available in the market, for example, KSFM (Gibco), CnT57 
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(CellnTec), EpiLife (Life Technologies), and DermaLife (Lifeline Cell 
Technology). However, not only are their formulations proprietary, it should 
also be noted that although these media are marketed as “serum free”, they are 
not fully defined. All the media listed above still require supplementation with 
bovine pituitary extract. The main advantage these media offer is that 
keratinocytes can be plated without feeders. This is particularly convenient if 
the keratinocytes are cultured for research use as DNA, RNA and protein can 
be harvested and analysed without the interference of cells of mouse origin. 
However in our experience, the plating efficiency in these media is much 
lower: more cells have to be seeded in the feeder-free system compared to a 
feeder system if the flask is to be confluent in the same amount of time. This 
could be because the keratinocytes have difficulty attaching to the culture 
vessel in the absence of feeders, or the media formulation is less favourable 
for growth. So far, the serum-free and feeder-free culture media in the market 
are still unable to match the Rheinwald and Green system in terms of cell yield, 
plating efficiency and cumulative population doubling. (Barrandon Y., 
personal communication and observations in our lab, unpublished results). The 
combination of optimized media components, serum, physical interaction and 
paracrine factors from the feeder layers appears key to a conducive 




1.3.3 Oxygen level in culture 
The culture oxygen level is not a frequently considered factor in keratinocyte 
culture, but current literature suggests that the in vivo oxygen level of skin is 
much lower than the atmospheric level (21% oxygen by volume). Although 
the few groups that have ventured to quantitate the level of oxygen in skin 
(Evans & Naylor, 1967; Stewart et al., 1982; Bedogni et al., 2005) agree that 
epidermal keratinocytes in vivo experience much lower than atmospheric 
oxygen levels, there is no consensus on the actual in vivo concentration. One 
of the challenges is the technical difficulty in obtaining an accurate 
measurement, as any invasive oxygen probe would inadvertently introduce 
oxygen to the skin. Secondly, since the skin is a multi-layered organ with 
differing levels of vascularity - the dermis is vascularised while the epidermis 
is not - one would expect an oxygen gradient to exist within the tissue. A 
frequently cited report by Evans and colleagues using a metabolic dye EF5, 
estimates the level of oxygen in the dermis to be about 10% and that of the 
epidermis to range from 10% to 0.5% (Evans et al., 2006). Another indication 
that the in vivo oxygen level in skin is lower than atmospheric levels is the 
presence of hypoxia-inducible factor–1 alpha (HIF-1α). HIF-1α is a 
transcription factor that is rapidly degraded in oxygen (Schofield & Ratcliffe, 
2005). We (unpublished data) and others have detected HIF-1α by 
immunohistochemistry in human and mouse skin (Distler et al., 2004; 
Bedogni et al., 2005; Boutin et al., 2008). Since the epidermis has evolved to 
be an effective barrier, it is plausible that the in vivo oxygen level of skin is 
indeed below that of the atmosphere.  
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The few reports of primary keratinocytes cultured in low oxygen have been 
contradictory. Early reports claimed that growth was retarded when 
keratinocytes were cultured below atmospheric oxygen levels (Pentland & 
Marcelo, 1983; Horikoshi et al., 1986). The slower growth in low oxygen was 
later attributed to the induction of p21 (WAF1/Cip1) by HIF-1α (Cho et al., 
2008). Recently however, a number of groups have reported improved growth 
of human and rabbit corneal keratinocytes in low oxygen (O’Callaghan et al., 
2011; Li et al., 2011; Nakajima & Takeda, 2014). A possible reason for this is 
that oxygen has been shown to be required for terminal differentiation of 
cultured keratinocytes (Ngo et al., 2007). In vivo, terminal differentiation is 
accompanied by an exit from mitosis (Fuchs, 1995; Eckert et al., 1997). Low 
oxygen culture could thus be maintaining proliferation by suppressing 
terminal differentiation. 
 
It is important at this point to clarify the usage of certain terms. Atmospheric 
oxygen level refers to the oxygen content in air at sea level. This corresponds 
to about 21% oxygen (160 mmHg). Many groups culturing cells at 
atmospheric oxygen levels also mistakenly describe this level as “normoxia”. 
This was initially derived from the observation of high altitude-induced 
polycythemia (Bert, 1882), which occurs with decreased oxygen pressure 
(hypobaric hypoxia) compared to the oxygen pressure at sea level (which the 
author referenced as “normoxia”). The term “normoxia” was later transposed 
from classical physiology to cell biology. However this usage is incorrect as 
the levels of oxygen in tissues are much lower than that of the atmosphere. 
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Culturing cells at 21% oxygen should be more appropriately termed hyperoxia 
as this level of oxygen is abnormally high compared to the tissues from which 
the cells were derived. Physiologic oxygen levels or in situ normoxia has been 
estimated to range from 2% to 9% in tissues (reviewed in Brahimi-Horn & 
Pouysségur, 2007) and even lower (< 1%) in the bone marrow (Chow et al., 
2001).  
 
Another word commonly misunderstood in the literature is “hypoxia”. It is 
very often used to describe any oxygen level below that of the atmospheric 
level. However this generalized usage would inadvertently mislabel 
physiologic oxygen as “hypoxia”. Of course, cells do sometimes encounter 
true hypoxia, which is usually in a diseased state, for instance, tumour hypoxia 
or ischemia. This usage of “hypoxia” is in relation to the oxygen level that 
these cells normally experience. Anoxia refers to extreme hypoxia (~ 0% 
oxygen). In this work, the terms “hypoxia” and “anoxia” are reserved to mean 
a pathophysiologic oxygen level. 
 
1.4. Heritable changes of cells in culture 
When a cell is taken from the in vivo environment and placed in culture, it 
experiences a number of environmental changes. These in vitro changes are 
sometimes called culture-induced stress and may result in phenotypic changes. 
These changes would affect the interpretation of results or undermine the 
safety of cultured cells for therapy. Phenotypic changes may arise and be 
propagated by genetic or epigenetic alterations. 
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1.4.1 Genetic changes in cell culture 
There are many instances of cells in culture that have acquired genetic changes 
over time. Most commonly, changes in karyotype and chromosomal 
aberrations have been documented in cultured stem cells. Working with 
human embryonic stem cells (hESCs), Draper and colleagues found a 
recurrent gain of chromosomes 12 and 17q in three different hESC lines, 
suggesting that these genetic loci provide a selective advantage for 
maintaining the undifferentiated state in cultured hESCs (Draper et al., 2004). 
This finding was confirmed by two other groups (Buzzard et al., 2004; 
Mitalipova et al., 2005), and it was traced to the abbreviated protocol for 
colony dissociation. When hESCs were subcultured by the original labour-
intensive manual method, cells maintained a normal karyotype even up to 105 
passages. Switching to the shorter protocol resulted in chromosomal 
aberrations within 23 passages (Mitalipova et al., 2005). Along with an 
abnormal karyotype was the increase in expression of candidate pluripotency 
genes (Rao & Stice, 2004). More recently, a comprehensive single-nucleotide 
polymorphism (SNP) analysis comparing a large number of hESCs and 
induced pluripotent stem cells (hiPSCs) revealed that the reprogramming 
process was associated with loss of tumour suppressors, while increased time 
in culture was associated with duplications in oncogenes (Laurent et al., 2011). 
These results have serious implications in the use of cultured stem cells for 
therapy, as a major issue is the removal of pluripotent precursors in cells 
destined for transplantation. 
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Another example of genetic changes arising in cell culture is the 
spontaneously immortalised keratinocyte cell line, HaCaT. This cell line is 
also maintained in our lab and it retains basal keratinocyte characteristics, such 
as a cuboidal morphology and robust expression of basal keratins K14 and K5. 
However, the creators of this cell line also reported an abnormal karyotype 
that changed over time: initially, both copies of chromosome 4 and one copy 
of chromosome 9 was missing at passage 2. By passage 17, a host of other 
aberrations were discovered, including trisomy of chromosomes 6, 10, 11, 14, 
15 and 19 (Boukamp et al., 1988). However, this cell line is still commonly 
used (a Pubmed search for this cell line returned 3092 articles) as it is a 
convenient and highly proliferative keratinocyte cell model that retains normal 
differentiation and stratification in organotypic cultures. 
 
Mitomycin C (MMC) is a DNA damaging agent that is commonly used as an 
alternative method to γ-irradiation to generate feeders for stem cell and 
keratinocyte culture. A recent SNP array study comparing both types of 
feeders detected significantly higher copy number variations and 
downregulation of DNA damage repair genes in hESCs grown on MMC-
treated feeders. This was in spite of multiple washes and detection by 
HPLC/MS/MS to ensure complete removal of MMC from the feeders after 




Mechanisms of genetic variation 
Genetic aberrations include aneuploidy, copy number variations and 
chromosomal translocations. Aneuploidy can arise from chromosomal mis-
segregation, most commonly due to defects in spindle microtubule attachment 
to the kinetochores during mitosis (reviewed in Compton, 2011). Copy 
number variations are deletions or duplications of chromosomal segments, and 
arise from mechanisms such as non-homologous end joining or perturbations 
in DNA replication (reviewed in Hastings et al., 2009). Chromosomal 
translocations do not result in a change in copy number, but the physical 
transfer of a normally silenced gene into a region of high transcriptional 
activity could result in aberrant transcription of the inserted gene. A classic 
example of this is the translocation of c-myc from chromosome 8 to the 
heavily transcribed immunoglobulin heavy chain locus on chromosome 14 in 
Burkitt’s lymphoma (Dalla-favera et al., 1982; Taub et al., 1982). All the 
genetic aberrations described above would result in changes in expression of 
genes in the affected loci.  
 
1.4.2 Epigenetic changes in cell culture 
The observation that cell culture can result in an inheritable change not caused 
by genetic alterations was reported as early as 1977 (Meins & Binns, 1977). 
Working with cells derived from the pith parenchyma of the tobacco plant, the 
authors noticed that with time in culture or in response to 35°C treatment, the 
cells lost their requirement for certain growth factors. These growth factors are 
normally produced by a different set of tissues in the intact plant. They 
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speculated that this de-differentiation process is epigenetic because it was 
directed, reversible, and leaves the cells totipotent.  
 
Reprogramming of induced pluripotent stem cells (iPSCs) and the subsequent 
differentiation into specific lineages is another example of how components in 
cell culture can cause epigenetic changes (reviewed in Cantone & Fisher, 
2013). Specifically, inhibition of DMNT1 (DNA methyltransferase 1) or G9a 
(a H3K9me2 methyltransferase) has been shown to improve the generation of 
iPSCs (Mikkelsen et al., 2008; Shi et al., 2008). Subsequent treatment of 
iPSCs with retinoic acid and bone-morphogenetic protein-4 then induces 
differentiation to a keratinocyte lineage (Kogut et al., 2014).  
   
Mechanisms of epigenetic variation 
Epigenetics refers to chemical modifications in chromatin that result in a 
change in gene expression without an alteration of the DNA nucleotide 
sequence. DNA methylation and histone modification are two major 
mechanisms by which chromatin can be modified. The net result of these 
modifications is the formation of either an “open” and loose conformation of 
the chromatin (known as euchromatin) or a “closed” and more compact 
conformation (known as heterochromatin). Euchromatin is associated with 
areas of active transcription while heterochromatin is generally found in areas 
of low transcriptional activity. 
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DNA can be methylated on the cytosine residue in CpG sites. The “p” in CpG 
refers to the phosphate bond between the neighbouring cytosine and guanine 
residue on the same DNA strand. This distinguishes the CpG from the usual 
CG in the Watson-Crick base pairing. Methylation of the cytosine residue is 
catalysed by DNA methyltransferase. To date, there are three known DNA 
methyltransferases; DNMT1 a maintenance methyltransferase), DNMT3A and 
DNMT3B (de novo methyltransferases). Because methylcytosine 
spontaneously deaminates to thymine, this results in an underrepresentation of 
CpG in the human genome (Lander et al., 2001) ). There are however, clusters 
of unmethylated CpGs (called CpG islands) and these are frequently 
associated with the promoter regions of genes (Larsen et al., 1992; Saxonov et 
al., 2006). Methylation of these CpG islands normally occurs in 
developmental processes, such as X-inactivation and genomic imprinting 
(reviewed in Reik, 2007; Edwards & Ferguson-Smith, 2007). Cancer cells 
have also hijacked this mechanism to silence tumour suppressor genes 
(reviewed in Esteller, 2007).  
 
The nucleosome consists of four types of histones (H); H2A, H2B, H3 and H4. 
A complete histone octamer contains 2 of each of these histones. In a histone 
octamer, the N-terminal tails of the histones stick out of the nucleosome and 
are particularly susceptible to modifications such as methylation, acetylation, 
phosphorylation, ubiquitination and SUMOylation by histone-modifying 
enzymes (histone “writers”). Advances in mass spectrometric-based analyses 
have uncovered new low abundance modifications such as lysine 
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crotonylation and butyrylation (Chen et al., 2007; Tan et al., 2011) and new 
positions on the histones where the modifications occur. One of the surprising 
findings in this field is the discovery of modifications not only on the N- and 
C- terminal tail domains but also on the histone globular regions (Zhang et al., 
2003; Vermeulen et al., 2010). The different combinations of modifications 
have given rise to what is believed to be the histone code. The histone code 
hypothesis was first suggested more than ten years ago by Strahl and Allis  
(Strahl & Allis, 2000). It proposed that specific modifications or combinations 
of modifications in histones confer special biological functions in that locus. 
Some histone modifications are typical marks of certain transcriptional states, 
for instance, methylation of lysines H3K9 and H3K27 is correlated with 
transcriptional repression, while acetylation of lysines H3K9 and H3K14 is 
associated with active transcription. Because many residues on each of the 4 
different histones have the capacity of being modified simultaneously, this 
gives rise to a potentially high number of permutations. This is made even 
more complex by the fact that each modification can be mono-, di- or tri-
methylated for instance.  
 
Along with the mapping of histone modifications was the exciting discovery 
that histone “readers” are capable of reading multiple histone modifications at 
once (known as multivalency of the histone code) (reviewed in Ruthenburg et 
al., 2007). This is because a single histone reader can contain multiple 
subunits such as Tudor domains (recognising methyllysine and 
methylyarginine) and bromodomains (recognising acetyllysine). Future work 
 32 
and challenges in this field would involve mapping the different histone 
reading domains and understanding how the different readers function in a 
coordinate manner to elicit specific biological responses. 
 
Although DNA methylation is generally associated with long-term repression 
while histone modification is thought to have a more short-term effect, recent 
studies have shown that both processes can influence each other. For instance, 
KDM2A (a H3K36me2 demethylase enzyme) also carries the CxxC domain (a 
reader of unmethylated CpG), and binding of KDM2A to H3K36me2 was 
perturbed by CpG methylation (Blackledge et al., 2010). This is a likely 
explanation why the H3K36me2 mark is absent in unmethylated CpG island 
promoters. Another example of the link between DNA methylation and 
recognition of histone modifications is in the re-establishment of parental 
DNA methylation patterns in the blastocyst. The de novo DNA 
methyltransferases DNMT3A/B and an associated but non-catalytic DNMT3L 
all contain an ADD domain (named after the four proteins known to harbour 
this motif: ATRX-DNMT3A/B-DNMT3L). The ADD domain recognizes the 
unmodified N-terminus of histone H3 and in vitro DNA methylation was 
inhibited when synthetic nucleosomes harboured H3K4me2/3. This is 
consistent with the anti-correlative genome-wide distribution of DNA 




1.5 Aims of the thesis 
Cultured keratinocytes are widely used in research and clinical laboratories, 
although clinical application is limited by the challenges of rapidly amplifying 
undifferentiated but functionally competent keratinocytes in culture. The aim 
of the work presented in this thesis is to understand the restrictions acting on 
keratinocytes, which currently limit rapid phenotypically stable long-term 
amplification in vitro. This was done by investigating the effects of two direct 
environmental factors affecting cell growth in vitro, culture medium 
composition and oxygen levels, on keratinocyte identity and keratinocyte 
longevity. 
 
(i) Keratinocyte identity  
Basal epidermal keratinocytes are most readily identified by their expression 
of keratins (K) 14 and 5 both in vivo and in vitro. In the epidermis, loss of 
basal keratin expression coincides with a commitment to terminal 
differentiation. How keratinocytes regulate keratin expression in response to 
different environmental cues is not fully understood. The observed 
spontaneous silencing of K14 expression in an immortalised cell line (NEB-1) 
provided an excellent opportunity to study phenotypic stability in culture and 
the factors affecting it.   
Thus the experimental approach proceeded in three stages: 
1) analysis of the keratin expression profile and characterization of NEB-1, 
2) identification of the mechanisms leading to altered K14 expression, and  
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3) investigation of the role of a culture media component, epidermal growth 
factor (EGF), in contributing to epigenetic silencing of K14. 
 
(ii) Keratinocyte longevity 
To study keratinocyte longevity and long-term amplification in vitro, primary 
keratinocytes were isolated from surgical waste human skin. Clonogenic 
potential was used for these experiments as the ultimate, most direct readout 
for amplification potential.  Current methods of primary keratinocyte culture 
for autologous skin grafting are limited by the lengthy time required to expand 
enough keratinocytes to construct the graft. For optimal cell growth, it is 
assumed that the conditions of an in vitro culture system should mimic those 
of the in vivo environment, but oxygen levels in the epidermis in situ have 
been reported to be lower than ambient atmospheric oxygen levels. The 
hypothesis was therefore investigated that lowering the tissue culture oxygen 
to a more physiological level would improve the growth potential and 
consequently shorten the time required to produce large cell numbers. 
Based on this hypothesis, the following experiments were undertaken: 
1) investigation of the growth potential of human primary keratinocytes 
cultured in varying oxygen levels, 
2) investigation of the effect of oxygen on the culture lifespan of human 
primary keratinocytes by serially passaging to senescence, 
3) investigation of the molecular mechanisms and pathways driving the 
observed improved keratinocyte growth in low oxygen, and 
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4) investigation of the functional potential of keratinocytes expanded in low 
oxygen to differentiate normally, and reduce the time required to generate 































2.1 Cell Culture 
2.1.1  Cell lines used in this study 
 
Table 2.1 Background of the cell lines used in this thesis 
 
NEB-1 and HaCaT were used in chapter 3, while primary keratinocytes and 
N/TERT-1 were used in chapters 4 and 5. The epigenetic work described in 
chapter 3 was carried out on NEB-1 because spontaneous K14 silencing 
was first observed in this cell line. The HaCaT cell line was used here as a 
positive control because this cell line does not show K14 silencing.  
 
However the progressive loss of K14 in NEB-1 made this cell-line an 
unsuitable choice to study the effect of oxygen on basal keratinocyte 
growth in chapters 4 and 5. In the oxygen work, primary keratinocytes 
were cultured in a serum-free system. The N/TERT-1 cell-line was also 
used in chapters 4 and 5 because it is similarly cultured in a serum-free 
manner and, being an immortalized cell-line, it offered an abundant 






Cell line Immortalisation method Reference Culture medium Used in
NEB-1 human papilloma virus 16 E6^E7 Morley et al., 2003 RM+ (serum-containing) Chapter 3
HaCaT spontaneous Boukamp et al., 1988 DMEM (serum-containing) Chapter 3
N/TERT-1 human telomerase, lacks functional p16 Dickson et al., 2000 KSFM (serum-free) Chapters 4 and 5
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2.1.2  Isolation and culture of human primary keratinocytes 
 
Abdominal skin was obtained from the National University Hospital, 
Department of Surgery (Division of Plastic, Reconstructive and Aesthetic 
Surgery) or the Singapore General Hospital, Department of Plastic, 
Reconstructive and Aesthetic Surgery from donors after informed consent, 
according to institutional guidelines.  Cell isolation followed the IMB skin 
bank protocol. Skin was trimmed of excess fat and dermis and rinsed in PBS 
containing 10% penicillin-streptomycin and an anti-mycotic cocktail (Sigma-
Aldrich) for 5 minutes. The cleaned skin was cut into 5 mm x 5 mm cubes 
using surgical scissors and incubated epidermis side down in 0.25% trypsin-
EDTA at 4°C overnight (~16 hours). The next morning, the epidermis was 
peeled from the dermis and minced into fragments with surgical scissors. The 
minced epidermis was resuspended in cFAD medium (3 parts DMEM, 1 part 
Ham’s F12 supplemented with 10% fetal bovine serum, 400 ng/ml 
hydrocortisone, 0.18 mM adenine, 10 ng/ml EGF, 5 μg/ml insulin, 2 nM 
liothyronin and 0.1 nM cholera toxin) and passed through a 100 μm cell 
strainer to obtain a single-cell suspension. The cells were counted and either 
seeded for experiments or frozen for later use. 
 
2.1.3  Serial passage of primary keratinocytes 
Primary keratinocytes were seeded in 6-well plates containing DermaLife 
(Lifeline Cell Technology) supplemented with 1% penicillin-streptomycin and 
incubated at 37°C, 5% CO2 at the indicated oxygen levels. DermaLife is a 
serum-free human keratinocyte medium marketed by Lifeline Cell 
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Technology. The basal medium formulation is proprietary, but is 
supplemented with a final concentration of 6 mM L-glutamine, 4% bovine 
pituitary extract, 1 μM epinephrine, 0.5 ng/ml transforming growth 
factor-α, 100 ng/ml hydrocortisone, 5 μg/ml insulin and 5 μg/ml apo-
transferrin. When cultures reached 70% confluence, cells were dissociated 
with 0.125% trypsin-EDTA. The trypsin reaction was stopped with DMEM 
containing 10% bovine serum. The cell suspension was counted and 
centrifuged at 1200 rpm for 5 minutes to remove the trypsin. Cells were 
seeded at a density of 18 x 103 cells/cm2. Passage of keratinocytes at 2% and 
5% oxygen was carried out in a hypoxia chamber (Coy Laboratories, USA). 
All reagents and media were incubated at the corresponding oxygen levels for 
at least 6 hours before use. Media was changed every three days. 
 
2.1.4  Fibroblasts and preparation of feeder stocks 
The Swiss 3T3-J2 strain of mouse foetal fibroblasts were obtained from the 
Skin Bank Unit (Singapore General Hospital), which in turn received them 
from Yann Barrandon’s laboratory (EPFL). Permission for their use in our 
laboratory was obtained from Prof H Green (Harvard). The J2 strain was one 
of many established in Green’s lab (Todaro & Green, 1963) and was 
subsequently found to be superior to the other strains in terms of supporting 
keratinocyte growth (Barrandon, personal communication). The fibroblasts 
were cultured in Dulbecco’s Modified Eagles Medium (DMEM) (Gibco) 
supplemented with 10% bovine serum and 1% penicillin-streptomycin. When 
confluent, cultures were dissociated with 0.125% trypsin-EDTA, counted and 
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re-seeded at a density of 1 x 106 cells per T175 flask. To generate mitomycin-
treated feeders, the fibroblasts were seeded at the same density into 5-layer 
cellSTACKs (Corning) with a total surface area of 3180 cm2. An indicator 
flask (T175) would also be seeded in order to monitor the confluence. When 
the cells reached 80% confluence (after 4 days), the medium was removed and 
cells were washed once with plain DMEM. Mitomycin (Sigma-Aldrich) was 
added to plain DMEM to a final concentration of 10 μg/ml and the solution 
was filter-sterilized. The fibroblasts were incubated in mitomycin media for 
2.5 hours at 37°C, 5% CO2. The medium was then removed and cells were 
washed twice with plain DMEM and dissociated with 0.125% trypsin-EDTA. 
DMEM with 10% bovine serum was used to stop the trypsin reaction. Cells 
were counted and centrifuged at 1200 rpm for 5 minutes to remove the trypsin. 
The pellet was resuspended in freezing medium (10% DMSO + 90% fetal 
bovine serum) and cells were frozen at a density of 8 x 106 cells / vial. This 
method allowed the production of large feeder stocks from the same bank, 
which would minimize variation between experiments. 
 
2.1.5 Colony forming assay 
10 cm culture dishes were coated with 0.1% gelatin in PBS for 1 hour at 37°C. 
The gelatin was removed and mitomycin-treated fibroblasts were seeded at a 
density of 2 x 106 cells / dish in DMEM with 10% bovine serum and 1% 
penicillin/streptomycin. The feeders were allowed to adhere overnight. The 
next day the medium was changed to cFAD and primary keratinocytes were 
seeded at the indicated densities and allowed to establish colonies for 12 days. 
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Media was changed every 4 days. On day 12, the plates were fixed with 10% 
neutral-buffered formalin for 10 minutes at room temperature. 1% (in water) 
rhodamine B (Mallinckrodt Baker, Inc. Phillipsburg, NJ, USA) was added to 
the fixed cells for 30 minutes. After staining, the plates were rinsed under 
running water to wash off excess dye and the plates were air-dried overnight. 
Scoring of the colonies was done on a stereomicroscope (Leica M165C). 
 
2.1.6  Culture of N/TERT-1 
N/TERT-1 was cultured in keratinocyte serum-free media (KSFM) (Life 
Technologies) according to Rheinwald’s formulation (basal KSFM 
supplemented with 25 μg/ml bovine pituitary extract (BPE), 2.5 ng/ml 
epidermal growth factor (EGF) and calcium chloride supplemented to a final 
concentration of 0.39 mM). Cultures were routinely maintained at low density 
and passaged when cells reach 30% confluence. Media were changed every 
three days. 
 
2.1.7  Differentiation of N/TERT-1 
The differentiation protocol for N/TERT-1 is depicted in Figure 2.1. The same 
setup was done for 2%, 5% and 21% oxygen. Cells were seeded in KSFM on 
6-well plates. To compensate for the difference in growth rates of N/TERT-1 
in different oxygen level, the seeding density was adjusted so that all wells 
will reach confluence on the same day. Seeding densities were as follows for 
the different oxygen percentages: 2% (1.5 x 105 cells/well), 5% (1.8 x 105 
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cells/well) and 21% (3 x 105 cells/well). When cells reached 80% confluence, 
media was changed to KSFM without BPE or EGF. Together with this growth 
factor starvation, the Notch gamma secretase inhibitor DAPT (N-[N-(3,5-
Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester, Sigma-Aldrich) 
was also added to a final concentration of 10 μM in the treated wells. Cells 
were then left to reach confluence and harvested on the 6th day post confluence. 
Media and drug change was done every two to three days. 
 
2.1.8  Cell culture of NEB-1 
NEB-1 was cultured in RM (Ready Mix) media (3 parts DMEM, 1 part Ham’s 
F12 supplemented with 10% fetal bovine serum, 400 ng/ml hydrocortisone, 
0.18 mM adenine, 10 ng/ml EGF, 5 μg/ml insulin, 2 nM liothyronin and 5 
μg/ml transferrin) according to the published protocol (Morley et al., 2003). 
Cells were passaged at 80% confluence and media was changed every 3 – 4 
days. For 5-aza-2’-deoxycytidine (5-aza-dC) treatment, 1 x 105 cells / well in 
6-well plates were seeded the day before and allowed to adhere overnight. The 
next day, 5-aza-dC was added to a final concentration of 1 μM for 24 hours. 
After treatment, cells were washed once in PBS and fresh media was replaced 
without the drug for recovery. Cells were recovered for 6 days before protein 
and RNA harvest. Media was changed every 3 days. For the EGF experiments, 
duplicate 6-well plates were seeded and sub-cultured (passage N+1) when the 
first plate was harvested. 
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2.1.9  Cell culture of HaCaT 
HaCaT was cultured in DMEM (Hyclone) supplemented with 10% fetal 
bovine serum (Hyclone). Flasks were routinely passaged when ~70% 
confluent. For the UV irradiation, cells were placed for 30 seconds in the UV 
cross-linker (Stratagene) with the lid of the culture dish removed. The cells 
were then returned to the cell culture incubator for 1 hour to recover before 
protein harvest. 
 
2.2  RNA analysis 
2.2.1  RNA extraction and RNA sequencing 
Primary keratinocytes grown in DermaLife was harvested at log phase 
according the manufacturer’s protocol (miRNeasy kit, Qiagen). The 
concentration of the eluted RNA was measured on the nanodrop and the RNA 
integrity was quantified with the BioAnalyzer (Agilent Technologies). 3 μg of 
total RNA was sent for RNA sequencing (AITbiotech, Singapore). The RNA 
was first depleted of ribosomal RNA and library construction was done using 
the Truseq mRNA kit (Illumina) but omitting the poly-A tail purification steps 
in order to capture all species of RNA. Sequencing was done on the NGS 
Ilumina Hiseq 2000 platform. 
 
2.2.2  Realtime PCR 
1 μg RNA was converted to cDNA according to the manufacturer’s protocol 
(first strand cDNA synthesis kit, Roche). 1 μl of cDNA was used in the SYBR 
 44 
green master mix (Roche) and loaded onto the Lightcycler 480. Normalization 
and relative quantification of transcripts were carried out on the Lightcycler 
480 software. The primer sequences used for realtime PCR is listed in Table 
2.1. 
 
2.2.3  Bioinformatics analysis 
STAR (Dobin et al., 2013) was used to align the Illumina reads in FASTQ 
formatted files to the human genome build hg19. The aligned reads were then 
counted using featureCounts (Liao et al., 2014) using UCSC’s known genes as 
the source of the gene annotations. The gene counts were then analysed in the 
edgeR (Robinson et al., 2010) Bioconductor package in the R statistical 
language (version 2.15.2) as a paired analysis where each sample has 
measures for both oxygen treatments (5% and 21%). Significantly 
differentially expressed genes were then selected with a FDR value of less 
than 0.05. This results in 473 genes which were then analysed using 
clusterProfiler (Yu et al., 2012) to identify significantly enriched Gene 
Ontology terms (FDR < 0.05). The Gene Ontology terms were then clustered 
into networks where each pair of Gene Ontology terms shared at least 50% of 
overlapping genes. This produced networks where the genes are similar 
among the Gene Ontology terms facilitating interpretation of the results. 
Visualizations were done in both R and TIBCO Spotfire while data processing 













Table 2.3 List of keratin 14 real-time primers used in chromatin 
immunoprecipitation 
 
Gene Full name Forward primer (5' - 3') Reverse primer (5' - 3')
K5 Keratin 5 TCAACATCTCTGTTGTCACAAGCAGTG CCCACCACCTAGGCCGACA
K10 Keratin 10 AAACAGAAGGTCGCTACTGTG TCGGTTTCAGCTCGAATCTCT
K14 Keratin 14 CAAGATTCTCACAGCCACAG GTTCAACTCTGTCTCATACTTGG
NRARP Notch Regulated Ankyrin Repeat Protein TCAACGTGAACTCGTTCGGG ACTTCGCCTTGGTGATGAGAT
B2M
Beta-2-microglobulin
(housekeeping gene) GATGAGTATGCCTGCCGTGTG GCATCTTCAAACCTCCATGATG
RPLP0
Large ribosomal protein P0
(housekeeping gene) GAAAACAACCCAGCTCTGGAG CAGCTGGCACCTTATTGGC
Position on K14 gene Forward primer (5' - 3') Reverse primer (5' - 3') Amplicon size (bp)
Enhancer GCAGTTGATCCCAGGAAGAGCAT CACCCTCCCATCAGCCCCTA 81
Promoter CAGTAAAATATGACAGACATGATGAGGC GTGGGTAGGGGGCGGGT 122
First exon-intron boundary GTCCCTACTTCAAGACCATTGAGGAC AGGGGCCTGGGGCATGA 110
First intron TGATGAGGTGGGGAAATCCAAC GGAACTTTCTCAAGAGATAAAACCCAACTA 116
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2.3  Protein analysis  
2.3.1  Cell lysis and protein quantification 
Protein lysates were harvested when cells reach 70% confluence in T25 flasks. 
Cells were washed once with cold PBS and scraped on ice with 350 μl of lysis 
buffer (Phosphosafe buffer (Merck) supplemented with Complete Mini 
(EDTA-free) protease inhibitor cocktail tablet (Roche) per 10 ml lysis buffer). 
The lysates were then homogenized by passing through a QIAshredder column 
(Qiagen) with centrifugation at 12, 000 rpm at 4°C for 2 mins. The resulting 
flow through containing the homogenized protein lysate was assayed for total 
protein concentration using the BCA kit (Thermo Scientific Pierce) and bovine 
serum albumin (BSA) as protein standards. Protein lysates were stored at -
20°C. 
 
2.3.2  Immunoprecipitation 
Immunoprecipitation (IP) of keratin 5 interacting proteins in HaCaT, NEB-1 
and N838 was carried out using the protein A IP kit (Sigma-Aldrich). 2 μg of 
anti-keratin 5 antibody (XM26) was used for each reaction. The workflow is 
summarized in Figure 2.2. 
 
2.3.3  Chromatin immunoprecipitation 
Confluent plates of HPK (in KSFM), NEB-1 and N838 (both in RM media) 
were fixed with 1% formaldehyde and enzymatically sheared using the ChIP-
 47 
IT express shearing kit (Active Motif) according to the manufacturer’s 
instructions. Tri-methylated histone 3 lysine 27 (H3K27me3) 
immunoprecipitation of the sheared chromatin complex (10 μl per reaction) 
was carried out using the Orange kit (Diagenode) according to the 
manufacturer’s instructions. For the detection of the K14 gene, primers were 
designed spanning the K14 enhancer, promoter, first exon-intron boundary, 
and the first intron of K14 (Chapter 3 Figure 3.11, blue arrows). One of the 
challenges faced in designing primers for this experiment was the presence of 
a K14 pseudogene on chromosome 17. This pseudogene is highly homologous 
to the K14 gene, particularly at the promoter region where there is only one or 
two base difference between the two genes. This limits the positions where 
primers could be placed. To maximize specificity, primers were designed such 
that the base mismatch with the pseudogene was on the 3’-end of the primer. 
Amplified regions were also chosen such that there was at least one base 
difference (between the pseudogene and the K14 gene) within the amplicon. 
This allowed sequencing of the PCR product to determine if the primers were 
indeed amplifying the K14 gene or just the pseudogene. All primers used for 
this experiment were validated in this way (data not shown) and the sequences 
can be found in Table 2.2. The control primers for BMX (a non-receptor 
tyrosine kinase) were supplied in the Orange kit (Diagenode) and the 
sequences are proprietary. 5 μl of eluted DNA was added to the LightCycler 
SYBR green master mix (Roche) together with the primer pairs (5 μM final 
concentration). Quantitative PCR was carried out using the LightCycler 480 
(Roche). Normalization and relative quantification of transcripts were carried 
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out on the Lightcycler 480 software. Figure 2.3 summarises the workflow of 
the chromatin immunoprecipitation (ChIP).  
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Figure 2.3 Summary of keratin 14 chromatin immunoprecipitation 
Keratin 14 
Chromatin Immunoprecipitation (ChIP) 
HPK NEB-1H 
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2.3.4  Western blot analysis 
Normalized protein lysates were mixed with 4X LDS sample buffer 
(Invitrogen) and 10X sample reducing agent (Invitrogen) and boiled for 5 
minutes at 99°C on a heat block. The cooled lysates were loaded on 4-12% 
gradient Bis-Tris SDS polyacrylamide precast gels (Invitrogen) and ran for 45 
minutes at 200V. After gel separation, the proteins were transferred to 
nitrocellulose membranes using the iBlot dry blotting system (Invitrogen). 
Blocking of the membrane was carried out with either 5% BSA in TBS-0.1% 
Tween 20 or 5% skimmed milk in PBS for 30 minutes with gentle agitation. 
Blots were incubated overnight at 4°C with primary antibodies diluted in 
blocking solution. Table 2.3 shows the list of antibodies. The next day, 
membranes were washed thrice with either TBS-0.1% Tween 20 or PBS and 
incubated with the appropriate secondary antibody HRP conjugate diluted in 
blocking solution for 30 minutes at room temperature. The blots were again 
washed thrice and protein bands were visualized by enhanced 
chemiluminescence (ECL) using the Fujifilm LAS4000 illuminator. 
 
2.4  Histology 
2.4.1  Immunohistochemistry 
Tissue sections were processed either as formalin fixed paraffin embedded 
(FFPE) samples or as frozen samples. For FFPE samples, tissues were fixed 
overnight in 10% neutral buffered formalin in PBS and sent to Institute of 
Molecular and Cell Biology (IMCB) Histopathology Laboratory for paraffin 
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embedding and sectioning. For frozen samples, tissues were embedded in 
Tissue Tek O.C.T. compound (Sakura Finetek) and snap frozen in liquid 
nitrogen. Frozen cryoblocks were sectioned on a cryomicrotome (Leica 
CM3050 Cryostat, Leica Microsystems) to obtain 10 μm thick sections. 
Frozen sections were stored in -80°C until use. FFPE sections were dewaxed 
in xylene and rehydrated in descending percentages of ethanol to water. 
Endogenous peroxidase was quenched with 1% hydrogen peroxide (Merck) in 
water for 30 minutes. Antigen retrieval was carried out under pressure at 
121°C with citrate buffer, pH 6 (Dako). Blocking was done for 1 hour with 
10% goat serum (Dako) in PBS. Sections were incubated overnight with 
primary antibodies diluted in 10% goat serum at 4°C in a humidified chamber. 
Table 2.3 shows the list of antibodies. The next day, sections were washed in 
running water for 10 minutes in a flow chamber, followed by secondary 
antibody incubation using the EnVisionTM system (Dako) for 30 minutes at 
room temperature. The sections were again washed for 10 minutes, and 
peroxidase activity was detected using diaminobenzidinetetrahydrochloride 
(DAB) substrate (Dako). Incubation times varied from 1 to 5 minutes, 
depending on the primary antibody used. Sections were rinsed in water to stop 
the DAB reaction and counterstained with haematoxylin. Dehydration was 
done with increasing percentages of ethanol and cleared in xylene before 
mounting with DPX (Sigma-Aldrich) and dried overnight. Slides were viewed 




2.4.2  Immunocytochemistry 
Cell seeded on glass coverslips were fixed in 4% paraformaldehyde in PBS for 
10 minutes and permeabilized with 0.1% Triton X-100 in PBS for 15 minutes. 
Blocking was carried out with 10% goat serum in PBS. The coverslips were 
incubated overnight with primary antibodies diluted in blocking solution. The 
next day, coverslips were washed thrice in PBS and the appropriate 
fluorophore conjugated secondary antibody diluted in PBS was added for 1 
hour in the dark. The coverslips were again washed thrice and counterstained 
with 4’,6-diamidino-2-phenylindole (DAPI). The DAPI was rinsed off with 
water and the coverslips were mounted on slides in HydromountTM (National 
Diagnostics) with 2.5% DABCO to reduce photobleaching. Slides were 





Table 2.4 List of antibodies 
The dilution factors in parentheses refer to the dilution for 
immunohistochemistry / immunocytochemistry. 
  
Antigen Clone	 Host	Species Dilution	for	Western	Blotting Source
Keratin	1 LHK1 Mouse 1:150 Leica
Keratin	5 XM26 Mouse 1:500	(1:50).	IP:	2	μg Leica
Keratin	5 Polyclonal Rabbit (1:100) In-house
Keratin	6 LHK6 Mouse 1:100 In-house
Keratin	8 RCK102 Mouse 1:100 Novus	Biologicals
Keratin	10 LH1 Mouse (neat) In-house
Keratin	13 CK13 Mouse 1:100	(1:50) Leica
Keratin	14 LL001 Mouse 1:100	(neat) In-house
Keratin	14 RCK107 Mouse (1:100) Abcam
Keratin	15 LHK15 Mouse (1:50) Leica
Keratin	16 LL025 Mouse 1:100 In-house
Keratin	17 E3 Mouse 1:100	(1:20) Leica
Keratin	18 LDK18 Mouse 1:100	(neat) In-house
Keratin	19 L2PK Mouse 1:50	(neat) In-house
E-cadherin 36 Mouse 1:100 BD	Transduction	Laboratories
N-cadherin Polyclonal	 Rabbit 1:100 Abcam
P-cadherin 56/P-Cadherin Mouse 1:500 BD	Biosciences
Mucin-1 Polyclonal Mouse 1:100 Abcam
Fibronectin IST-9 Mouse 1:100 Abcam
Vimentin RV202 Mouse 1:100 Abcam
H3K27me3 181-050 Mouse ChIP:	0.5	μg Diagenode
HIF-1α Polyclonal Rabbit (1:100) Genetex
HIF-1α 54 Mouse 1:500 BD	Biosciences
Superoxide	dismutase	1	(SOD1) 71G8 Mouse 1:1000 Cell	Signaling	Technology
Superoxide	dismutase	2(SOD2) D3X8F Rabbit 1:1000 Cell	Signaling	Technology
Lactate	dehydrogenase	A	(LDHA) C4B5 Rabbit 1:1000 Cell	Signaling	Technology
γH2AX 2F3 Mouse 1:1000 Novus	Biologicals
p16 JC8 Mouse 1:200 Santa	Cruz	Biotechnology
p53 DO1 Mouse 1:1000	(1:400) In-house
Retinoblastoma	(Rb) 4H1 Mouse 1:2000	(1:200) Cell	Signaling	Technology
β1	integrin Polyclonal Rabbit 1:1000 Cell	Signaling	Technology
β4	integrin Polyclonal Rabbit 1:1000 Cell	Signaling	Technology
α6	integrin Polyclonal Rabbit 1:1000 Cell	Signaling	Technology
Histone	H3	(loading	control) D1H2 Rabbit 1:1000 Cell	Signaling	Technology
β-actin	(loading	control) AC15 Mouse 1:2000 Leica
Anti-mouse	HRP Polyclonal Rabbit 1:2000 Dako
Anti-rabbit	HRP Polyclonal Pig 1:2000 Dako
Anti-mouse	Alexa	488 Polyclonal Goat (1:500) Life	Technologies
Anti-mouse	Alexa	594 Polyclonal Goat (1:500) Life	Technologies
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3.1 Introduction  
 
Keratinocytes of the epidermis lend themselves well to tissue culture 
experiments. The cells in culture also abundantly express K14 and K5 proteins, 
mimicking the mitotically active basal layer from the stratified epithelium of 
the epidermis (Figure 3.1). Keratin intermediate filament proteins are obligate 
heterodimers: a type I keratin pairs with a type II keratin and this forms the 
basic building block of the keratin intermediate filament network. In the 
absence of a partner, a keratin monomer is quickly degraded. In the case of 
basal keratinocytes, K14 (a type I keratin) pairs with K5 (a type II keratin). 
 
The work described in this section started from an observation that a 
commonly used immortalised keratinocyte cell model was exhibiting 
phenotypic changes over time in culture. NEB-1 is a HPV16 E6^E7 
immortalised keratinocyte cell line generated from a healthy individual 
(Morley 2003), originally as a reference “normal” cell line for a comparative 
study of similarly-immortalised cells from patients with epidermolysis bullosa 
simplex (EBS), a skin fragility disorder caused by mutations in K14 or K5. 
However it was noticed that NEB-1 expressed decreasing amounts of K14 
after extensive passaging in tissue culture. This presented an interesting 
opportunity to investigate keratin regulation in keratinocytes, about which 




3.2 Progressive loss of K14 expression in an immortalised keratinocyte 
line 
 
It was observed that with increasing passages, the proportion of K14 positive 
cells (stained with antibody LL001) decreased (Figure 3.2). However 
immunofluorescence staining showed a clear K5 filament network (antibody 
XM26) in the absence of K14 in NEB-1. This suggests that K5 is pairing with 
an alternative type I keratin. Immunocytochemistry staining of other 
commonly expressed type I keratins revealed that K18 and K19 are also found 
abundantly in NEB-1. K13 and K17 are also expressed, but only in a few cells 
(Figure 3.3). In order to determine the type I keratin binding to K5 in NEB-1, 
immunoprecipitation (IP) was performed with an antibody targeting K5.  K5 
IP pulled down not only K19 and K18, but also the sparsely expressed K17 
(Figure 3.4). Although K13 was also expressed, no interaction of this keratin 
with K5 was detected. HaCaT is a spontaneously immortalised keratinocyte 
cell line expressing both K14 and K5 and was used here as a positive control. 
N838 is another HPV16 E6^E7 immortalised keratinocyte cell line which does 
not express these keratins and was used as a negative control. The results of 
the immunoprecipitation showed that K5 interacts with K18, K19 and K17 in 
NEB-1 cells. Although K14 is the major partner of K5 in normal epidermis, an 
interaction of K5 with K18 and K19 was also seen in HaCaT. This indicates 
that the keratins are similar enough for K5 to partner K18 or K19 in the both 




Figure 3.1 Keratin 14 expression in the epidermis 
Immunofluorescence staining of human epidermis showing keratin 14 expression in 
the basal and lower spinous layers of the epidermis. Magnification: 100X. 
 
Figure 3.2 K14 but not K5 expression in NEB-1 is reduced with increasing passage 
Immunofluorescent staining of K5 (the partner of K14) in NEB-1 at the same 









Figure 3.3 Potential type I keratin partners for K5 in NEB-1 






Figure 3.4 K5 associates with K17, K18 and K19. 
Immunoprecipitaion with XM-26 (an antibody specific for K5) followed by Western blot analysis using antibodies against the commonly expressed type I 
keratins in NEB-1 revealed that high levels of K18 and K19 and lower levels of K17 were associated with K5 in NEB-1. K13 was not found to associate with 
K5. HaCaT expresses both K14 and K5 and served as a positive control. N838 is a cell line that does not express K5 or K14 and served as a negative control







































































Heavy: Ig heavy chain (55 kDa) 
Light: Ig light chain (25 kDa) 
Immunoblotting:  
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3.3 K14 is epigenetically silenced in NEB-1 
The gradual loss of K14 in NEB-1 cells that have undergone multiple passages 
could be due to either genetic or epigenetic modifications. To exclude 
potential genetic modifications, Sanger sequencing of multiple clones was 
carried out, but this did not reveal any mutation either in the K14 gene or its 
regulatory regions (I. Szeverenyi, personal communication). 
 
The first indication that K14 was epigenetically modified was in the 3D 
organotypic models (Szeverenyi I. et al, manuscript in preparation). NEB-1 at 
low passage (NEB-1L, passage number < 15) expressed abundant K14 at the 
basal layer of the organotypics, while NEB-1 at high passage (NEB-1H, 
passage number > 80), although initially K14-negative at the time of seeding, 
showed weak K14 expression after two weeks of air-liquid organotypic culture 
(Figure 3.5).  
 
Further evidence that K14 was epigenetically silenced was from the re-
induction of K14 expression after treatment with the DNA methyltransferase 
inhibitor 5-aza-2’-deoxycytidine (5-aza-dC). The re-induction occurred both at 
the RNA and protein levels (Figure 3.6 a and b). K5 expression on the other 
hand decreased with 5-aza-dC treatment. Moreover, treatment with the histone 
deacetylase inhibitor trichostatin A augmented K14 expression (Figure 3.7).  
Trichostatin A treatment alone, however, was unable to induce K14, 
suggesting that although histone acetylation enhances K14 expression, DNA 
methylation is the principal mechanism of silencing the K14 gene. 
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Figure 3.5 K14 expression in NEB-1 can be induced 
Keratinocytes were seeded onto collagen-embedded fibroblasts and allowed to stratify for 2 weeks at air-liquid interface. NEB-1L and NEB-1H refers to 
NEB-1 at low and high passage respectively. The last column shows keratin 5 and 14 expression in the cells at the time of seeding. K14 expression was 








Figure 3.6 K14 is epigenetically silenced 
a) RT-PCR of K14 mRNA levels in NEB-1 treated for 7 days with the DNA 
methyltransferase inhibitor 5’-aza-deoxycytidine (5-aza-dC). 7dR: 7 days treatment 
with 2 days recovery. b) Western blot analysis of K14 levels in NEB-1. K14 protein 




Figure 3.7 5’-aza-dC-induced K14 expression is augmented by trichostatin A 
(TSA) 
Western blot analysis of K14 expression in NEB-1 co-treated with 5-aza-dC and TSA 
(a histone deacetylase inhibitor) for four days. TSA treatment alone could not induce 
K14. Expression of K14 was further increased after 3 days recovery from the drug 
treatment.  
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The K14 gene lies in a cluster of keratin genes on chromosome 17q12-21. It 
was not known if the silencing was a general phenomenon in that locus or if it 
was specific to K14 alone. Immunoblotting of keratins in that genetic locus 
showed that other than K14, K16 was the only other keratin induced by 5-aza-
dC (Figure 3.8). However, K16 is a stress-associated keratin and its levels are 
not consistent in culture. The induction observed here could have been due to 
the stress of 5-aza-dC treatment.  
 
The extent of DNA methylation can be tracked by sodium bisulfite sequencing. 
Previous work by colleagues in our lab (Szeverenyi I. et al, manuscript in 
preparation) revealed that all seven CpGs in the K14 enhancer region were 
progressively methylated as the passage number of NEB-1 increased. Figure 
3.9 shows the workflow of mapping the methylated CpGs. In Figure 3.10, 
each circle represents one clone picked from the colony PCR. Compared to 
human primary keratinocytes expressing K14 in 100% of the cells, NEB-1L 
showed increased methylation in all seven CpGs. The proportion of 
methylated CpGs increased further in NEB-1H, where none of the cells were 
expressing K14. 
 
Tri-methylated lysine 27 in histone 3 (H3K27me3) is a frequent mark of 
transcriptional repression. Chromatin immunoprecipitation (ChIP) was carried 
out with an antibody recognizing H3K27me3, followed by realtime PCR with 
primers specific to the K14 enhancer, promoter, first exon and first 
exon/intron boundary (Figure 3.11). The H3K27me3 mark was enriched in the 
 65 
enhancer and promoter regions of NEB-1H compared to HPKs. H3K27me3 
was enriched in the first exon/intron boundary and intron of both HPKs and 
NEB-1H, suggesting that tri-methylation of this residue within the K14 coding 
region does not affect K14 expression. BMX, a non-receptor tyrosine kinase, 
is a frequently silenced gene in keratinocytes and was used here as a positive 
control for H3K27me3 enrichment. 
 
In summary, the results indicate that the progressive loss of K14 expression in 
NEB-1 is accompanied by a concomitant increase in DNA methylation and 
H3K27me3 in the K14 regulatory region. Moreover, K14 expression can be 






Figure 3.8 Silencing is localized to the K14 gene 
Western blot analysis of the keratin cluster located on human chromosome 17q. NEB-
1M (passage number between 15 to 40) was an intermediate passage of NEB-1 






Figure 3.9 Workflow of mapping the methylated CpGs 
Genomic DNA from cells was isolated for sodium bisulfite conversion. In this process, methylated cytosines would remain but unmethylated cytosines 
would be converted to uracil. The bisulfite converted DNA was then PCRed, cloned and sequenced. Bases corresponding to a cytosine (blue arrows on the 







Figure 3.10 Fine mapping of methylated CpGs (MetCpG) in the K14 enhancer 
There are 7 CpGs in the enhancer region of K14. Each circle represents one clone picked from the colony PCR. As K14 is progressively silenced, there was 






Figure 3.11 Enrichment of H3K27me3 in K14 promoter and enhancer of NEB-1H 
Primers were designed to amplify regions (blue arrows) in the K14 enhancer, promoter, intron/exon boundary, and the first intron. Enrichment of H3K27me3 
was seen in the enhancer and promoter of NEB-1H but not in HPK. BMX (a non-receptor tyrosine kinase) is a frequently silenced gene and served as a 





3.4 Epidermal growth factor accelerates K14 silencing 
In an attempt to explain the trigger of epigenetic silencing of K14 in NEB-1, 
we compared this cell line to another frequently used keratinocyte model in 
the lab. Unlike NEB-1, HaCaT is a spontaneously immortalised keratinocyte 
cell line that does not show progressive K14 silencing with increasing 
passages. Besides the difference in the immortalisation process, another 
difference between the two cell lines is the culture media composition. 
Epidermal growth factor (EGF, 10 ng/ml final concentration) is routinely used 
in the culture media of NEB-1, but not in HaCaT.  
 
In the first experimental passage (passage N), NEB-1H was cultured either in 
the presence or absence of EGF. Removal of EGF alone was not sufficient to 
induce K14 expression. However, treatment with 5-aza-dC in the absence of 
EGF resulted in slightly increased K14 levels compared to the same treatment 
in the presence of EGF (Figure 3.12). The increase in K14 expression in the 
absence of EGF in the 5-aza-dC treated samples compared to those in the 
presence of EGF was seen at both the mRNA and protein levels (Figures 3.12 
and 3.13a). Treated and untreated cells in passage N were sub-cultured again 
either in the absence or presence of EGF, giving rise to 8 possible 
combinations of culture  (Figure 3.12, passage N+1). No 5-aza-dC was added 
in any of the samples in passage N+1, so any K14 expression in this passage 
was due to the induction by the drug in the previous passage. As expected, 
only cells that were previously treated with 5-aza-dC in passage N expressed 
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K14 in passage N+1. However, K14 expression was retained at a higher level 
in the absence of EGF in passage N+1.  
 
Sodium bisulfite sequencing of the enhancer region of all passage N samples 
showed reduced methylated CpGs in 5-aza-dC treated cells (Figure 3.13b). 
Moreover, the reduction in methylated CpGs was even higher in treated 
samples without EGF. Without 5-aza-dC treatment, the removal of EGF alone 
was not enough to remove the methylation mark in the CpGs. However once 
the K14 gene has been “turned on” by DNA demethylation, subsequent 
exposure to EGF accelerated the re-methylation process. This suggests that 
EGF has an impact on the retention of DNA methylation.  
 
EGF is a potential trigger of epithelial mesenchymal transition (EMT) (Hardy 
et al., 2010), and keratin loss is one of the characteristics of this process 
(Thiery & Sleeman, 2006). K14 loss in NEB-1 may have been the result of 
EMT. However, NEB-1H still retained expression of all the epithelial proteins 
found in NEB-1L (Figure 3.14). Also, a comparison with a EMT-like 
keratinocyte cell line in our lab (N838) showed that NEB-1H was not 






Figure 3.12 EGF accelerates K14 re-silencing 
NEB-1H was treated with 5’-aza-dC in the absence or presence of epidermal growth 
factor (EGF). After 4 days 5’-aza-dC was removed and cells from each condition 
were passaged again either in absence or presence of EGF. No 5’-aza-dC was given 






Figure 3.13 EGF affects K14 expression by increasing K14 enhancer methylation 
a) K14 mRNA levels and b) percentage methylation of the seven CpGs located in the 






Figure 3.14 NEB-1H retains expression of epithelial markers 
Western blot analysis of common epithelial and mesenchymal markers. N838 is 







NEB-1 is an HPV16 E6^E7 immortalised cell line routinely used as a 
keratinocyte cell model in the lab (Morley et al., 2003). Keratin (K) 14, 
together with K5 are the predominant keratins expressed in the basal layer in 
the epidermis and form the defining mark of a basal cell (reviewed in Porter & 
Lane, 2003). Progressive loss of K14 in culture undermines the identity of 
NEB-1 as a basal keratinocyte.  
 
K14 is the major polymerisation partner of K5 (reviewed in Fuchs, 1995; 
Porter & Lane, 2003). Despite the loss of K14 in NEB-1, 
immunocytochemistry staining showed robust K5 filaments, suggesting that 
K5 could be partnering an alternative type I keratin.  Immunoprecipitation of 
K5 identified K17, K18 and K19 as potential partners. Keratin 17 is a stress-
associated keratin and is expressed in a wound situation in adult skin. Keratins 
18 and 19 are simple epithelial keratins expressed in fetal skin but not 
normally expressed in adult skin (Tan et al., 2014). Keratinocytes in culture 
therefore, present a unique situation where combinations of keratins not 
normally co-expressed in vivo are allowed to interact with each other. HaCaT, 
another frequently used keratinocyte cell model, retains K14 expression even 
in high passages and was used as a positive control in the K5 pulldown. 
HaCaT expresses K14, K17, K18 and K19. Immunoprecipitation with an 
antibody against K5 was able to pull down both K18 and K19, indicating an 
interaction of K5 with these two type I keratins. Interestingly, K5 was also 
shown to interact with K18 and K19 in the presence of K14 in HaCaT. This 
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suggests that dimerization between type I and type II keratins is dynamic and 
not exclusive to a specific pairing.  
 
The ability of keratins to pair with multiple partners highlights a certain 
redundancy in keratin filament formation (reviewed in Coulombe & Omary, 
2002). Indeed this is the case for K18 and K19 expression. In vivo, K19 
expression in simple epithelia frequently overlaps that of K18. Although K18-
null and K19-null mice each show no obvious phenotype (Magin et al., 1998; 
Tamai et al., 2000), the double K18- K19- null mutation resulted in embryonic 
lethality at day 9.5 (Hesse et al., 2000). However, not all keratins show such 
functional redundancy. Although we showed that K5 is capable of partnering a 
few different type I keratins in vitro, this does not imply that the resulting 
filaments can perform the same biological functions as the original K14-K5 
pair. It was reported that K18 supplementation in K14-null mice was unable to 
fully rescue the blistering phenotype (Hutton et al., 1998). Although they 
found that K18 was capable of forming filaments with K5 in vivo, the authors 
attributed the partial rescue to the inability of K18-K5 filaments to withstand 
mechanical stress.  
 
Extended in vitro culture of cells may introduce mutational aberrations that 
result in changes in protein expression. In this case, rather than a genetic cause, 
we found that K14 loss was due to epigenetic silencing of the K14 gene. Not 
only was no mutation detected by sequencing of the K14 regulatory and gene 
regions, K14 can be re-induced by air-liquid organotypic culture. Moreover, 
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silencing of K14 is specific to that gene, as the DNA methyltransferase 
inhibitor 5-aza-2’-deoxycytidine had no effect on other keratins located in the 
same chromosomal locus. The augmented K14 expression in the presence of 
5-aza-dC and trichostatin A (TSA) co-treatment suggests that there is a 
synergistic repression driven by both DNA methylation and histone 
acetylation. However TSA treatment alone could not induce K14. This pattern 
of synergism between 5-aza-dC and TSA was also seen in the induction of 
hMLH1 (human MutL Homolog 1), a DNA mismatch repair protein 
frequently silenced in cisplatin-resistant ovarian cancer (Meng et al., 2008). 
Similar to our case, TSA treatment alone did not induce hMLH1 expression, 
but co-treatment with 5-aza-dC and TSA resulted in higher levels of hMLH1 
compared to treatment with 5-aza-dC alone. It is possible that DNA 
methylation is the primary mechanism for silencing K14 and hMLH1. Also, 
the presence of DNA methylation in both genes may render the region 
refractory to histone acetylases.  
 
Fine mapping of CpGs in the K14 enhancer region revealed an inverse 
correlation between K14 expression and CpG methylation. DNA methylation 
and histone modification can act synergistically to alter the local chromatin 
structure. It has been reported that binding of the Polycomb group protein 
EZH2 (Enhancer of Zeste Homolg 2) to a gene locus directly recruits DNA 
methyltransferases (Viré et al., 2006). Tri-methylated histone H3 lysine 27 
(H3K27me3) is a mark of facultative heterochromatin written by the EZH2 
subunit of the PRC2 complex (reviewed in Di Croce & Helin, 2013). 
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Chromatin immunoprecipitation with an antibody against H3K27me3 showed 
a correlation of this mark with CpG methylation in the K14 enhancer and 
promoter regions. Moreover H3K27me3 was enriched in the K14 regulatory 
region of K14-negative NEB-1 but not in K14-expressing primary 
keratinocytes. 
 
A possible reason for the increased repressive marks observed in NEB-1 could 
be due to immortalisation by HPV16 E6^E7. p16 is a commonly used 
surrogate marker for HPV infection in oropharyngeal carcinoma (OC) and 
correlates well with high risk strains such as HPV16 (Mooren et al., 2014). A 
study of tumour specimens from 44 patients with advanced OC showed that 
global elevation of H3K27me3 levels correlated well with p16 positivity. 
However, another group working on HPV16E6^E7 immortalised 
keratinocytes reported that although EZH2 mRNA and protein levels 
increased in vitro, there was an unexpected reduction in the H3K27me3 mark. 
They speculated that this could be due to a concomitant increase in the histone 
demethylase KDM6A which is capable of removing this mark (Hyland et al., 
2011). This group cultured the cells in EpiLife (EGF added but concentration 
not reported) and were not specifically looking at keratin expression. 
 
The epidermal growth factor receptor (EGFR) is expressed in the basal layer 
of the epidermis and plays a role in regulating epidermal homeostasis 
(reviewed in Repertinger et al., 2004; Pastore et al., 2008). Use of EGFR 
inhibitors in anti-cancer therapies frequently results in dermatological side 
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effects such as dry and itchy skin, inflammation around the nails, 
papulopustular rashes on the face and trunk, and hair loss, thus highlighting 
the importance of maintaining EGFR signalling in skin (reviewed in Lacouture, 
2006). Epidermal growth factor (EGF) binds exclusively to EGFR (reviewed 
in Wong, 2003) and is a usual media component in keratinocyte culture. This 
practice started from the observation that EGF enhances growth and inhibits 
differentiation of primary keratinocytes in culture (Rheinwald & Green, 1977; 
Peus et al., 1997). Similar to the Rheinwald and Green formulation, the 
published culture media recipe for NEB-1 also contains EGF (10 ng/ml) 
(Morley et al., 2003) and this protocol was adopted in our lab.  
 
Treatment with the DNA methylase inhibitor 5-aza-2’-deoxycytidine (5-aza-
dC) in the presence or absence of EGF revealed a hitherto unknown role of 
EGF in accelerating DNA re-methylation. At the protein level, 5-aza-dC 
treatment showed a modest increase in K14 in the absence of EGF compared 
to the presence of the ligand. Although we cannot rule out increased protein 
degradation in the presence of EGF, 5-aza-dC treated samples showed higher 
K14 mRNA levels in the absence of EGF, and this correlated well with a 
decrease in CpG methylation in the enhancer region, suggesting that there was 
increased transcriptional activity in the K14 gene. Moreover, when cells were 
passaged again in the absence of the drug (thus allowing the dilution of 
incorporated 5-aza-dC), the difference in K14 protein levels in the presence 
and absence of EGF became more apparent. Long-term culture in EGF was 
also reported to downregulate K14 levels in a murine basal mammary 
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epithelial cell line (Deugnier et al., 1999). The cells were derived from a 
spontaneously immortalised cell line also cultured in 10 ng/ml EGF 
(Danielson et al., 1984). 
 
Loss of keratin expression is a frequent mark of epithelial mesenchymal 
transition (EMT) (reviewed in Thiery & Sleeman, 2006), and K14 loss in 
NEB-1 may signal a change to a mesenchymal phenotype. EMT is 
characterised by a number of changes including 1) changes in cell 
morphology: specifically, a change from a cobblestone to a spindle-shaped 
appearance, 2) a switch in protein expression: loss of keratin expression and 
gain of specific EMT markers such as vimentin, fibronectin, slug and snail 
transcription factors, and 3) loss of adhesion and increase in cell motility 
(Thiery & Sleeman, 2006). It was reported that features of EMT were 
observed in another HPV 16 immortalised cell line named HF1 (Geiger et al., 
2008). Unlike NEB-1 which was immortalised with HPV16 E6^E7 (Morley et 
al., 2003), HF1 was immortalised by transfecting whole HPV16 genome into 
human foreskin keratinocytes (Ben-bassat et al., 1997). Increasing passages of 
HF1 resulted in reduced expression of desmosomal and adheren junction 
genes, ultimately leading to anchorage independent growth. Interestingly, the 
loss of expression of adhesion genes did not result in increased motility in late 
passage HF1. The authors attributed this to poor actin organisation and 
defective lamellipodia formation due to a decrease in Rac1 activity in late 
passage HF1. Microarray comparison of primary keratinocytes with early 
passage (~60 population doublings post HPV transfection) and late passage 
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(~1000 population doublings post HPV transfection) HF1 did not show any 
reduction in basal keratins 14 and 5. Moreover, EGF is a potential trigger of 
EMT (reviewed in Hardy et al., 2010), and although this group cultured HF1 
in the same level of EGF as described here (10 ng/ml), they did not consider 
the contribution of EGF to the EMT-like change in HF1. Although we cannot 
definitively rule out EMT in our case, it is unlikely that the loss of K14 in 
NEB-1 is a result of EMT as K14-negative NEB-1 maintained a cuboidal 
morphology in culture and retained robust expression of many epithelial 
markers. Moreover, a critical molecular feature of EMT is the loss of E-
cadherin expression (reviewed in Larue & Bellacosa, 2005). NEB-1 retained 
E-cadherin even at high passage, and no mesenchymal markers such as 
vimentin and fibronectin were detected in this line. 
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3.6 Conclusion, significance and future work 
Although K14 expression is a definitive feature of basal keratinocytes, loss of 
this protein does not seem to affect differentiation both in vitro and in vivo. 
K14-silenced NEB-1 cells were still capable of expressing early differentiation 
keratins in organotypic cultures. Epidermolysis bullosa simplex (EBS) is a 
skin fragility disorder characterised by a split that occurs within the basal cell 
layer upon mild trauma. In the majority of patients, this is caused by a 
dominant negative mutation in either K14 or K5. However, a subset of EBS 
patients carry homozygous K14 null mutations, and are effectively K14 
“knockouts”. These patients suffer a milder form of EBS and histological 
sections from these patients show a normal differentiated epidermis (Rugg et 
al., 1994; Batta et al., 2000). This suggests that K14-null basal keratinocytes 
can proliferate and differentiate normally in vivo, and the main impact of K14 
loss is a reduction of mechanical strength in the tissue.  
 
In the epidermis, K14 is expressed in the basal layer and expression is 
suppressed as keratinocytes move up to the suprabasal layers. We show here 
that one mechanism of silencing the K14 gene involves epigenetic 
modification of the K14 regulatory region. It would be interesting to see if this 
process also happens in vivo. In order to answer this, we have isolated 
populations of integrin α6-positive basal and integrin α6-negative suprabasal 
primary keratinocytes by FAC sorting (Figure 3.15). We plan to map the 
methylation status of the CpG sites in the K14 regulatory regions of these cells. 
The idea of epidermal differentiation being driven by epigenetic changes was 
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recently explored (Back et al., 2012). The authors used trypsin on peeled 
human epidermis to perform an “epidermal fragmentation”. Fractions of 
keratinocytes were collected at different time points which corresponded to the 
basal, spinous, granular and cornified layers. The basal and cornified fractions 
were then used for DNA methylation microarray. However most of the top 
hypermethylated and hypomethylated genes picked up from this study have 
not previously been associated with epidermal differentiation. Perhaps the 
crude keratinocyte extracts were not pure enough to provide sufficient 
resolution for methylation analysis. Sample collection by laser capture 
microdissection or FAC sorting with appropriate markers could have been a 
better option.  
 
K5 and K14 are frequently expressed together and the transcription factor 
ΔNp63 has been shown to bind to the enhancer region of both K14 and K5 to 
activate transcription (Romano et al., 2009). It is puzzling why only K14 but 
not K5 is silenced in NEB-1. Romano highlighted that expression of ΔNp63 in 
cell culture consistently results in higher K14 expression compared to K5. 
Perhaps the specific mechanism of transcriptional activation of both genes 
may be different. Although it is agreed that p63 is essential for epidermal 
commitment and differentiation (Senoo et al., 2007; Barton et al., 2010), there 
are six different isoforms of p63 and reports of RT-PCR and RNA in situ 
hybridization of the isoforms present in the epidermis have been contradictory 
(Koster et al., 2004; Laurikkala et al., 2006). It is not improbable that K5 and 
K14 could be regulated by different isoforms of ΔNp63. Another question we 
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would like to address is whether the progressive CpG methylation of the K14 
enhancer in NEB-1 has any effect on p63 binding in that region. 
 
EGFR and K14 expression co-exist in the basal layer of the epidermis. 
However, basal keratinocytes in vivo exhibit robust expression of K14. The 
EGFR signalling network is complex and at least 3 receptors (EGFR, HER2 
and HER3) of the EGFR family are expressed in skin (De Potter et al., 2001). 
It would be challenging to recreate in vitro the complex in vivo interplay 
between various growth factors such as TGF and KGF in keratinocytes. 
Although the level of EGF used in our culture system is commonly used for 
keratinocyte culture, this concentration may not be an accurate reflection of 
normal physiological levels. Moreover, EGF was first added to keratinocyte 
culture to maintain the proliferative lifespan of primary keratinocytes. 
Immortalised cell lines may not require such a high level of EGF for 
proliferation.  
 
We showed in this chapter that routinely used immortalised keratinocyte cell 
models could sometimes deviate from their original basal phenotype. This 
could be due to factors such as culture components or the immortalization 
process. One factor we did not look into yet is the possible role of HPV 
immortalization in silencing K14 expression. NEB-1 was immortalised with 
high grade HPV16 E6^E7. Infection with high-grade HPV has been linked to 
K14 loss in a series of cervical squamous intraepithelial lesions (Southern et 
al., 2001). How K14 loss contributes to HPV pathogenesis remains to be 
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elucidated. Perhaps the change in cytoskeleton architecture could alter the 






Figure 3.15 Summary of future plan to track CpG methylation status in primary 
keratinocytes 
Primary keratinocytes are dissociated from human epidermis, fixed and stained with 
K14 antibody. Genomic DNA from FAC sorted K14-positve  and K14-negative cells 
are  extracted and CpG methylation status in both populations are analyzed by 
bisulfite sequencing. An alternative method to obtain genomic DNA from K14-
positive (basal) and K14-negative (suprabasal) cells would be to collect the different 










ANALYSIS OF EFFECTS OF OXYGEN 






Most keratinocyte culture optimization efforts to date have focussed on 
improving the media components to ensure maximum growth. Another culture 
factor we can optimize is the level of oxygen. Keratinocytes in skin experience 
lower oxygen levels than that of the atmosphere. Since the in vivo oxygen 
level is lower than that routinely used in current culture protocols, we 
hypothesise that lowering the culture oxygen to a more physiological level 
may improve keratinocyte growth. The aim of this chapter therefore is to study 
the effect of culture oxygen on the growth of keratinocytes. 
 
Cell Sources 
The initial work described in the first section of this chapter was carried out on 
keratinocytes from the skin bank (pilot study). However, a concern was that 
these cells had been expanded at least once in atmospheric oxygen and this 
step might have selected for cells that grew well in this condition. Thus in the 
next set of experiments described in the second section, keratinocytes were 
isolated in atmospheric oxygen but cultured directly in low oxygen. One of the 
challenges in this part of the project was generating sufficient primary 
keratinocytes at atmospheric oxygen in serum-free conditions for downstream 
studies. A cell line was therefore sought that grew more readily and could be 
used as an alternative to primary keratinocytes to examine the effect of oxygen 
on downstream processes such as differentiation and adhesion. The final part 
of this chapter presents recent data using the immortalised cell-line N/TERT-1. 
All cell manipulations were carried out in an oxygen-regulated environment in 
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a hypoxia workstation (Figure 4.1). All primary keratinocytes used in this 
thesis are of Singaporean Asian origin (i.e., predominantly Chinese, and 
sometimes Malay and Indian). 
 
Results 
HIF -1α expression in skin 
HIF-1α (hypoxia inducible factor 1 alpha) is a transcription factor that is 
quickly degraded in the presence of oxygen. When HIF-1α expression was 
analysed in situ in human skin by immunohistochemistry, nuclear expression 
of HIF-1α was found predominantly in the basal layer (Figure 4.2). The basal 
layer is the proliferative compartment in the epidermis and these are the cells 
that are propagated in culture. The presence of HIF-1α in the basal layer of 
skin suggests that basal keratinocytes experience a low oxygen level in vivo. 
 
4.2 Effect of oxygen levels on early passage keratinocytes (pilot 
study) 
Initial experiments were performed with primary keratinocytes deposited in 
IMB Skin Bank. Keratinocytes from patient-consented skin from local 
hospitals were isolated and expanded on irradiated 3T3-J2 mouse feeders to 
generate cell stocks (Figure 4.3). The Skin Bank provides cells as frozen vials 
at passage 1 or 2 after extraction from tissue. These cells are labelled here as 
SB1-HPK (Skin Bank 1 - Human Primary Keratinocyte), in which “1” (or 2, 3, 
4 etc) refers to a cell stock from one individual. 
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Figure 4.1 Hypoxia workstation (Coy Laboratories) 






Figure 4.2 Hif1α is expressed in the basal layer of the epidermis 






Figure 4.3 Summary of the different starting cell sources used for the 
experiments
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To determine if the level of oxygen during culture had an effect on cell yield, 
we used the colony forming assay (CFA), a technique developed in Howard 
Green’s lab to assess the growth potential of keratinocytes in culture 
(Barrandon & Green, 1987). Keratinocytes were seeded at low density on a 
feeder layer of lethally irradiated Swiss 3T3-J2 mouse fibroblasts in cFAD 
(complemented F12 adenine DMEM) media. At the end of 12 days, formalin-
fixed, rhodamine-stained colonies were scored based on size and morphology 
(Figure 4.4). In order to ensure consistent scoring across plates of 
keratinocytes from different skin samples, a cut-off value of 1.4 mm was 
implemented. Colonies below the diameter of 1.4 mm would be scored as 
abortive. This value was decided upon after consultation with the laboratory of 
Yann Barrandon (Nicolas Grasset, personal communication). 
 
Primary keratinocytes obtained from the skin bank were expanded in 
keratinocyte serum-free media (KSFM). After 4 days, cells were trypsinzed, 
counted and seeded for CFA at the indicated oxygen levels. After 10 days, 
more colonies were obtained from the dishes that were incubated at 21% 
oxygen (atmospheric oxygen) than those that were kept in low oxygen (Figure 
4.5).  
 
In order to see if the increased growth at higher oxygen could be maintained 
over time, keratinocytes were serially passaged on feeders over 7 weeks at 
various oxygen levels (Figure 4.6). At each passage, when the flasks were 
70% confluent, cells were re-plated onto new flasks containing feeders. 
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Throughout the experiment duration, cells grown at 21% oxygen consistently 






Figure 4.4 Types of colonies 
Colonies were scored based on morphology after 12 days. Growing colonies were 
either large with smooth perimeters, or medium-sized with wrinkled edges. Abortive 




Figure 4.5 Keratinocytes from skin bank vials proliferate faster at 21% oxygen 
Keratinocytes (SB1-HPKp2) were seeded in 5 cm dishes at the indicated cell densities 
and percentage oxygen levels for 10 days. Colonies were then fixed in neutral 




Figure 4.6 Serially passaged keratinocytes maintain higher population doublings 
in atmospheric oxygen 
Keratinocytes (SB2-HPKp1) were serially passaged on irradiated 3T3-J2 feeders.  
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Higher culture oxygen levels could drive increased mitochondrial oxidative 
phosphorylation, resulting in higher levels of reactive oxygen species (ROS) 
by-products. It is therefore possible that keratinocytes incubated in 
atmospheric oxygen were also exposed to higher levels of ROS. CellROX® 
(Invitrogen) is an intracellular dye that is converted to a fluorescent product 
upon oxidation by ROS. Keratinocytes grown in KSFM were treated for 30 
minutes with CellROX® followed by FAC sorting. This experiment was 
carried out in serum-free conditions in order to exclude the use of feeders, as 
the irradiated feeders may contribute to an artificially high level of ROS. As a 
positive control, parallel cultures were treated with exogenous hydrogen 
peroxide. 
 
Upon analysis, an increased CellROX® positive population was seen at 21% 
oxygen compared to cells kept in low oxygen (Figure 4.7a). The proportion of 
CellROX® positive cells was further increased when hydrogen peroxide was 
added. Treatment with the antioxidant N-acetyl-cysteine (NAC) had no effect 
on ROS levels (Figure 4.7b), possibly because the NAC treatment time length 
or concentration was not enough to dampen ROS levels. Thus it seems that 
although primary keratinocytes at 21% oxygen showed increased growth, they 
also had increased levels of ROS. 
 
In order to study the effect of increased ROS on the expression of stress 
proteins, serum-free medium (KSFM) was used again, as many antibodies 
show cross-reactivity between proteins from human (keratinocytes) and mouse 
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(feeders) origin. The increased ROS level in cells at 21% oxygen was 
accompanied by an increase in DNA damage as assessed by γH2AX levels 
(Figure 4.8). Moreover, the stress-associated markers p53 and retinoblastoma 
protein (Rb) were also induced (Figure 4.8). The difference was particularly 
striking in the early passages (p2 and p3). By passage 4, cells at 21% oxygen 
showed a slight increase in p16 levels compared to their low oxygen 
counterparts, suggesting an earlier onset of senescence at high oxygen.  
 
Thus it appears that low oxygen is less stressful for keratinocytes in culture, 
yet the CFA showed more colonies in high oxygen. One possible reason is that 
the experiments showing increased oxidative stress at 21% oxygen was carried 
out in serum-free conditions while the CFA experiments were conducted in 
the presence of serum and feeders. Thus, it may be difficult to extend the 







Figure 4.7 Primary keratinocytes at 21% oxygen experience higher levels of 
reactive oxygen species (ROS) 
Keratinocytes (SB1-HPK) were grown in KSFM and pulsed for 30 minutes with 
CellROX® (Invitrogen). Hydrogen peroxide was used as a positive control for ROS.  
a) Representative FACS data. Numbers in red refer to percentage of CellROX® 
positive cells. b) Quantification of CellROX® positive cells. All conditions were 




Figure 4.8 Increased DNA damage and stress markers in primary keratinocytes at high oxygen 
Western blot analysis of keratinocytes serially passaged at the indicated oxygen levels in KSFM and harvested after 48 hours. UV-irradiated HaCaT was 
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The conclusion that more colonies were obtained at 21% oxygen (Figure 4.5) 
was drawn from cultures assessed at passage 3, after growing in different 
oxygen levels at passages 2 and 3. In order to dissect the contribution of these 
two steps (i.e., the effect of maintenance in low oxygen (p2) from the CFA 
performance in low oxygen (p3)), cells were first maintained in low oxygen 
and the CFA plates from all conditions were carried out at 21% oxygen 
(Figure 4.9). This change in experimental design resulted in a different growth 
behaviour of the cells. Keratinocytes that were initially expanded at 5% 
oxygen gave the best growth potential. This was the first indication that low 
oxygen may improve keratinocyte yield. 
 
In summary, primary keratinocyte cultures from the skin bank show: 
1) reduced growth at low oxygen, both in terms of colony forming assays 
(CFAs) and cumulative population doublings over 6 passages, and  
2) reduced reactive oxygen species (ROS) levels and reduced stress 
markers at low oxygen. 
However, 
3) when keratinocytes were kept in low oxygen, followed by a CFA in 
atmospheric oxygen, cells that were previously maintained at 5% 





Figure 4.9 Pre-incubation at low oxygen improves subsequent growth at 21% 
oxygen 
Keratinocytes were kept in varying levels of oxygen for 2 weeks before plating onto 




4.3 Effect of oxygen levels on newly isolated keratinocytes 
Growth of keratinocytes seeded directly in low oxygen after isolation 
The previous experiments were done on keratinocytes expanded from the skin 
bank, and a concern was that this first expansion could be selecting for cells 
that grew well in atmospheric oxygen. In this set of experiments therefore, 
keratinocytes were isolated in atmospheric oxygen and cultured directly in 
different oxygen levels. These cells were labelled Skin1-HPK (referring to 
cells that were cultured directly from skin). Keratinocytes from four site-
matched, middle-aged Asian individuals were isolated and seeded directly in 
parallel on CFA plates. Keeping all experimental conditions constant (e.g., 
using the same batch of feeders and media), it was clear that keratinocytes 
from different individuals already carry an inherent difference in growth 
ability. For instance, keratinocytes from Skin4-HPK showed an average 
colony forming efficiency (CFE) of 3.5% in atmospheric oxygen whereas 
those from Skin1-HPK and Skin2-HPK showed only 1% CFE under the same 
conditions (Figure 4.10a and b). Within each skin sample, the CFE was 
generally found to be greater in low oxygen, although there was one sample 
(Skin2-HPK) that did not show any difference across all oxygen levels (Figure 
4.10b). 
 
Besides counting the total number of colonies, colonies were also scored based 
on size as previously mentioned (Figure 4.4) into either growing or abortive 
colonies. At the endpoint of the assay on day 12, larger colonies were seen in 
keratinocytes at 5% oxygen compared to the other conditions. This was 
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consistent across all four skin samples tested. The morphological difference in 
colonies between keratinocytes kept in low and atmospheric oxygen are shown 




Figure 4.10a Colonies are larger in low oxygen 
Keratinocytes were isolated from four different skin samples and directly cultured at the indicated densities and percentage oxygen levels on feeders in 10 cm 








Figure 4.10b Percentage colony forming efficiency (CFE) from the four skin samples (continued from previous page) 
Higher percentage CFE (except for Skin2-HPK) was generally obtained in low oxygen. Percentage CFE was calculated from the following equation: 







Figure 4.10c Percentage growing colonies from the four skin samples (continued from previous page) 
Low oxygen favours large colony formation. The percentage growing colonies was calculated from the following equation: Percentage growing colonies = 









Figure 4.11 Phase contrast images of colonies 
Pictures of keratinocyte colonies in culture on day 9 of the colony forming assay. 
Primary keratinocytes form tight colonies when cultured on feeders in cFAD medium.  
 106 
Growth kinetics of serially passaged keratinocytes 
 
Because the initial expansion at low oxygen gave larger, and generally more, 
colonies, the question arose whether low oxygen conferred a growth 
advantage over time, and whether primary keratinocytes could be maintained 
in a proliferative state for longer in low oxygen. Primary keratinocytes were 
serially passaged in DermaLife at different oxygen levels. A serum-free 
medium was chosen for the serial passage because this system does not require 
keratinocytes to be grown on feeders. This improves the accuracy of the cell 
count for seeding for the next passage and for population doubling calculation. 
At each passage, cells were counted and a portion of the cell suspension was 
used to seed on colony forming plates (Figure 4.12a). This process was 
repeated until the cells failed to divide further. The seeding density for cells at 
passage 1 was higher than for the later passages because the cell suspension 
from skin isolates contain largely suprabasal cells that are post-mitotic. 
Similar to the previous pattern observed in the CFA plates at passage 1, 
keratinocytes grown in DermaLife also showed improved cell yield in low 
oxygen. Same cell numbers were seeded in low oxygen and atmospheric 
oxygen at passage 1, and by day 7, cells at 2% oxygen were ready to be 
passaged but those at 21% were not (Figure 4.12b). From the CFA plates, it 
was also evident by passage 4 that keratinocytes kept constantly at 2% oxygen 
could not be maintained (Figure 4.12c). There was a drastic reduction in the 
proliferative capacity of cells continuously maintained at 2% oxygen 
compared to those kept at the other oxygen levels. Moreover, although cells in 
atmospheric oxygen started slowly compared to those in low oxygen (Figure 
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4.12c, column p1), their growth accelerated by the second passage, and from 






Figure 4.12 Serial passaging of primary keratinocytes from skin 
a) Experimental plan of serial passage. Isolated keratinocytes in suspension were 
counted and seeded in triplicate maintenance flasks (T25) of DermaLife. At the same 
time, a portion of the cell suspension was serially diluted and plated onto feeders in 
cFAD to assess the colony forming efficiency (CFE). CFE plates (10 cm dishes) were 
done in duplicates. When flasks were confluent, cells from each triplicate flask were 
trypsinized, counted and pooled together before seeding into new flasks in triplicates. 
A portion from the cell suspension was again diluted and seeded onto feeders for CFE. 
This diagram shows the setup for one oxygen condition. Identical setups were done 
for 2%, 5% and 21% oxygen. b) Cell culture pictures of representative images of 
keratinocytes (Skin5-HPK) in DermaLife before trypsinization. 
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Figure 4.12 (continued from previous page) Serial passaging of primary keratinocytes from skin 






Since cells at 2% oxygen gave better early growth that was not sustainable, 
while those at 21% oxygen started slow but growth picked up later, we 
wondered whether growth could be sustained by an initial expansion at 2% 
oxygen followed by a switch to 21% oxygen. In the oxygen switching 
experiment (Figure 4.13), keratinocytes were expanded in the first passage at 
different oxygen levels. When the flasks at low oxygen were 70-80% 
confluent, cells were dissociated, counted and seeded in duplicate sets: one set 
was maintained at the original oxygen level and the other placed in 21% 
oxygen. Keratinocytes that were transferred from 2% to 21% oxygen after the 
first passage (Figure 4.14, Row B) fared better than those constantly 
maintained at 2% (Figure 4.14, Row A). Based on the percentage of growing 
colonies at p4, there was virtually no difference in proliferative capacity 
between the transferred cells and those maintained at 21% oxygen. The 
transfer to atmospheric oxygen after the initial p1 expansion rescued the 
growth potential of the keratinocytes. However, a similar switch for cells at 
5% oxygen did not show a growth improvement after transfering from 5% to 
21% oxygen after the first passage (Figure 4.15). There was no difference in 
growth capacity when cells were grown continuously at 5% (Row A) or 
switched from 5% to 21% oxygen after the first passage (Row B) compared to 
those kept constantly at 21% oxygen (Row C). The above experiment was 




Figure 4.13 Experimental design to study the effect of oxygen switching 
Isolated keratinocytes from skin were again serially passaged in either low oxygen (blue box) or atmospheric oxygen (green box). When flasks from the first 
passage (p1) in low oxygen were confluent, duplicates conditions were seeded for passage 2 (p2): one set was maintained in the original 2% or 5% oxygen, 
while the second set was transferred to 21% oxygen. Once cells were transferred, they were serially passaged in 21% oxygen until the end of the experiment. 









Figure 4.14 Switching from 2% to 21% oxygen at passage 2 preserves growth potential of keratinocytes 
a) CFE plates of serially passaged primary keratinocytes (Skin5-HPK), including the transfer from 2% to 21% oxygen (Row B) after passage 1 (p1). b) The 









Figure 4.15 Cells cultured at 5% oxygen from p0 sustain good growth potential without switching to 21% oxygen 
a) CFE plates of serially passaged primary keratinocytes (Skin5-HPK), including the transfer from 5% to 21% oxygen (Row B) after passage 1 (p1). b) No 







In order to test the reproducibility of the results, the experiment shown in 
Figure 4.13 was repeated using keratinocytes from another individual (Skin2-
HPK). This time, keratinocytes in all oxygen conditions were passaged until 
senescence (Figure 4.16a). The colonies were generally smaller in the repeat 
experiment, however the pattern observed was similar to the first one. Firstly, 
although the total colony number from CFA at 21% oxygen was lower than 
those in low oxygen at first, it picked up by passages 3 and 4 (Figure 4.16b, 
green bars). At passages 3 and 4, the total colony number of cells at 21% 
oxygen even exceeded those in low oxygen. Secondly, keratinocytes 
maintained continuously at 2% oxygen were again senescing before the other 
oxygen levels (Figure 4.16b, blue bars). Also, regardless of the oxygen level, 
the total colony numbers in all conditions peaked at passages 3 and 4 before 
slowly declining.  
 
The trend in the percentage of colonies that were actively growing (Figure 
4.16c) was slightly different from the total number of colonies: cells in all 
conditions showed the highest proportion of growing colonies at the beginning 
of the experiment and this proportion steadily decreased with increasing 
passage number. This means that over time in culture, keratinocytes form 
smaller colonies. The drop in percentage growing colonies was also faster at 
2% oxygen compared to the other conditions; there were hardly any growing 
colonies at passage 6 in 2% oxygen. (Figure 4.16c, blue bars).  
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Figure 4.16 Serial passage of keratinocytes isolated from a second skin sample (Skin6-HPK)  
Skin6-HPK shows a similar growth pattern to the first skin sample (Skin5-HPK). Keratinocytes maintained at 2% oxygen lose growth potential before those 
kept at 5% and 21% oxygen. a) CFE plates of Skin6-HPK after 12 days. Graphical representation of b) the total colony numbers and c) percentage growing 
colonies of keratinocytes kept in different oxygen levels. Scoring of the colonies was done for passage 2 onwards because the colonies in passage 1 were too 




















When the oxygen conditions were switched, and keratinocytes that were 
initially expanded at 2% oxygen were transferred to 21% oxygen at the second 
passage (Figure 4.17a, Row B), the transferred cells fared better than those 
maintained continuously at 2% oxygen (Figure 4.17a, Row A). This was 
similar to observations made on the first biopsy (Skin1-HPK). The total 
colony numbers and percentage growing colonies of transferred cells (Figure 
4.17b and c, dark blue bars) were always higher than that of those remaining at 
2% oxygen (Figure 4.17b and c, light blue bars). In the case of cells expanded 
at 5% oxygen in the first passage and subsequently maintained at 21% oxygen, 
there was minimal increase both in the total colony number and the proportion 




Figure 4.17 Serial passage and oxygen switching (2% to 21%) of keratinocytes isolated from a second skin sample (Skin6-HPK).  
Switching from 2% to 21% oxygen after p1 rescues the growth potential of keratinocytes. a) CFE plates of Skin6-HK after 12 days.  Graphical representation 



























Figure 4.18 Serial passage  and oxygen switching (5% to 21%) of keratinocytes isolated from a second skin sample (Skin6-HPK) 
Cells cultured at 5% oxygen from p0 sustain good growth potential without switching to 21% oxygen. a) CFE plates after 12 days.  Graphical representation 























Figure 4.19 shows the cumulative population doubling of keratinocytes over 
time. The population doubling could only be calculated from passage 2 
onwards as the cells seeded from the first passage contained mainly suprabasal 
cells, which would have contributed to the apparent seed count but would not 
have actually divided.  All flasks in this experiment were passaged when they 
reached 70% confluence. From the graph, cells at 21% oxygen (green line) 
took the longest time to reach confluence at passage 2 (21 days) compared to 
those at 2% (light blue line) and 5% (pink line). Cells kept continuously at 2% 
in DermaLife stopped proliferating after 42 days, while those at 21%, although 
having started more slowly, could be passaged for 65 days. Switching cells 
from 2% to 21% oxygen after the first passage rescued the proliferation (dark 
blue line). A similar rescue was not observed in cells that were switched from 
5% to 21% after the first passage (red line). Keratinocytes kept continuously at 
5% (pink line) reached a modestly higher cumulative population doubling 
compared to any of the other conditions. Also, the slope of the 5% (pink) and 
21% (green) curves at log phase are very similar. This suggests that once the 
culture is established, keratinocytes at both conditions proliferate at a similar 
rate. However, because the cells expanded faster in passages 1 and 2 at 5% 
oxygen, these cells had a “headstart” in their cumulative population doubling 
number, and this difference is maintained throughout the rest of the culture. 
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Figure 4.19 Cumulative population doubling of keratinocytes (Skin6-HPK) 
Keratinocytes kept constantly at 5% oxygen showed the highest population doubling over time. The values were calculated from the serial passage and cell 
counts of the triplicate maintenance flasks in DermaLife. The population doubling (PD) was calculated by the formula, PD = [log(Final cell count) – 






Taken together, the following conclusions can be made: 
1) Colony forming assays at passage 1: primary keratinocytes isolated 
from skin and cultured directly into 5% oxygen gave the highest 
proportion of proliferating clones (growing colonies). This was 
observed in all skin samples tested. 
 
2) Serial passage of keratinocytes in serum-free media (DermaLife): 
a. Continuous culture of keratinocytes at 2% oxygen cannot be 
sustained. Although at passage 1 cells at 2% sometimes show a 
higher number of growing colonies and total colonies, the 
growth potential quickly declines in comparison to cells kept at 
5% and 21% oxygen. 
b. The failure of keratinocytes to be propagated at 2% oxygen can 
be rescued if the cells are transferred from 2% to 21% oxygen 
after the first expansion at 2% oxygen. 
c. A similar transfer of cells grown at 5% oxygen to 21% after the 
first passage has no effect on the growth potential of the 
transferred cells compared to those maintained at 5% oxygen. 
Cells kept continuously in 5% oxygen grew as well as those 
transferred to 21% oxygen. 
d. The primary keratinocytes are kept continuously at 5% oxygen 
showed the highest cumulative population doubling.   
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4.4 N/TERT-1 as a surrogate cell model for oxygen studies 
The challenge of conducting downstream analyses on primary keratinocytes in 
low oxygen was firstly, the difficulty in getting enough cell numbers from the 
flasks grown at 21% oxygen in serum free conditions. Secondly, these 
experiments required primary keratinocytes isolated directly from skin with no 
prior expansion at atmospheric oxygen. This meant that primary keratinocyte 
sources were limited as the expanded cell stocks from the skin bank could not 
be used.  
 
In order to overcome this problem, a cell line was sought that could be used as 
a surrogate for downstream studies to unravel the mechanisms of improved 
growth in low oxygen.  The N/TERT-1 cell-line is derived from primary 
keratinocytes immortalised with human telomerase and lacks functional p16 
(Dickson et al., 2000). This allows the cell line to bypass senescence but still 
retain the growth and differentiation characteristics of primary keratinocytes. 
Another advantage is the ability of these cells to grow continuously in a 
feeder-free system. This simplifies RNA and protein analyses, as there is no 
interference from murine cells. The disadvantage of N/TERT-1 is that it 
cannot be used to study some aspects of primary keratinocyte culture, like 
senescence for instance. The aim therefore, was to use N/TERT-1 as a cell 
model for preliminary studies on the effects on oxygen on processes such as 




Firstly, the effect of oxygen on N/TERT-1 proliferation was analysed. 
N/TERT-1 is a cell line routinely passaged in atmospheric (21%) oxygen. This 
would be similar to the primary keratinocytes that were initially expanded in 
atmospheric oxygen by the skin bank in the pilot study. Routine culture of 
N/TERT-1 in atmospheric oxygen will therefore have selected for cells that 
grow well in this condition rather than at low oxygen. N/TERT-1 cells were 
seeded at low density on feeder layers to mimic the colony-forming assays 
usually performed on primary cultures. Because N/TERT-1 is a robustly 
growing cell line, lower seeding densities could be used than those required 
for primary keratinocytes. Gratifyingly, a similar behaviour of N/TERT-1 to 
that of the primaries isolated and cultured directly in low oxygen was 
observed: N/TERT-1 at 5% oxygen formed the largest colonies (Figure 4.20a), 
followed by cells at 2% and then those at 21% oxygen. It was also found that 
although N/TERT-1 is an established cell line, there is much heterogeneity in 
the colony morphologies. This was more obvious in the colony plates at low 
oxygen. Scoring of the colonies revealed that there was no difference in the 
total colony number for all conditions (Figure 4.20b). When growing colonies 
were scored based on the same criteria as that for primary keratinocytes (i.e., 
having a diameter ≥ 1.4 mm), again there was no obvious difference between 
the conditions. However, simply by visual inspection, it was clear that 
colonies at 5% oxygen were generally larger than at other conditions. When 
the scoring criterion was made more stringent (growing colonies: diameter ≥ 4 
mm), the difference between the conditions became apparent. On average, 
30% of colonies formed at 5% oxygen had a diameter greater or equal to 4 
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mm, while at 2% oxygen only 8% of colonies could reach this size. There 
were hardly any colonies at 21% oxygen that reached 4 mm in diameter. 
 
According to the Rheinwald group (the lab that generated and characterized 
the N/TERT-1 cell-line) (Dickson et al., 2000), these cells should be 
maintained routinely in KSFM. Thus their potential for higher cell yield in low 
oxygen was investigated in serum-free medium. Cells were seeded in 
triplicates at a density of 1.6 x 105/T25 flask in KSFM and incubated in 
different oxygen conditions for 4 days. On day 4, cells were trypsinized and 
counted (Figure 4.21). Although there was no significant difference between 
the cell numbers at 2% and 5% oxygen, cell yield from low oxygen culture 
was up to three times higher than that in atmospheric oxygen.  
 
In conclusion, it was found that although N/TERT-1 is an immortalised line 
that is cultured routinely at atmospheric oxygen, the cell yield and colony 
forming pattern at low oxygen was even greater. The low oxygen growth 
enhancement was thus similar to that observed in primary keratinocytes that 
have been directly isolated and cultured in low oxygen. This made the 





Figure 4.20 N/TERT-1 forms larger colonies in low oxygen 
Cells were seeded in 10 cm dishes on mitomycin C-treated feeders at the indicated densities and oxygen levels for 12 days. cFAD media was 















Figure 4.21 Increased N/TERT-1 cell yield in low oxygen 
Cells were seeded in KSFM and incubated for four days at the indicated oxygen levels. The graph shows the average cell number from triplicate flasks. The 








Data on keratinocyte culture in low oxygen have been contradictory. Some 
groups claim that keratinocytes grow better at levels closer to atmospheric 
oxygen (Horikoshi et al., 1986; Ouyang et al., 2002) while others assert that 
low oxygen favours proliferation and expansion of keratinocytes in culture 
(Miyashita et al., 2007; Nakajima & Takeda, 2014). Besides inconsistent 
oxygen levels chosen by the different groups for the experiments, the work 
presented here shows that another potential factor for the seemingly 
contrasting reports is the starting cell material used for the experiments.  
 
HIF-1α expression was detected in the basal layer of human epidermis. 
Although Distler et al reported suprabasal staining of HIF-1α (Distler et al., 
2004), the results presented here are consistent with Bedogni et al, who also 
reported basal expression of HIF-1α (Bedogni et al., 2005). Since HIF-1α is 
rapidly degraded in the presence of oxygen (Schofield & Ratcliffe, 2005), the 
detection of HIF-1α in the epidermis implies that the in vivo oxygen level is 
low enough to allow stabilization of this transcription factor. The basal layer is 
the proliferative compartment in the epidermis and when primary 
keratinocytes isolated from skin is cultured, only the basal cells are propagated. 
Since the proliferative compartment of the epidermis corresponds to a low 
oxygen level, the hypothesis proposed here is that culturing keratinocytes in 
low oxygen would maintain their proliferative capacity since this may mimic a 
more physiological condition.  
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Keratinocytes from the skin bank (pilot study) showed increased cell yield 
when grown in atmospheric oxygen. The increase in yield was also sustained, 
at least over 6 passages, with cells at 21% oxygen showing the highest 
cumulative population doubling. This is consistent with two early reports 
comparing the effect of low and atmospheric oxygen on primary keratinocyte 
culture (Pentland & Marcelo, 1983; Horikoshi et al., 1986). Pentland and 
Marcelo found that culturing mouse epidermal keratinocytes at oxygen 
tensions of 5% to 15% (which they termed the physiologic oxygen range) 
resulted in decreased proliferation compared to 21% oxygen as assessed by 
[3H] thymidine incorporation in the DNA. In the other study, neonatal foreskin 
keratinocytes were cultured over a range of oxygen levels from 1% - 89% for 
up to 14 days (Horikoshi et al., 1986). Based on final cell numbers, they 
concluded that keratinocytes grew best at 18% oxygen, and anything above or 
below this level resulted in a reduction in proliferation.  
 
Furthermore, higher reactive oxygen species (ROS) levels were detected in 
keratinocytes at 21% oxygen in the pilot study. This was accompanied by 
increased γH2AX, p53 and retinoblastoma levels, suggesting that cells at 21% 
oxygen could be subjected to stress. It seemed that keratinocytes at 21% 
oxygen were proliferating faster despite increased levels of ROS. One possible 
reason is that the increased ROS and stress markers were detected in 
keratinocytes that were grown in a serum-free and feeder-free system while 
the colony forming assays and cumulative population doubling experiments 
were carried out with keratinocytes seeded on feeders. The presence of feeders 
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improves the growth ability of keratinocytes (Smola et al., 1993; Maas-
Szabowski et al., 1999) and may have reduced the culture stress. Another 
reason for the increased proliferation at 21% oxygen was that the cells used in 
the pilot study were from the skin bank. Keratinocytes from the bank would 
have been expanded in atmospheric oxygen before being distributed to users. 
This initial expansion could have selected for cells that grew well in 
atmospheric oxygen. 
 
In order to address these concerns, we switched to using keratinocytes that 
were isolated in atmospheric conditions, but cultured directly in low oxygen 
thereafter. The change in cell source resulted in an opposite effect on 
proliferation to that initially observed in keratinocytes from the pilot study. 
Keratinocytes cultured directly in low oxygen after isolation showed improved 
growth both in the feeder and feeder-free system. This result was in line with a 
more recent report that challenged human primary keratinocytes to conditions 
of anoxia (Kino-oka et al., 2005). They found a 2.1 fold increase in 
cumulative population doubling of anoxic cells compared to those at 21% 
oxygen. A similar conclusion was reached by another group using mouse 
epidermal keratinocytes (Ouyang et al., 2002). Both the growth rate and 
cumulative population doubling increased in cells kept at lower oxygen 
tensions. A number of groups working on improving keratinocyte culture for 
corneal graft production have also reported that both rabbit and human corneal 
limbal epithelial cells show increased Ki67 staining and larger colonies in the 
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colony forming assay at lower oxygen (Miyashita et al., 2007; O’Callaghan et 
al., 2011; Li et al., 2011; Nakajima & Takeda, 2014).  
 
In order to investigate whether the improved growth at low oxygen in the first 
passage could be maintained, keratinocyte cultures were passaged 
continuously at different oxygen levels until they reached senescence. 
Although keratinocytes directly cultured at 2% oxygen showed improved 
growth initially, they could not be maintained. On the other hand, although 
cells at atmospheric oxygen were slower in the first passage, these cells could 
remain in culture for longer, resulting in a higher cumulative population 
doubling by the time they reached senescence compared to those kept 
continuously at 2% oxygen. Interestingly, when cultures were switched from 
2% to 21% oxygen after the first passage, this resulted in sustained growth of 
the transferred cells in the later passages. A possible reason for this is that 
continuous culture only selects for fast growing cells. A suspension of 
keratinocytes from the skin isolate would contain a mixture of mitotic cells 
with high and low activity. The stress of continuous culture at 2% oxygen 
could be inhibiting cell proliferation. The presence of transiently mitotically 
active cells in the skin isolate could have contributed to an increased cell yield 
in the early passages at 2% oxygen. These cells could be analogous to 
transient amplifying cells, for example; because transient amplifying cells are 
proposed to have a limited number of mitotic divisions, the culture would be 
unsustainable in later passages. Transferring cells from 2% to 21% oxygen 
after the first passage could have triggered the slow growing cells (possibly 
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stem or progenitor cells) into mitosis. This would explain why the transferred 
cells exhibited a higher cumulative population doubling. Cultures maintained 
at 5% oxygen could represent a balance that was sufficient to maintain a 
continuous population of cycling cells. Thus the transfer of cells from 5% to 
21% oxygen after the first passage had no effect on the growth potential of 
subsequent passages. 
 
Once it was established that keratinocytes showed improved growth in low 
oxygen at least in the early passages, the possible mechanisms driving this 
behaviour were sought. The limited amount of cells obtainable from 
keratinocytes grown in 21% oxygen in serum-free conditions posed a problem 
for downstream analyses. N/TERT-1 is a cell-line derived from primary 
epithelial keratinocytes transfected with the catalytic domain of human 
telomerase and displays normal features of growth and differentiation 
(Dickson et al., 2000). It was decided to see if this cell-line could be a suitable 
candidate for further studies. 
 
N/TERT-1 is routinely passaged in atmospheric oxygen. This would have 
been analogous to the primary keratinocytes that were initially expanded in 
atmospheric oxygen by the skin bank. Surprisingly, N/TERT-1 showed 
improved cell yield at low oxygen in both the feeder and feeder-free system. 
These results mimicked the behaviour of primary keratinocytes that were 
directly cultured in low oxygen after isolation. Although a number of studies 
have looked at the effect of oxygen on proliferation of immortalised cell-lines, 
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these have been largely in the context of tumour growth in hypoxia. There is 
however one report using a spontaneously immortalised NIKS (normal 
immortal keratinocytes) keratinocyte cell-line showing normal growth and 
differentiation characteristics (Straseski et al., 2009).  They reported a 
reduction in proliferation of the NIKS cell-line at low oxygen. They based this 
conclusion from organotypic cultures, which were allowed to stratify for 12 
days in atmospheric oxygen before being transferred for up to 2 days in 0% 
oxygen. Reduced Ki67 staining (a proliferation marker) was seen in 
histological sections of cultures that had undergone the anoxic treatment. A 
possible reason for the reduced proliferation reported here is that extreme 
hypoxia (anoxia) was used to treat the cultures and this may not be 
physiological. Also, proliferation was not measured per se in actively growing 
monolayer cultures. Instead a surrogate marker of proliferation was used in 
cultures that were undergoing terminal differentiation.  
 
The improved cell yield at low oxygen observed in an immortalised cell-line 
such as N/TERT-1 mirrored the growth improvement seen in primary 
keratinocytes in low oxygen. This suggests that factors other than delayed 
replicative senescence could be contributing to increased growth in the 
primary keratinocytes.  
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4.6 Conclusion and significance 
In conclusion, this chapter presents the effect of oxygen on the growth 
potential of keratinocytes. To date, there is little or no agreement on the effect 
of varying oxygen concentrations on keratinocyte culture (see Chapter 1 
section 1.3.3). The work described in this thesis showed that variation in the 
keratinocyte source, i.e., whether the cells were initially expanded at 
atmospheric oxygen, or whether the cells were isolated and cultured directly in 
low oxygen, would result in contrasting conclusions about the effect of oxygen 
on primary keratinocyte culture. This is a possible explanation for the 
contradictory reports on keratinocyte culture in low oxygen in the current 
literature. Although it is not always mentioned in their material and methods, 
it is likely that the reports of decreased keratinocyte growth in low oxygen 
were using cells that were previously expanded at atmospheric oxygen. 
Groups that reported better keratinocyte growth in low oxygen were generally 
working on human or rabbit corneal keratinocytes, which are slightly different 
from epidermal keratinocytes. These groups isolated keratinocytes from the 
cornea and cultured the cells directly in low oxygen. (Miyashita et al., 2007; 
O’Callaghan et al., 2011; Li et al., 2011; Nakajima & Takeda, 2014). 
 
Results presented here show that although N/TERT-1 is a cell line that is 
routinely maintained in atmospheric oxygen, the growth pattern in low oxygen 
was similar to primary keratinocytes that were isolated and cultured directly in 
low oxygen. The increased cell yield at low oxygen was observed in both the 
serum-containing feeder system and the serum- and feeder-free system. Since 
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N/TERT-1 is an immortalised cell line, this implies that there may be other 
non-senescence related factors, such as suppression of differentiation or 
reduced oxidative stress in culture, that are contributing to the improved 

















BIOLOGICAL EFFECTS OF OXYGEN 





In chapter 4, it was observed that low oxygen culture of primary keratinocytes 
and N/TERT-1 resulted in an increase in cell yield. This is potentially useful 
for research and clinical applications where large amounts of primary 
keratinocytes have to be expanded in a short period of time, for instance, in the 
construction of cultured epithelial autografts for skin grafting. In order to 
elucidate the potential mechanisms that contributed to this observation, we 
took two approaches. In the first approach, we listed candidate biological 
processes that could contribute to increased cell yield at low oxygen and 
validated these by functional assays, quantitative PCR and protein analysis. 
These experiments were mainly carried out using the N/TERT-1 cell line as it 
provided an abundant cell source. In the second approach, we used global 
transcriptome profiling on human primary keratinocytes isolated and cultured 
directly in 5% and 21% oxygen.  
 
Results 
5.2 HIF-1α expression in N/TERT-1 
Since HIF-1α was found to be expressed in the basal layer in human epidermis 
(Figure 4.2), we wanted to find out if we could mimic HIF-1α stabilization in 
vitro. Cobalt chloride-stimulated hypoxia at atmospheric condition was used 
as a positive control. Western blot analysis showed that HIF-1α protein could 
be stabilized by as little as four hours at 2% or 5% oxygen compared to 21% 




Figure 5.1 Hypoxia-inducible factor 1 alpha expression in N/TERT-1 
Hypoxia-inducible factor 1 alpha expression (HIF-1α) expression in N/TERT-1 at 
low oxygen. HIF-1α is stabilized at 2% and 5% oxygen in N/TERT-1. Cobalt chloride 
(CoCl2) is a hypoxia mimic and was used as a positive control. 
 
 
5.3 Candidate biological processes contributing to improved growth 
In the epidermis, commitment to differentiation is accompanied by an exit 
from the cell cycle. It was reported that oxygen triggers differentiation in 
keratinocytes (Kairuz et al., 2007, Ngo et al., 2007). Thus, one possibility why 
keratinocytes at 21% oxygen consistently showed a lower cell yield was that 
there was increased differentiation in these cells. Another possibility is that 
21% oxygen may result in a higher level of ROS and an increase in oxidative 
stress. A third possibility is that cells in low oxygen may be adhering better. If 
so, this would result in a higher actual seeding density at low oxygen 
compared to atmospheric oxygen. We decided to systematically investigate the 
effect of oxygen on all three processes, namely, differentiation, oxidative 




5.3.1 The Notch pathway is essential for oxygen-dependent 
differentiation in keratinocytes 
At the protein level, differentiation associated markers can only be detected in 
post confluent keratinocytes. Thus, in order to detect oxygen-induced 
differences in proteins involved in differentiation, N/TERT-1 cells were 
differentiated in vitro: N/TERT-1 was seeded in KSFM and incubated in 
different oxygen levels up to 80% confluence, before withdrawing bovine 
pituitary extract (BPE) and EGF from the culture supplements. The cultures 
were then allowed to grow to confluence and RNA and protein were harvested 
6 days post confluence. The detailed description and schematic diagram 
(Figure 2.1) of the protocol can be found in chapter 2. The combination of 
BPE starvation and confluence triggers N/TERT-1 to undergo differentiation. 
Both K1 and K10 were detected in differentiated N/TERT-1 at 5% and 21% 
oxygen (Figure 5.2). N/TERT-1 maintained at 2% oxygen however, did not 
express either K1 or K10, implying that low oxygen suppresses keratinocyte 
differentiation.  
 
The Notch signalling pathway has been implicated in keratinocyte 
differentiation. Canonical Notch signalling involves cleavage of the 
transmembrane receptor by γ-secretase and subsequent translocation of the 
intracellular domain to the nucleus to activate transcription of downstream 
Notch target genes. Addition of a γ-secretase inhibitor, DAPT (N-[N-(3,5-
difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester) prevented 
expression of K1 and K10, indicating that the oxygen-induced differentiation 
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of N/TERT-1 occurs via Notch activation (Figure 5.2). Induction of the early 
differentiation keratins K1 and K10 was accompanied by a reduction of 
KRT14 and KRT5 transcripts at higher oxygen (Figure 5.3). This reduction 
was only observed at the mRNA level but not at the protein level. Addition of 
DAPT had no effect on either keratins 14 or 5, suggesting that the regulation 
of these keratins occurs independently of Notch.   
 
Moreover, a reported downstream target of Notch signalling, NRARP (Notch 
regulated ankyrin repeat protein) was induced in an oxygen-dependent manner 
in differentiated N/TERT-1. This induction was abolished in the presence of 







Figure 5.2 Notch is required for differentiation at 21% oxygen 
a) Real-time PCR quantification of K10 mRNA (normalized to B2M (beta-2-
microglobulin)) of 6-day post-confluent (differentiated) N/TERT-1. Graphs show an 
average fold change of triplicate PCRs. b) Western blot analysis of keratin 1 in a 









Figure 5.3 Basal layer-associated keratins decrease with increasing oxygen in N/TERT-1 
a) Real-time PCR quantification of K14 and K5 mRNA (normalized to RPLP0 (Large ribosomal protein P0)) from differentiated N/TERT-1. Graphs show 
an average fold change of triplicate PCRs. b) Western blot analysis of keratin 14 in a duplicate set of differentiated N/TERT-1. DAPT is a γ-secretase 









Figure 5.4 Low oxygen downregulates Notch signalling in differentiated 
N/TERT-1 
NRARP (a target gene of activated Notch) expression was reduced in low oxygen. 
NRARP mRNA levels were normalized to the housekeeping gene B2M. Data shows 




5.3.2 Increased oxidative stress associated with atmospheric-level 
oxygen 
One potential factor contributing to increased cell yield at low oxygen is a 
reduction in oxidative stress. FACS analysis of N/TERT-1 pulsed for 30 
minutes with CellROX® showed a shift towards a higher fluorescence with 
increasing oxygen concentration (Figure 5.5b). The median shift in fluorescent 
intensity was significant even between cells at 2% and 5% oxygen (Figure 
5.5a). This suggests that N/TERT-1 kept at 21% oxygen experience greater 
oxidative stress compared to those kept in lower oxygen.  The CellROX® 
treatment with N/TERT-1 shown in Figure 5.5 is similar to the earlier findings 
in primary keratinocytes (Figure 4.7). In spite of the increase in ROS levels, 
no difference in levels of superoxide dismutase (SOD) 1 and 2 were detected 
in human primary keratinocytes (Figure 5.6). Although HIF1α was earlier 
shown to be stabilized in 5% oxygen, Western blot analysis of one of the 




Figure 5.5 N/TERT-1 at 21% oxygen experience higher levels of reactive oxygen 
species (ROS) 
a) Quantification of CellROX® (Invitrogen) positive cells. Cells were grown in 
KSFM for 5 days at the indicated oxygen percentages and pulsed for 30 minutes with 
CellROX®. All conditions were carried out in duplicates. b) Representative FACS 
data. Mean and median values were calculated by the FlowJo software. Negative 





Figure 5.6 Expression of SOD and LDHA in human primary keratinocytes 
Western blot analysis of Skin1-HPK harvested at passage 1 in different oxygen 
conditions. No change in expression was observed for superoxide dismutases (SOD) 
1 and 2, and lactate dehydrogenase (LDHA). 
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5.3.3 Cell adhesion is decreased in low oxygen 
One possible reason for the increased cell yield at low oxygen is that cells 
could be more efficient in adhering to the culture vessel, thereby contributing 
to a higher actual seed count than cells at 21% oxygen. However, when 
N/TERT-1 was plated onto 96-well plates at different oxygen levels and 
allowed to adhere over time, it was found that cells at 21% oxygen adhered 
faster than cells kept in low oxygen (Figure 5.7). At 30 minutes, 
approximately 10% of cells had adhered in all conditions. But by one hour 
post seeding, almost twice as many cells had adhered at 21% oxygen 
compared to their counterparts in low oxygen. This was true for both seeding 
densities tested. Moreover, Western blot analysis of the commonly expressed 
adhesion molecules in keratinocytes showed that N/TERT-1 at low oxygen, 
particularly at 2% oxygen, had a lower expression of β1, β4 integrins and P-






Figure 5.7 Adhesion is decreased in low oxygen in N/TERT-1 
N/TERT-1 cells adhere faster in 21% oxygen. Cells were seeded in 96-well plates and 
incubated for different lengths of time at the indicated oxygen levels. Wells were then 
washed, fixed with neutral buffered formalin and stained with DAPI. Graph shows 







Figure 5.8 Adhesion is decreased in low oxygen in N/TERT-1 and human 
primary keratinocytes 
Western blot analysis of common adhesion proteins in pre-confluent N/TERT-1 and 
human primary keratinocytes (passage 1). 
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5.3.4 Conclusion from oxygen studies in N/TERT-1 
The preliminary results presented above confirm the earlier reports that 
oxygen triggers differentiation. Moreover, oxygen induces differentiation via 
the Notch pathway. The work described here also show that low oxygen 
downregulates Notch signalling. Increased oxygen levels correlated with 
increased reactive oxygen species (ROS) in N/TERT-1, although no change 
was detected in the antioxidant enzymes, superoxide dismutases (SOD) 1 and 
2. This suggests that both differentiation and oxidative stress may negatively 
regulate keratinocyte proliferation at 21% oxygen. Adhesion, on the other 
hand did not seem to be a possible reason for the improved growth in low 
oxygen since keratinocytes at 21% oxygen adhered faster compared to those at 
low oxygen. 
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5.4 Transcriptome profiling of human primary keratinocytes 
In the second approach, RNA sequencing was used in order to obtain a global 
snapshot of gene expression and potentially different processes that are 
contributing to improved keratinocyte growth in low oxygen. Primary 
keratinocytes from two individuals (Skin2-HPK and Skin4-HPK) were 
cultured in DermaLife at 5% and 21% oxygen directly after isolation. Five 
percent oxygen was chosen instead of 2% because colonies at 5% oxygen 
were consistently larger than at 2% (Figure 4.10c). The keratinocytes from 
both individuals were also site-matched (samples were from abdominal skin) 
to minimize expression differences arising from different anatomical sites.  
 
Cells were harvested when the flasks were about 70% confluent (Figure 5.9), 
given that post-confluence in culture triggers keratinocytes to exit the cell 
cycle in favour of terminal differentiation. Since the aim of this experiment 
was to identify the mechanisms leading to improved cell yield in low oxygen, 
it was important that RNA was derived from actively growing keratinocytes. 
Total RNA was extracted using the miRNeasy kit (Qiagen) which captures all 
species of RNA including small (<200 bp) RNAs. The sequencing results were 
recently received at the time of writing of this thesis and all the data discussed 







Figure 5.9 Cell pictures of human primary keratinocytes at the time of RNA 
isolation 





5.4.1 Identification of oxygen-dependent gene expression profiles  
EdgeR analysis identified 473 differentially expressed genes (DEGs) from the 
biological replicates at 5% and 21% oxygen. The heatmap of all 473 genes 
from each RNA sample is depicted in Figure 5.10. From the figure, it seems 
that the DEGs in the two biological replicates tend to cluster together in the 
same oxygen condition. 
 
Tables 5.1 and 5.2 show the top 20 upregulated and downregulated genes 
respectively in 21% oxygen. The full list of 473 DEGs can be found in the 
Appendix. ELF5 (E74-like factor 5) encodes for an epithelium-specific Ets 
transcription factor involved in terminal differentiation of keratinocytes and 
showed the highest difference in gene expression (Table 5.1). Additionally, 
another differentiation related gene which is found in this list is 
transglutaminase 3 (TGM3), which catalyses the cross-linking of proteins in 
the upper epidermis to form the cornified envelope. Genes involved in sebum 
production (AWAT1, acyl-CoA wax alcohol acyltransferase 1) and lipid 
metabolism (CYP2C18, cytochrome P450, family 2, subfamily C, polypeptide 
18) were also found here. Interestingly, this list also includes markers of 
oxidative stress such as MIR663A (microRNA 663a) and OSGIN1 (oxidative 
stress induced growth inhibitor 1) which were upregulated 53-fold and 5-fold 
respectively in 21% oxygen. 
 
Carbonic anhydrase (CA9), a common hypoxia marker, was listed in the top 
20 most downregulated genes at 21% oxygen (Table 5.2). This served as a 
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good validation that the keratinocytes were indeed experiencing the effects of 
lower oxygen. Some genes in this list also suggest a loss of stemness at 21% 
oxygen. For instance, the FZD2 (frizzled class receptor 2), which is involved 
in beta-catenin signalling, and KRT7 (keratin 7), a simple epithelia keratin 




Figure 5.10 Heatmap of all 473 differentially expressed genes between 
keratinocytes at 5% and 21% oxygen.
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Table 5.1 List of the 20 most upregulated genes in keratinocytes at 21% oxygen.  
 
No. Gene Symbol Gene Name Gene Id logFC Fold change p-value
1 ELF5 E74-like factor 5 (ets domain transcription factor) 2001 6.94 122 7.45E-07
2 SNORD116-8 Small Nucleolar RNA, C/D Box 116-8 (snoRNA) 100033420 6.07 67 0.000229848
3 LINC00885 Long Intergenic Non-Protein Coding RNA 885 (lncRNA) 401109 5.94 61 0.000362454
4 HRH4 Histamine H4 Receptor 59340 5.89 59 0.000482645
5 LEMD1 LEM Domain-Containing Protein 1 93273 5.82 57 0.000576428
6 MIR663A miR-663 724033 5.72 53 0.000962107
7 DYNAP Dynactin Associated Protein 284254 4.28 19 2.48E-06
8 TMPRSS11A Transmembrane Protease, Serine 11A 339967 3.99 16 3.77E-05
9 APOBEC3A Apolipoprotein B MRNA Editing Enzyme, Catalytic Polypept-Like 3A 200315 3.90 15 2.49E-07
10 AWAT1 Acyl-CoA wax alcohol acyltransferase 1 158833 3.82 14 0.000120551
11 TGM3 Transglutaminase 3 7053 3.76 14 2.82E-65
12 CYP2C18 Cytochrome P450, Family 2, Subfamily C, Polypeptide 18 1562 2.46 6 3.30E-12
13 OSGIN1 Oxidative Stress Induced Growth Inhibitor 29948 2.39 5 0.000458904
14 ARG1 Arginase 1 383 2.39 5 2.13E-13
15 CHRNA9 Cholinergic Receptor, Nicotinic, Alpha 9 (Neuronal 55584 2.22 5 0.000375033
16 OASL 2'-5'-Oligoadenylate Synthetase-Like 8638 2.21 5 1.36E-21
17 CALB2 Calbindin 2, 794 2.17 4 6.94E-18
18 SERPINA12 Serpin Peptidase Inhibitor, Clade AMember 12 145264 2.06 4 4.26E-13
19 PTGER3 Prostaglandin E Receptor 3 5733 2.01 4 0.000142607






Table 5.2 List of the 20 most downregulated genes in keratinocytes at 21% oxygen 
 
No. Gene Symbol Gene Name Gene Id logFC Fold change p-value
1 FAM133CP Family with sequence similarity 133, member C, pseudogene 728640 -6.95 0.008 8.26E-07
2 THY1 Thy-1 cell surface antigen 7070 -6.52 0.011 5.26E-05
3 LOC100507156 Uncharacterized LOC100507156 100507156 -6.32 0.012 0.000215135
4 CELF4 CUGBP, Elav-like family member 4 56853 -5.84 0.017 0.000716932
5 BZRAP1 Benzodiazepine receptor (peripheral) associated protein 1 9256 -3.83 0.071 4.48E-05
6 LOC148696 Uncharacterized LOC148696 148696 -3.66 0.079 0.000210214
7 CA9 Carbonic anhydrase IX 768 -3.25 0.105 4.23E-45
8 LINC01347 Long intergenic non-protein coding RNA 1347 731275 -3.08 0.118 0.000979476
9 HCAR1 Hydroxycarboxylic acid receptor 1 27198 -3.07 0.119 0.000285676
10 ANGPTL7 Angiopoietin-like 7 10218 -2.93 0.131 0.000643321
11 STC1 Stanniocalcin 1 6781 -2.77 0.147 0.000315288
12 ISYNA1 Inositol-3-phosphate synthase 1 51477 -2.75 0.148 0.00077216
13 SARM1 Sterile alpha and TIR motif containing 1 23098 -2.65 0.159 0.000807429
14 NGFR Nerve growth factor receptor 4804 -2.30 0.203 0.000736352
15 SERPING1 Serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 710 -2.20 0.217 2.91E-08
16 MXRA5 Matrix-remodelling associated 5 25878 -2.19 0.220 3.43E-22
17 FZD2 Frizzled class receptor 2 2535 -2.11 0.232 0.000567984
18 PXDN Peroxidasin homolog (Drosophila) 7837 -2.06 0.241 2.11E-09
19 KRT7 Keratin 7 3855 -2.05 0.242 3.58E-10






5.4.2 Effect of oxygen on keratin expression 
Since keratin 7 expression was shown to be regulated by oxygen (it was one of 
the main downregulated genes at 21% oxygen, Table 5.2), we did a search of 
all differentially expressed keratins within the 473 DEGs. Table 5.3 
summarizes the results. Basal keratinocytes express abundant levels of K14 
and K5. However both keratins were not listed in the 473 DEGs. Keratin 
genes that were upregulated in 21% oxygen generally fell into two categories. 
First was the stress-associated keratins: KRT6A, 6B, 6C, 16 and 17. Second 
was the differentiation-associated keratins KRT1, 10 and 2. Keratins 
associated with simple epithelia (KRT8, 9, 18 and 19) had mixed expression 
changes, with some higher and some lower at 21% oxygen. 
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Table 5.3 List of all significant differentially expressed keratins  









5.4.3 Functional clustering of differentially expressed genes 
All 473 DEGs were analysed by Gene Ontology (GO) to group them based on 
biological functions. This resulted in a list of 242 GO terms (Appendix I). 
However, because many of the genes in different GO terms overlapped (i.e., a 
gene classified under one GO term could still be found in another GO term), a 
higher order clustering was carried out to group similar GO terms and to 
remove gene redundancy. The list of the first 12 over-represented functional 
gene groups from this clustering can be found in Table 5.4. The clusters are 
ranked based on the highest number of genes involved in that process, and the 
full list of 43 clusters can be found in the Appendix. Within this list, 
differentiation (cluster 1) was the main biological network with 197 
differentially expressed genes out 473 (Table 5.4). This corresponded to 41% 
of all DEGs. Cellular response to oxidative stress (cluster 11) was also found, 
with 7 GO terms representing 33 differentially expressed genes.  
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Table 5.4 Clustering of related GO terms ranked in descending order of number of genes involved.  
 
Cluster ID No. of GO Terms No. of Genes List of Genes GO ID GO Terms No. of Genes
GO:0032501 multicellular organismal process 180
GO:0032502 developmental process 162
GO:0048856 anatomical structure development 144
GO:0007275 multicellular organismal development 143
GO:0048731 system development 130
GO:0048869 cellular developmental process 108
GO:0030154 cell differentiation 106
GO:0048513 organ development 100
GO:0009888 tissue development 86
GO:0008544 epidermis development 50
GO:0060429 epithelium development 48
GO:0030855 epithelial cell differentiation 44
GO:0009913 epidermal cell differentiation 33
GO:0030216 keratinocyte differentiation 32
GO:0031424 keratinization 20
GO:0042221 response to chemical stimulus 99
GO:0010033 response to organic substance 77
GO:0070887 cellular response to chemical stimulus 68
GO:0009605 response to external stimulus 60
GO:0009719 response to endogenous stimulus 46
GO:0071310 cellular response to organic substance 46
GO:0009725 response to hormone stimulus 39
GO:0009991 response to extracellular stimulus 30
GO:0031667 response to nutrient levels 26
GO:0048545 response to steroid hormone stimulus 24
GO:0007584 response to nutrient 21
GO:0033273 response to vitamin 17
GO:0043627 response to estrogen stimulus 15
GO:0031960 response to corticosteroid stimulus 14
GO:0051384 response to glucocorticoid stimulus 13
GO:0007565 female pregnancy 12
GO:0032355 response to estradiol stimulus 11




































Cluster ID No. of GO Terms No. of Genes List of Genes GO ID GO Terms No. of Genes
GO:0005576 extracellular region 106
GO:0044421 extracellular region part 56
GO:0005615 extracellular space 44
GO:0002376 immune system process 63
GO:0006955 immune response 47
GO:0009611 response to wounding 45
GO:0006952 defense response 44
GO:0051704 multi-organism process 44
GO:0009607 response to biotic stimulus 29
GO:0051707 response to other organism 28
GO:0009617 response to bacterium 21
GO:0002237 response to molecule of bacterial origin 16
GO:0032496 response to lipopolysaccharide 16
GO:0009605 response to external stimulus 60
GO:0009719 response to endogenous stimulus 46
GO:0006629 lipid metabolic process 61
GO:0044255 cellular lipid metabolic process 44
GO:0008610 lipid biosynthetic process 32











































Cluster ID No. of GO Terms No. of Genes List of Genes GO ID GO Terms No. of Genes
GO:0016491 oxidoreductase activity 38
GO:0006082 organic acid metabolic process 37
GO:0019752 carboxylic acid metabolic process 37
GO:0042180 cellular ketone metabolic process 37
GO:0043436 oxoacid metabolic process 37
GO:0032787 monocarboxylic acid metabolic process 25
GO:0060429 epithelium development 48
GO:0030855 epithelial cell differentiation 44
GO:0030216 keratinocyte differentiation 32
GO:0006508 proteolysis 39
GO:0004175 endopeptidase activity 21
GO:0017171 serine hydrolase activity 14
GO:0008236 serine-type peptidase activity 14
GO:0004252 serine-type endopeptidase activity 13
GO:0072358 cardiovascular system development 35
GO:0072359 circulatory system development 35
GO:0001944 vasculature development 31
GO:0001568 blood vessel development 30
GO:0048514 blood vessel morphogenesis 29
GO:0001525 angiogenesis 24
GO:0010035 response to inorganic substance 28
GO:0010038 response to metal ion 21
GO:0006979 response to oxidative stress 20
GO:0000302 response to reactive oxygen species 13
GO:0042542 response to hydrogen peroxide 11
GO:0034614 cellular response to reactive oxygen species 7
GO:0070301 cellular response to hydrogen peroxide 6



































Cluster ID No. of GO Terms No. of Genes List of Genes GO ID GO Terms No. of Genes
GO:0004857 enzyme inhibitor activity 22
GO:0030414 peptidase inhibitor activity 19
GO:0061135 endopeptidase regulator activity 19
GO:0061134 peptidase regulator activity 19
GO:0004866 endopeptidase inhibitor activity 19
GO:0051346 negative regulation of hydrolase activity 15
GO:0052547 regulation of peptidase activity 15
GO:0004867 serine-type endopeptidase inhibitor activity 15
GO:0010466 negative regulation of peptidase activity 12
GO:0010951 negative regulation of endopeptidase activity 10









We decided to focus our initial analysis of the RNA-seq data to a few key 
areas for the following reasons: 
1) genes involved in differentiation were overrepresented among those 
differentially expressed between keratinocytes grown at low and high oxygen 
levels, suggesting that this is a major process affecting growth,  
2) our earlier experiments detected higher intracellular levels of reactive 
oxygen species (ROS) in keratinocytes cultured at 21% oxygen, which is 
suggestive of increased oxidative stress,  
3) since we had preliminary data showing the contribution of a few candidate 
biological processes to improved growth in low oxygen, we wanted to verify 
that the RNA-seq results were consistent with our earlier findings. 
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5.4.4 Differentiation is the major process downregulated in low oxygen 
The top biological process identified by GO analysis related to differentiation, 
as 197 DEGs out of the 473 DEGs (i.e., 41%) were associated with it  (Table 
5.4).  Out of the 197 differentiation-associated DEGs, 130 genes (or two-thirds 
of the 197 DEGs) were upregulated while 67 genes were downregulated by 
21% oxygen. This cluster contained gene ontologies that broadly fell into two 
categories: either 1) development (e.g., developmental process (GO:0032502), 
anatomical structure development (GO:0048856) and epidermis development  
(GO:0008544)), or 2) differentiation (e.g., epidermal cell differentiation 
(GO:0009913), keratinocyte differentiation (GO:0030216) and keratinization 
(GO:0031424)). 
 
Many of the genes involved in keratinocyte terminal differentiation can be 
found on a specific locus in human chromosome 1q21.3 known as the 
epidermal differentiation complex (EDC). This is a 2 Mb stretch of DNA 
harbouring at least 65 genes organised into three classes: the S100 fused genes, 
the cornified envelope precursors, and the S100A genes. Half (32 genes) of all 
EDC genes were upregulated by 21% oxygen (Figure 5.11). The upregulated 
genes came from all three classes. No EDC gene was downregulated. 
 
Since the preliminary data in N/TERT-1 showed that the Notch pathway is 
important for oxygen-induced differentiation, a search was done for all Notch 
receptors, ligands and some of the downstream targets. In humans, there are 
four genes encoding Notch receptors (Notch 1, 2, 3 and 4) and five genes 
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encoding ligands (Jagged 1 and 2, and Delta-like 1, 3 and 4). NOTCH-
regulated ankyrin repeat protein  (NRARP), and transcription factors HES1 and 
HEY2 are downstream targets of Notch signaling. However, no significant 
change in the any of these genes was found in the RNA-seq data. 
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Figure 5.11 List of differentiation-related DEGs mapping to the 
epidermal differentiation complex (EDC) on human chromosome 1q21.3. 










































Cornified Envelope Precursors 
Late Cornified Envelope (LCE) 
Small Proline-Rich Region (SPRR) 
S100 fused genes 
S100A genes 
2 Mb 
~ 65 genes 
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5.4.5 Oxidative stress response is increased in higher oxygen 
Response to oxidative stress was listed as the 11th process in the GO clustering 
(Table 5.4). A heat map of a subset of the genes involved in the response to 
oxidative stress is displayed in Figure 5.12. Although the expression of 
NFE2L2 (nuclear factor erythroid 2-like-2) transcription factor, the master 
regulator of the anti-oxidant pathway did not show significant differences in 
the two oxygen conditions, a number of NFE2L2 downstream target genes 
were upregulated at 21% oxygen (Figure 5.12). These included the enzyme 
NQO1 (NAD(P)H quinone oxidoreductase 1), which detoxifies highly reactive 
quinones,  HMOX1 (heme oxygenase-1), catalysing the conversion of heme to 
the antioxidant biliverdin. Another NFE2L2 target, GCLC (glutamate-cysteine 
ligase, catalytic) was similarly upregulated. GCLC is the catalytic subunit of 
glutamate-cysteine ligase, the rate-limiting enzyme in the synthesis of 
glutathione, the major antioxidant species in cells. Notably, some members of 
the CYP (cytochrome P450) family were also found in this list. This class of 
enzymes catalyse the detoxification of many compounds with the concomitant 
reduction of oxygen to water. CYP2C18 expression is highly induced upon 
culturing the cells at atmospheric conditions; it is among the top 20 genes 
(Table 5.1). EGLN3 (also known as PHD3) encodes for the hypoxia-inducible 
factor prolyl hydroxylase 3, and was one of the genes involved in oxidative 
stress as identified by GO analysis. Although this enzyme is responsible for 
degradation of HIF1α, levels of EGLN3 transcripts decreased at 21% oxygen 





Figure 5.12 DEGs associated with the response to oxidative stress 
Expression heatmap of selected genes involved in oxidative stress as identified by the 
top 50 most significant GO terms. The heat map was generated by using the 
following terms: : GO 0006979: response to oxidative stress; GO 0042542: response 
to hydrogen peroxide; GO 0016705: oxidoreductase activity and GO 0000302: 
response to reactive oxygen species. 
Genes are listed in ascending magnitude of average log2CPM of both 5% and 21% 
oxygen (i.e., from the least to the most abundant transcripts). (CPM = counts per 




5.4.6 Adhesion was not identified as a process affected by oxygen 
Preliminary adhesion studies with N/TERT-1 suggest that keratinocytes 
adhere faster at 21% oxygen. However, cellular adhesion was not identified in 
any of the 242 gene ontology terms, suggesting that adhesion of primary 
keratinocytes is not affected between 5% and 21% oxygen. One explanation 
for the seeming contradiction between the preliminary work and the RNA-seq 
data is that the preliminary results showed a downregulation of integrins β1 
and β4 at 2% oxygen only, while the RNA-seq data is based on a comparison 
of cells at 5% and 21% oxygen. A second possibility is that the cell type in 
both cases is different: the preliminary work was carried out on N/TERT-1 
while the RNA-seq experiment used primary keratinocytes. A third reason is 
that the preliminary work identified a difference in integrin expression at the 
protein level, but this may not necessarily co-relate with the transcript level. 
 
Taken together, the results presented in this chapter show that keratinocytes at 
21% oxygen experience greater ROS levels and are triggered to start 
differentiation even before reaching full confluence. These two factors could 




In an effort to find out the underlying mechanisms leading to improved 
keratinocyte growth in low oxygen, two approaches were undertaken. The first 
approach involved the use of functional assays, quantitative PCR and protein 
analysis to probe candidate processes in the N/TERT-1 cell line. The main 
reason for using an immortalised cell line for the downstream experiments was 
the difficulty in culturing sufficient amounts of primary keratinocytes in a 
serum-free condition at 21% oxygen. This cell line was chosen because the 
growth pattern mimicked that of human primary keratinocytes that were 
isolated and cultured directly in low oxygen; increased cell yield was obtained 
when N/TERT-1 was cultured in low oxygen.  
 
Western blot analysis showed that HIF-1α was stabilized in 5% oxygen in 
N/TERT-1. However, HIF1A was not one of the 473 differentially expressed 
genes (DEGs) in the RNA-seq dataset. HIF-1α is an oxygen-sensitive 
transcription factor that is normally regulated at the protein level (Schofield & 
Ratcliffe, 2005). In the presence of oxygen, the proline residues pro 402 and 
pro 564 on HIF-1α are hydroxylated by HIF prolyl-hydroxylases (PHD), 
allowing the recognition and ubiquitination of HIF-1α by the VHL E3 
ubiquitin ligase (Schofield & Ratcliffe, 2005). This results in the degradation 
of HIF-1α. Since HIF-1α is regulated at the protein level, it was not surprising 
that HIF-1α was not one of the DEGs identified in the RNAseq. Carbonic 
anhydrase 9 (CA9) is a downstream target of HIF-1α and because it is one of 
the most consistent markers of hypoxia, it has been proposed to be a 
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biomarker for several tumour types (Benej et al., 2014; Tafreshi et al., 2014). 
It is a transmembrane enzyme catalyzing the interconversion of carbon dioxide 
and water into carbonic acid, protons and bicarbonate ions. CA9 was one of 
the most downregulated transcripts in 21% oxygen. Thus, although no 
difference in HIF-1α  transcripts was detected in the RNA-seq, the 10-fold 
induction of CA9 in 5% oxygen suggests that the HIF-1α protein was 
stabilized in these cells. 
 
EGLN3 (also known as PHD3) is one of the oxygen-dependent HIF prolyl 
hydroxylases involved in HIF-1α protein degradation. Interestingly, RNA-seq 
showed that ELGN3 transcript was higher at 5% compared to 21% oxygen. 
This finding was similar to that reported by Walmsley and colleagues 
(Walmsley et al., 2011). Using neutrophils from Phd3-/- mice, they found that 
expression of Phd3/Egln3 was essential for hypoxic survival via the induction 
of the pro-survival gene Bcl-XL. Also, Phd3/Egln3 levels were shown to be 
downregulated in Hif-1α-/- neutrophils in hypoxia (Walmsley et al., 2005), 
suggesting that there may be a negative feedback loop where Phd3/Egln3 is a 
downstream target of HIF-1α. This would explain why levels of Phd3/Egln3 
increased when HIF-1α protein was stabilized at 5% oxygen. 
 
In the epidermis, only the basal layer is proliferative, and as cells move into 
the spinous layer they stop proliferating and start the process of terminal 
differentiation. The commitment to terminal differentiation is thus 
accompanied by an exit from mitosis. If low oxygen results in increased 
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proliferation, one would expect that this would result in a concomitant 
decrease in terminal differentiation. This was affirmed in a report by Ngo and 
colleagues (Ngo et al., 2007). Monolayer cultures grown to confluence at 2% 
and 5% oxygen showed markedly reduced levels of the differentiation markers 
K1, K10 and involucrin. Kairuz et al did the reverse experiment and incubated 
3D organotypic models in hyperbaric oxygen (100% oxygen, 2.4 atmospheric 
pressure) for 90 minutes daily (Kairuz et al., 2007). Hyperbaric oxygen 
treatment was found to accelerate cornification of the stratum corneum. 
Contrary to Ngo et al, they reported an increase in proliferation under 
hyperbaric conditions.  However, this conclusion was based purely on 
increased p63 levels in hyperbaric-treated organotypics and no other 
proliferation marker was used. Moreover the organotypics were only subjected 
to intermittent hyperbaric oxygen treatment and allowed to recover in 
atmospheric oxygen. 
 
The widespread and concerted upregulation of epidermal differentiation-
related genes detected in this RNAseq (197 out of 473 DEGs were related to 
differentiation) supports the earlier findings by Kairuz et al and Ngo et al 
(Kairuz et al., 2007; Ngo et al., 2007). However, their conclusion that oxygen 
triggers differentiation was based only on post-confluent monolayer cultures 
or 3D organotypic keratinocyte models. In this thesis, we describe data from 
high throughput sequencing of RNA samples derived from pre-confluent 
keratinocytes. Differentiation-related gene products are typically only detected 
at the protein level a few days after cultures have reached confluence. The 
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finding that differentiation genes are upregulated in pre-confluent 
keratinocytes at 21% oxygen suggests that the commitment to differentiation 
in culture occurs much earlier than previously thought.  
 
The top gene upregulated in 21% oxygen was ELF5 (also known as ESE-2), a 
transcription factor restricted to differentiated keratinocytes (Oettgen et al., 
1999). It was upregulated 122-fold in 21% oxygen. The locus where this gene 
resides, human chromosome 11p13-15, is frequently subjected to loss of 
heterozygosity and chromosomal rearrangement in human carcinoma cell lines 
(Zhou et al., 1998), suggesting that it may be important in triggering 
differentiation. Many genes residing in the epidermal differentiation complex 
(EDC) were also upregulated in 21% oxygen. The EDC is a 2.5 Mb cluster of 
genes found on human chromosome 1q21 and encodes many of the structural 
and regulatory components involved in terminal differentiation of 
keratinocytes (Jackson et al., 2005). Three major classes of genes are located 
here: the S100 fused genes, the cornified envelope precursors (containing the 
late cornified envelope (LCE) and small proline-rich regions (SPRR) genes), 
and the S100A genes. These genes encode proteins that participate in 
epidermal barrier formation by cross-linking with filaggrin, keratins, 
involucrin and loricrin thus forming a highly insoluble water-retaining matrix  
(reviewed in Kypriotou et al., 2012). RNA-seq showed that 32 genes in this 
locus were upregulated by oxygen in a concerted manner. 
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SPRRs have also been shown to have anti-oxidative properties. This ability is 
dependent on the number and accessibility of cysteine residues present of 
which SPRR4 is the most potent antioxidant member (Vermeij et al., 2011). 
Members of S100A were found to be upregulated by stress in keratinocytes at 
21% oxygen. A wide variety of epidermal stresses induce S100A members, 
including tape-stripping, detergent exposure and Vaseline application 
(Marionnet et al., 2003). Moreover, S100A8 is induced by UVA irradiation 
and this induction can be inhibited by Tempol (a superoxide dismutase 
mimicking agent), suggesting a role for oxidative stress in S100A8 induction 
(Grimbaldeston et al., 2003).  
 
Transglutaminases (TGMs) play an important role in cornified envelope 
formation by catalysing the cross-linking of proteins encoded by the EDC. 
Nine TGMs have been identified in humans, of which TGMs 1, 3 and 5 are 
known to be involved in the formation of the cornified envelope in the 
epidermis (reviewed in Hitomi, 2005). Similar to the EDC genes, all three 
epidermis-associated TGMs were upregulated by oxygen. Moreover, TGM 3 
was also listed in the top 20 upregulated genes at 21% oxygen, with a 14-fold 
increase. 
 
Notch is an evolutionarily conserved pathway involved in many cellular 
processes such as proliferation, migration, differentiation and apoptosis. In 
humans, four Notch receptors (Notch 1-4) and five ligands (Jagged 1 and 2 
and Delta-like 1, 3 and 4) have been identified (reviewed in Lai, 2004). It was 
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previously reported that hypoxia inhibits neuronal and myogenic 
differentiation via activation of the Notch pathway (Gustafsson et al., 2005). 
However in keratinocytes, activation of Notch seems to have an opposite 
effect; Notch activation results in differentiation (Rangarajan et al., 2001; 
Panelos & Massi, 2009). Addition of the Notch γ-secretase inhibitor DAPT in 
differentiated N/TERT-1 resulted in a loss of K1 and K10, confirming that the 
differentiation induced by oxygen is Notch-dependent. Moreover, quantitative 
PCR showed that NRARP, a downstream target of Notch, was downregulated 
in low oxygen. This suggests that contrary to the earlier report by Gustafsson 
(Gustafsson et al 2005), low oxygen in our case downregulates Notch 
signalling, and this observation is unique to keratinocytes. The RNA-seq data 
confirmed the initial finding in N/TERT-1 implicating oxygen as an essential 
trigger of differentiation in keratinocytes. However, no increase in any of the 
Notch receptors or target genes, including NRARP was detected in the RNA-
seq data. One reason for this is that the implication of Notch in differentiation 
was concluded from experiments using post-confluent N/TERT-1 while the 
RNA used for sequencing was extracted from pre-confluent primary 
keratinocytes. Perhaps the involvement of Notch occurs in a later stage of 
keratinocyte differentiation. 
 
Interestingly, the frizzled class receptor 2 (FZD2) was one of the 20 most 
downregulated genes in 21% oxygen. This 7-transmembrane protein is a 
receptor involved in canonical Wnt signalling (reviewed in Malbon, 2004). 
Activation of Wnt signaling was recently found to be key in maintaining stem 
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cell self-renewal in keratinocytes (Lim et al., 2013). Another interesting gene 
downregulated in 21% oxygen was keratin 7. This gene is normally expressed 
in simple epithelia (Porter & Lane, 2003), and has been proposed to be a 
useful diagnostic marker for non-small cell lung carcinomas (Camilo et al., 
2006). Taken together, this suggests that 5% oxygen suppresses terminal 
differentiation in keratinocytes, and this could be a reason for the higher cell 
yield described in Chapter 4. 
 
Treatment of N/TERT-1 with the ROS-sensitive dye CellROX® showed that 
N/TERT-1 incubated in atmospheric oxygen experienced higher levels of ROS. 
NFE2L2 (also known as Nrf2) is a master regulator of the cellular anti-oxidant 
pathway (Ma, 2013). However, RNAseq did not show any difference in 
NFE2L2 levels between 5% and 21% oxygen in primary keratinocytes. This 
could be because NFE2L2 is regulated at the protein level by the E3 ubiquitin 
ligase Keap1. Exposure to oxidants modifies reactive cysteine residues on 
Keap1, resulting in decreased E3 ligase activity and stabilization of NFE2L2 
(Taguchi et al., 2011). The RNA-seq data showed that although there was no 
change in NFE2L2 transcript levels, there was an upregulation of a number of 
NFE2L2 target genes such as NQO1, HMOX-1 and GCLC at 21% oxygen, 
suggesting that the NFE2L2 protein could have been stabilized and more 
transcriptionally active at this oxygen level. Other upregulated genes in the 
response to oxidative stress included members from the cytochrome P450 
(CYP) super family of detoxifying enzymes. These enzymes are of particular 
interest to pharmaceuticals for their drug-metabolising abilities when 
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challenged with xenobiotic compounds (reviewed in Ahmad & Mukhtar, 
2004). CYP levels have also been found to be elevated by UVB exposure and 
skin diseases such as psoriasis (Smith et al., 2003). 
 
Response to oxidative stress was one of the processes identified in the GO 
clustering, with 33 DEGs out of the total 473 DEGs classified under this 
process. Two genes involved in the oxidative stress response were also listed 
within the top 20 genes upregulated in 21% oxygen. They were MIR663a 
(microRNA-663a) and OSGIN1 (oxygen stress induced growth inhibitor 1). 
Levels of microRNA-663a were increased 63-fold in cells at 21% oxygen. 
This microRNA has been reported to be upregulated upon hydrogen peroxide-
induced oxidative stress in cultured human fibroblasts (Maes et al., 2009). 
This increase when challenged with oxidative stress is age-dependent; 
rotenone-treated dermal fibroblasts from elderly donors showed higher 
microRNA-663 expression compared to similarly challenged fibroblasts from 
young donors (Waaijer et al., 2014). Although the current targets of 
microRNA-663 are not known, the identification of this gene in the RNA-seq 
dataset suggests that high culture oxygen may be triggering culture-induced 
senescence in keratinocytes. 
 
Apart from its pathological effects, ROS has also been shown to have 
important physiological functions. Increased ROS has been reported to be 
correlated with terminal differentiation (Hamanaka et al., 2013; Bause et al., 
2013). In particular, Hamanaka showed that conditional deletion of the 
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mitochondrial transcription factor TFAM in basal keratinocytes in vivo 
effectively reduced mitochondrial ROS production and this resulted in 
impaired epidermal differentiation. This suggests that one possible way 21% 
oxygen induces differentiation in keratinocytes is via ROS induction. On the 
other hand, increased oxidative stress by SOD2 deletion triggered cellular 
senescence, epidermal thinning, and an overall reduction in cell numbers in 
mouse skin (Velarde et al., 2012). This suggests that a delicate balance of 
ROS is essential for homeostasis. 
 
Increased ROS is also known to mediate cell adhesion (reviewed in Chairugi, 
2003). This is in line with the observations presented here, where N/TERT-1 
at 21% oxygen had higher levels of intracellular ROS, and showed faster 
adherence. Basal keratinocytes adhere to substrates via integrin-mediated cell 
adhesion. The main adhesive complexes anchoring basal keratinocytes are 
focal adhesions and hemidesmosomes (reviewed in Margadant et al., 2010). 
Integrins form heterodimers of an alpha and beta subunit: α6 pairs with β4, 
and α3 pairs with β1 to form hemidesmosomes and focal adhesions 
respectively. Adhesion of N/TERT-1 to the culture plate was faster at 21% 
oxygen compared to those kept in 2% and 5% oxygen. At the protein level, 
only keratinocytes at 2% but not 5% oxygen showed a reduction in β1, β4 
integrins and P-cadherin. RNA-seq comparison of 5% and 21% oxygen also 
showed that there was no significant change in hemidesmosomal and focal 
adhesion integrins.  
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Integrin signalling directly activates survival pathways such as PI3-kinase and 
MAPK pathways and is key to cell survival (reviewed in Stupack, 2002). The 
down-regulation of major basal keratinocyte integrins at 2% oxygen may 
explain why primary keratinocytes serially passaged at 2% oxygen cannot be 
sustained (discussed in Chapter 4). The inability of these cells to adhere 
efficiently over time at 2% oxygen could have resulted in the subsequent 
reduction in total colony numbers in later passages. Since keratinocytes at 5% 
oxygen show higher integrin expression than those at 2% oxygen, this may 
explain why serial cultivation of keratinocytes at 5% instead is sustainable. 
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5.6 Conclusion, significance and future work 
Preliminary results presented here suggest that the increased cell yield of 
keratinocytes in lower oxygen is possibly caused by a suppression of 
differentiation. Terminal differentiation of keratinocytes in vivo is 
accompanied by an exit of the cell cycle. This choice of either mitosis or 
differentiation may reflect a shift in resource allocation by the cell. Since low 
oxygen suppresses differentiation, this would explain why higher keratinocyte 
yields were consistently obtained in this condition.  
 
Increased ROS levels were detected in N/TERT-1 cultured at 21% oxygen. A 
number of GO terms relating to oxidative stress response was also found in the 
GO clustering. Interestingly, increase in ROS levels at higher oxygen has been 
reported to be linked to differentiation and cell adhesion (Chairugi, 2003; 
Hamanaka et al., 2013). Possibly, higher ROS levels at 21% oxygen could be 
the underlying trigger of both processes.  
 
This chapter shows that the improved growth in low oxygen is probably due to 
an inhibition of differentiation. The next step would involve characterization 
of 3D organotypic models from keratinocytes expanded in low oxygen to 
investigate the ability of these cells to differentiate when switched to 
atmospheric oxygen. In this chapter, we have only focused on differentiation, 
oxidative stress and adhesion. Future work would firstly include investigating 
the contribution of other biological processes uncovered in the RNA-seq data. 
Secondly, as discussed above, ROS has been implicated in triggering 
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differentiation. We have shown here that intracellular ROS levels correlate 
with differentiation. To establish a direct link between reduced ROS and 
suppression of differentiation, the next step would be to artificially increase 
ROS levels (via exogenous ROS addition or knockdown of an antioxidant 
enzyme for instance) in keratinocytes in low oxygen and see if this reduces 
proliferation in favour of differentiation. Lastly, although the correlation of 
ROS levels with differentiation supports the physiological role of ROS, it is 
currently unknown if the higher ROS levels in keratinocytes at 21% oxygen 
has pathological effects. Future work in this area would include assessing 




















Overall conclusion and future perspective 
Cultured keratinocytes make useful cell models and have wide clinical and 
research applicability. The choice of primary keratinocytes versus 
immortalised keratinocytes depends on many considerations, among which is 
the final purpose: whether it is used as a cell model for research or it is 
cultured for therapeutic use. The work presented in this thesis describes how 
culture conditions can sometimes alter the behaviour of keratinocytes in vitro. 
 
The ease of handling and the almost unlimited proliferative capacity of 
immortalised keratinocytes make them a popular choice for research use. In 
most cases, these cells retain enough of their original phenotype to be useful as 
cell models. In our case, NEB-1 was immortalised from keratinocytes 
expressing wild type keratin (K) 14, along with keratinocytes from patients 
suffering from a skin fragility disorder, epidermolysis bullosa simplex (EBS) 
(Morley et al., 2003). EBS keratinocytes express a dominant negative mutant 
form of K14 or K5  (reviewed in Porter & Lane, 2003). NEB-1 was originally 
meant to be used as a wild type “healthy” control cell line in comparison to 
diseased EBS cell lines. Keratinocytes express abundant levels of keratin, and 
in basal cells in particular, it is K14 and K5. The observation that K14 
expression was progressively lost in NEB-1 brought into question the basal 
identity of this cell line. The work presented here showed that the underlying 
reason for K14 loss was an epigenetic silencing of K14, and that one factor 
contributing to the silencing was the routine addition of epidermal growth 
factor (EGF) to the culture media. Since differentiating keratinocytes 
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downregulate K14 and K5 expression in favour of K1 and K10 in vivo, 
epigenetic silencing may be a mechanism by which keratinocytes “turn off” 
the expression of K14. Future work in this area would include analysing the 
epigenetic marks, if any, that are present in basal versus suprabasal 
keratinocytes from cells directly isolated from skin. This would minimise any 
epigenetic modifications arising from culturing of these cells. Although the 
case of NEB-1 was an example of how cells in culture can deviate from their 
original phenotype, this does not rule out the use of immortalised cells for 
research. Immortalised cell lines still serve as important tools for research. For 
instance, in our later experiments described in chapters 4 and 5, the limited 
ability of primary keratinocytes to be expanded in serum-free conditions made 
it necessary to consider the use of an immortalised cell line, N/TERT-1 as a 
surrogate to probe the mechanisms of improved keratinocyte growth in low 
oxygen. 
 
Since the first report on the successful culture of primary keratinocytes in the 
1970s, little has changed in terms of the way keratinocytes are cultured today. 
Attempts to improve culture growth by optimizing culture media formulations 
have met with little success so far. The Rheinwald and Green system 
(Rheinwald & Green, 1975b) is still the gold standard in terms of maintenance 
of keratinocyte growth potential. Although serum-free media formulations are 
generally good enough to support growth for a limited number of passages for 
research purposes, expansion of keratinocytes for clinical use such as in the 
production of cultured epithelial autograft for transplantation onto burn 
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victims still requires the method established by Rheinwald and Green (Wong 
et al., 2012). Even with optimized media conditions, graft production still 
takes about 2 – 3 weeks (Ronfard et al., 2000). The main bottleneck in this 
process is the time required to expand enough keratinocytes in vitro to seed 
onto the graft bed. 
Thus the finding that low oxygen significantly improves keratinocyte yield has 
immediate clinical relevance, particularly in the construction of cultured 
epithelial autografts.  Maximising cell yield is critical in cases of limited 
availability of healthy skin from which to extract the keratinocytes: such as in 
third-degree burn victims or in patients suffering from severe blistering 
disorders. We propose that the time required for cell expansion can be 
shortened considerably by culture in low oxygen.  
 
In an effort to understand the mechanisms driving improved growth in low 
oxygen, two approaches were undertaken: 1) probing candidate biological 
processes and 2) global transcriptome profiling. Both approaches were in 
agreement, and highlighted the suppression of differentiation as a major 
mechanism driving improved growth. This is in agreement with other groups 
who reported that oxygen is an essential trigger for keratinocyte differentiation 
(Kairuz et al., 2007; Ngo et al., 2007). In culture, keratinocytes generally start 
expressing genes with differentiation-related function a few days after 
confluence. Keeping in mind the earlier reports on the effect of oxygen on 
keratinocyte differentiation, keratinocytes for the RNA-seq experiment were 
harvested before reaching full confluence. This was to minimize the 
 194 
contribution of differentiation to the differentially expressed genes (DEGs). 
Also, another reason for harvesting pre-confluent cells was that we wanted to 
investigate the factors leading to improved cell yield in actively growing 
monolayer cultures. The enrichment of many DEGs belonging to 
differentiation in the RNA-seq analysis showed that although differentiation 
proteins are expressed post-confluence, keratinocytes at 21% oxygen commit 
to differentiation much earlier, even as a pre-confluent monolayer culture.   
In summary, according to our knowledge this is the first report on gene 
expression in primary keratinocytes at low oxygen concentration using RNA 
sequencing. We also show that in atmospheric oxygen, the commitment to 
differentiation in culture occurs much earlier than previously reported. Lastly, 
the finding that keratinocytes at low oxygen concentration exhibit higher cell 
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 Full list of 473 differentially expressed genes (DEGs) between human primary keratinocytes at 5% and 21% oxygen
Genes are listed in descending order of logFoldChange
Gene$Symbol Gene$Name Gene$Id logFoldChange p"value
ELF5 E74$like)factor)5)(ets)domain)transcription)factor) 2001 6.936569361 7.45E$07
SNORD116,8 small)nucleolar)RNA,)C/D)box)116$8 100033420 6.070115109 0.000229848
LINC00885 long)intergenic)non$protein)coding)RNA)885 401109 5.941468285 0.000362454
HRH4 histamine)receptor)H4 59340 5.890126043 0.000482645
LEMD1 LEM)domain)containing)1 93273 5.824652055 0.000576428
MIR663A microRNA)663a 724033 5.724222112 0.000962107
DYNAP dynactin)associated)protein 284254 4.284861632 2.48E$06
TMPRSS11A transmembrane)protease,)serine)11A 339967 3.990951703 3.77E$05
APOBEC3A apolipoprotein)B)mRNA)editing)enzyme,)catalytic)polypeptide$like)3A 200315 3.902781653 2.49E$07
AWAT1 acyl$CoA)wax)alcohol)acyltransferase)1 158833 3.818060629 0.000120551
TGM3 transglutaminase)3 7053 3.762288762 2.82E$65
CYP2C18 cytochrome)P450,)family)2,)subfamily)C,)polypeptide)18 1562 2.463763559 3.30E$12
OSGIN1 oxidative)stress)induced)growth)inhibitor)1 29948 2.386782893 0.000458904
ARG1 arginase)1 383 2.385377285 2.13E$13
CHRNA9 cholinergic)receptor,)nicotinic,)alpha)9)(neuronal) 55584 2.221847875 0.000375033
OASL 2'$5'$oligoadenylate)synthetase$like 8638 2.208521751 1.36E$21
CALB2 calbindin)2 794 2.169507889 6.94E$18
SERPINA12
serpin)peptidase)inhibitor,)clade)A)(alpha$1)antiproteinase,)
antitrypsin),)member)12 145264 2.061346498 4.26E$13
PTGER3 prostaglandin)E)receptor)3)(subtype)EP3) 5733 2.013466071 0.000142607
DHRS9 dehydrogenase/reductase)(SDR)family))member)9 10170 1.97031855 2.45E$32
PLA2G4D phospholipase)A2,)group)IVD)(cytosolic) 283748 1.962758236 4.42E$14
DIO2 deiodinase,)iodothyronine,)type)II 1734 1.932071058 5.27E$13
FGD3 FYVE,)RhoGEF)and)PH)domain)containing)3 89846 1.928394232 4.74E$06
ATP13A4 ATPase)type)13A4 84239 1.913296787 7.34E$07
BPIFC BPI)fold)containing)family)C 254240 1.909526269 1.11E$17
SLC6A14 solute)carrier)family)6)(amino)acid)transporter),)member)14 11254 1.905759832 6.54E$34
C9orf169 chromosome)9)open)reading)frame)169 375791 1.905425377 1.65E$09
PRSS22 protease,)serine,)22 64063 1.873391828 1.29E$11
CLDN17 claudin)17 26285 1.867066466 0.000201294
AKR1C1 aldo$keto)reductase)family)1,)member)C1 1645 1.851160882 1.58E$29
PI3 peptidase)inhibitor)3,)skin$derived 5266 1.808468619 3.09E$39
LCE2D late)cornified)envelope)2D 353141 1.791876008 1.80E$05
GDPD3 glycerophosphodiester)phosphodiesterase)domain)containing)3 79153 1.783923673 5.88E$15
LIPM lipase,)family)member)M 340654 1.77262266 5.95E$15
LCE1B late)cornified)envelope)1B 353132 1.768780464 3.66E$11
LOC344887 NmrA$like)family)domain)containing)1)pseudogene 344887 1.737284952 1.61E$14
RNF222 ring)finger)protein)222 643904 1.727417206 3.92E$13
NPR3 natriuretic)peptide)receptor)3 4883 1.71634178 1.21E$05
SERPINB4 serpin)peptidase)inhibitor,)clade)B)(ovalbumin),)member)4 6318 1.706662719 2.63E$13
GUCA1B guanylate)cyclase)activator)1B)(retina) 2979 1.698070801 0.000394343
SLPI secretory)leukocyte)peptidase)inhibitor 6590 1.689758718 2.52E$26
SDR9C7 short)chain)dehydrogenase/reductase)family)9C,)member)7 121214 1.66493491 1.03E$25
LIPN lipase,)family)member)N 643418 1.662397824 1.91E$12
XKRX XK,)Kell)blood)group)complex)subunit$related,)X$linked 402415 1.658140272 4.69E$14
IGFL2 IGF$like)family)member)2 147920 1.645738167 8.26E$11
FGD2 FYVE,)RhoGEF)and)PH)domain)containing)2 221472 1.631331299 0.000611171
CYP4F22 cytochrome)P450,)family)4,)subfamily)F,)polypeptide)22 126410 1.630990113 8.37E$10
S100A8 S100)calcium)binding)protein)A8 6279 1.630254137 1.73E$22
HOPX HOP)homeobox 84525 1.628953929 6.49E$34
KLK12 kallikrein$related)peptidase)12 43849 1.623945766 7.57E$05
TSPAN7 tetraspanin)7 7102 1.621060619 2.62E$05
VSIG10L V$set)and)immunoglobulin)domain)containing)10)like 147645 1.604253955 1.46E$11
LCE1A late)cornified)envelope)1A 353131 1.599601897 0.000704574
SERPINB3 serpin)peptidase)inhibitor,)clade)B)(ovalbumin),)member)3 6317 1.599423621 3.15E$20
IL36G interleukin)36,)gamma 56300 1.595895659 3.40E$13
AQP9 aquaporin)9 366 1.587841626 3.86E$14
ANKRD35 ankyrin)repeat)domain)35 148741 1.586078022 3.86E$10
S100A9 S100)calcium)binding)protein)A9 6280 1.584290272 1.13E$24
ACER1 alkaline)ceramidase)1 125981 1.569085494 0.000673375
ALDH3A1 aldehyde)dehydrogenase)3)family,)member)A1 218 1.56778378 0.000358015
ENDOU endonuclease,)polyU$specific 8909 1.566074677 9.92E$16
LCE3E late)cornified)envelope)3E 353145 1.56413586 8.51E$16
WFDC12 WAP)four$disulfide)core)domain)12 128488 1.550932289 4.17E$16
SERPINB9 serpin)peptidase)inhibitor,)clade)B)(ovalbumin),)member)9 5272 1.544210729 4.89E$08
AKR1C3 aldo$keto)reductase)family)1,)member)C3 8644 1.512378813 4.61E$11
TMEM86A transmembrane)protein)86A 144110 1.507470813 1.99E$14
SPTSSB serine)palmitoyltransferase,)small)subunit)B 165679 1.497340629 8.18E$12
DNASE1L3 deoxyribonuclease)I$like)3 1776 1.494412017 2.06E$11
ERP27 endoplasmic)reticulum)protein)27 121506 1.489460851 0.000328886
RHCG Rh)family,)C)glycoprotein 51458 1.480788642 7.08E$28
AZGP1 alpha$2$glycoprotein)1,)zinc$binding 563 1.470080314 4.54E$12
FLG2 filaggrin)family)member)2 388698 1.459727309 5.24E$21
AADACL2 arylacetamide)deacetylase$like)2 344752 1.446090099 2.58E$06
KRT78 keratin)78 196374 1.434602542 1.26E$11
LPHN2 latrophilin)2 23266 1.433856648 4.82E$25
PNPLA1 patatin$like)phospholipase)domain)containing)1 285848 1.426982911 7.87E$05
BNIPL BCL2/adenovirus)E1B)19kD)interacting)protein)like 149428 1.420559191 3.32E$15
RDH12 retinol)dehydrogenase)12)(all$trans/9$cis/11$cis) 145226 1.419905383 4.14E$11
KRT16P1 keratin)16)pseudogene)1 729252 1.415134273 0.00016245
LIPK lipase,)family)member)K 643414 1.412005069 1.76E$08
LCE6A late)cornified)envelope)6A 448835 1.405207387 7.14E$08
 Gene$Symbol Gene$Name Gene$Id logFoldChange p"value
ATP6V1C2 ATPase,(H+(transporting,(lysosomal(42kDa,(V1(subunit(C2 245973 1.403058142 2.98EF10
IL36RN interleukin(36(receptor(antagonist 26525 1.401990776 3.18EF13
CYP4F3 cytochrome(P450,(family(4,(subfamily(F,(polypeptide(3 4051 1.392135557 9.45EF05
SCNN1G sodium(channel,(nonFvoltageFgated(1,(gamma(subunit 6340 1.38657359 0.000509733
TGM5 transglutaminase(5 9333 1.374549199 1.26EF09
KRT6B keratin(6B 3854 1.371592056 1.94EF16
NCCRP1 nonFspecific(cytotoxic(cell(receptor(protein(1(homolog((zebrafish) 342897 1.369187027 1.53EF11
HPGD hydroxyprostaglandin(dehydrogenase(15F(NAD) 3248 1.365522932 8.31EF16
METRNL meteorin,(glial(cell(differentiation(regulatorFlike 284207 1.357351773 0.000799674
TTC39A tetratricopeptide(repeat(domain(39A 22996 1.353058293 2.79EF10
KLK9 kallikreinFrelated(peptidase(9 284366 1.342510438 0.000336443
TMPRSS13 transmembrane(protease,(serine(13 84000 1.334264854 2.19EF10
SPRR2G small(prolineFrich(protein(2G 6706 1.33359749 0.000126338
MYEF2 myelin(expression(factor(2 50804 1.33301786 0.000128638
MMP1 matrix(metallopeptidase(1((interstitial(collagenase) 4312 1.330271193 3.03EF23
SLC26A11 solute(carrier(family(26((anion(exchanger),(member(11 284129 1.329740603 0.000982604
SLC15A1 solute(carrier(family(15((oligopeptide(transporter),(member(1 6564 1.328935279 4.06EF09
CRCT1 cysteineFrich(CFterminal(1 54544 1.328681442 4.56EF13
ADAP2 ArfGAP(with(dual(PH(domains(2 55803 1.326528676 4.74EF08
IL13RA2 interleukin(13(receptor,(alpha(2 3598 1.324050736 0.000233496
KPRP keratinocyte(prolineFrich(protein 448834 1.32365414 4.65EF07
LYPD5 LY6/PLAUR(domain(containing(5 284348 1.32347465 7.93EF20
S100A12 S100(calcium(binding(protein(A12 6283 1.321094913 1.31EF06
GCOM1 GRINL1A(complex(locus(1 145781 1.30781749 0.000302069
DGAT2 diacylglycerol(OFacyltransferase(2 84649 1.304491599 1.47EF09
FAM43A family(with(sequence(similarity(43,(member(A 131583 1.303724552 3.55EF08
IVL involucrin 3713 1.299526268 5.80EF12
S100P S100(calcium(binding(protein(P 6286 1.294125595 6.40EF07
SPINK7 serine(peptidase(inhibitor,(Kazal(type(7((putative) 84651 1.291760676 3.82EF08
LCE3D late(cornified(envelope(3D 84648 1.287728 1.72EF11
ALDH3B2 aldehyde(dehydrogenase(3(family,(member(B2 222 1.278851443 1.17EF06
CIDEA cell(deathFinducing(DFFAFlike(effector(a 1149 1.27660494 6.32EF07
HMOX1 heme(oxygenase((decycling)(1 3162 1.276034361 5.87EF09
SLC5A1 solute(carrier(family(5((sodium/glucose(cotransporter),(member(1 6523 1.270352896 1.46EF08
HAL histidine(ammoniaFlyase 3034 1.270272517 2.38EF08
PLA2G4F phospholipase(A2,(group(IVF 255189 1.268778735 2.05EF07
PGLYRP4 peptidoglycan(recognition(protein(4 57115 1.26841143 1.30EF07
PLA2G4E phospholipase(A2,(group(IVE 123745 1.252387529 9.59EF09
MMP10 matrix(metallopeptidase(10((stromelysin(2) 4319 1.250297336 4.04EF07
ELMOD1 ELMO/CEDF12(domain(containing(1 55531 1.247974003 2.83EF07
KRT6C keratin(6C 286887 1.247697535 7.97EF13
TMEM45A transmembrane(protein(45A 55076 1.244261398 2.92EF18
TNFAIP2 tumor(necrosis(factor,(alphaFinduced(protein(2 7127 1.242950163 1.98EF06
ANKRD22 ankyrin(repeat(domain(22 118932 1.241686522 5.02EF13
KRT16 keratin(16 3868 1.235824724 8.22EF16
RPTN repetin 126638 1.232511203 2.05EF08
PTGS2
prostaglandinFendoperoxide(synthase(2((prostaglandin(G/H(synthase(
and(cyclooxygenase) 5743 1.232461649 2.23EF21
LIPH lipase,(member(H 200879 1.226521299 4.32EF06
PAQR5 progestin(and(adipoQ(receptor(family(member(V 54852 1.22072933 1.04EF10
KALRN kalirin,(RhoGEF(kinase 8997 1.216420051 2.72EF06
SLC28A3
solute(carrier(family(28((concentrative(nucleoside(transporter),(
member(3 64078 1.214242016 4.62EF09
CNFN cornifelin 84518 1.208846478 3.21EF06
TMPRSS11E transmembrane(protease,(serine(11E 28983 1.193327962 9.10EF06
LYPD3 LY6/PLAUR(domain(containing(3 27076 1.190789745 5.05EF07
SPRR1A small(prolineFrich(protein(1A 6698 1.185375755 8.32EF07
TMEM45B transmembrane(protein(45B 120224 1.17702961 1.21EF13
TMPRSS11F transmembrane(protease,(serine(11F 389208 1.173560572 4.03EF08
SOWAHB sosondowah(ankyrin(repeat(domain(family(member(B 345079 1.17132908 0.00013109
GRHL1 grainyheadFlike(1((Drosophila) 29841 1.16944065 5.25EF12
CGN cingulin 57530 1.1641208 2.39EF05
FUOM fucose(mutarotase 282969 1.162412797 0.000874315
STX19 syntaxin(19 415117 1.160442938 2.90EF06
SBSN suprabasin 374897 1.156984758 1.45EF15
BBOX1
butyrobetaine((gamma),(2Foxoglutarate(dioxygenase((gammaF
butyrobetaine(hydroxylase)(1 8424 1.153579916 1.90EF06
ATP12A ATPase,(H+/K+(transporting,(nongastric,(alpha(polypeptide 479 1.144020084 1.71EF07
GDA guanine(deaminase 9615 1.140514134 1.38EF06
FLVCR2 feline(leukemia(virus(subgroup(C(cellular(receptor(family,(member(2 55640 1.140166613 2.13EF06
FABP5 fatty(acid(binding(protein(5((psoriasisFassociated) 2171 1.139804212 3.14EF09
CRABP2 cellular(retinoic(acid(binding(protein(2 1382 1.136466182 2.13EF07
EPS8L1 EPS8Flike(1 54869 1.136098929 1.06EF07
KLK11 kallikreinFrelated(peptidase(11 11012 1.132540092 3.49EF09
A2ML1 alphaF2FmacroglobulinFlike(1 144568 1.132059793 2.63EF13
SERPINB13 serpin(peptidase(inhibitor,(clade(B((ovalbumin),(member(13 5275 1.12544344 2.64EF17
NOD2 nucleotideFbinding(oligomerization(domain(containing(2 64127 1.118776813 5.48EF07
KLK6 kallikreinFrelated(peptidase(6 5653 1.108646218 4.43EF12
BSPRY BFbox(and(SPRY(domain(containing 54836 1.105342382 5.96EF05
RGS16 regulator(of(GFprotein(signaling(16 6004 1.103985313 1.72EF05
KRT42P keratin(42(pseudogene 284116 1.094938917 4.30EF06
GGT6 gammaFglutamyltransferase(6 124975 1.090042402 5.89EF07
WFDC5 WAP(fourFdisulfide(core(domain(5 149708 1.08814428 1.44EF08
NQO1 NAD(P)H(dehydrogenase,(quinone(1 1728 1.087796202 4.85EF16
 Gene$Symbol Gene$Name Gene$Id logFoldChange p"value
SPINK5 serine&peptidase&inhibitor,&Kazal&type&5 11005 1.081451559 6.17E=16
CGNL1 cingulin=like&1 84952 1.079202121 4.44E=07
MUC15 mucin&15,&cell&surface&associated 143662 1.074541498 4.69E=05
PRR9 proline&rich&9 574414 1.073619192 2.87E=07
TEC tec&protein&tyrosine&kinase 7006 1.069353912 6.55E=06
EREG epiregulin 2069 1.068217451 1.68E=15
FUT3
fucosyltransferase&3&(galactoside&3(4)=L=fucosyltransferase,&Lewis&
blood&group) 2525 1.063931024 1.95E=05
CCT6B chaperonin&containing&TCP1,&subunit&6B&(zeta&2) 10693 1.06277902 0.000757319
FUT2 fucosyltransferase&2&(secretor&status&included) 2524 1.062611599 9.20E=07
SLC7A118AS1 SLC7A11&antisense&RNA&1 641364 1.060343884 2.29E=06
SULT2B1 sulfotransferase&family,&cytosolic,&2B,&member&1 6820 1.058229799 2.60E=05
GSDMA gasdermin&A 284110 1.055312371 2.18E=11
TCHH trichohyalin 7062 1.051304858 7.60E=05
FGF2 fibroblast&growth&factor&2&(basic) 2247 1.041811226 0.000298613
DEFB1 defensin,&beta&1 1672 1.040877743 1.52E=07
CEACAM6
carcinoembryonic&antigen=related&cell&adhesion&molecule&6&(non=
specific&cross&reacting&antigen) 4680 1.036791979 1.13E=07
RASEF RAS&and&EF=hand&domain&containing 158158 1.032754374 0.000834111
SPRR2D small&proline=rich&protein&2D 6703 1.029670773 5.40E=07
GJB6 gap&junction&protein,&beta&6,&30kDa 10804 1.029539881 1.72E=12
ASPRV1 aspartic&peptidase,&retroviral=like&1 151516 1.027251289 1.99E=06
IL1B interleukin&1,&beta 3553 1.023210385 8.47E=14
SPRR3 small&proline=rich&protein&3 6707 1.022953518 5.39E=10
KRTDAP keratinocyte&differentiation=associated&protein 388533 1.020697225 3.68E=13
SPRR2E small&proline=rich&protein&2E 6704 1.018745207 7.50E=06
RHOV ras&homolog&family&member&V 171177 1.013018862 7.64E=05
PAPL iron/zinc&purple&acid&phosphatase=like&protein 390928 1.012510889 5.02E=05
LCE1C late&cornified&envelope&1C 353133 1.008033289 0.000556517
TGM1 transglutaminase&1 7051 1.003748093 9.72E=12
PVRL4 poliovirus&receptor=related&4 81607 0.993050373 8.13E=08
ARRDC4 arrestin&domain&containing&4 91947 0.992667728 7.21E=11
AGPAT9 1=acylglycerol=3=phosphate&O=acyltransferase&9 84803 0.990662278 7.70E=09
DSC1 desmocollin&1 1823 0.988944213 5.59E=08
SLC13A3
solute&carrier&family&13&(sodium=dependent&dicarboxylate&
transporter),&member&3 64849 0.98512112 1.68E=05
KRT80 keratin&80 144501 0.982798299 6.09E=06
SMPD3
sphingomyelin&phosphodiesterase&3,&neutral&membrane&(neutral&
sphingomyelinase&II) 55512 0.979994734 2.14E=05
GRAMD1C GRAM&domain&containing&1C 54762 0.955562777 5.31E=06
ANXA9 annexin&A9 8416 0.95057671 2.68E=05
KLK7 kallikrein=related&peptidase&7 5650 0.950073163 1.23E=09
CXCL8 chemokine&(C=X=C&motif)&ligand&8 3576 0.948131192 1.08E=05
GLTP glycolipid&transfer&protein 51228 0.937670996 2.91E=10
EFR3B EFR3&homolog&B&(S.&cerevisiae) 22979 0.93416557 1.62E=05
AKR1C2 aldo=keto&reductase&family&1,&member&C2 1646 0.932916966 8.43E=09
SPRR1B small&proline=rich&protein&1B 6699 0.932718773 2.87E=06
KRT75 keratin&75 9119 0.931506494 6.98E=06
RAET1L retinoic&acid&early&transcript&1L 154064 0.903398476 0.000228372
CHAC1 ChaC,&cation&transport&regulator&homolog&1&(E.&coli) 79094 0.901736155 2.47E=05
DHRS11 dehydrogenase/reductase&(SDR&family)&member&11 79154 0.899386927 3.68E=05
RGS2 regulator&of&G=protein&signaling&2,&24kDa 5997 0.895823715 1.98E=09
SERPINB2 serpin&peptidase&inhibitor,&clade&B&(ovalbumin),&member&2 5055 0.881276478 9.10E=12
LCN2 lipocalin&2 3934 0.880831737 2.39E=05
KRT1 keratin&1 3848 0.875709936 4.87E=06
SCNN1A sodium&channel,&non=voltage=gated&1&alpha&subunit 6337 0.8725885 0.000102398
KRT4 keratin&4 3851 0.87170676 7.08E=05
SLC7A11
solute&carrier&family&7&(anionic&amino&acid&transporter&light&chain,&xc=&
system),&member&11 23657 0.86135896 7.82E=11
TPRG1 tumor&protein&p63&regulated&1 285386 0.852899193 1.81E=05
OVOL1 ovo=like&zinc&finger&1 5017 0.85258157 2.01E=07
LINC01094 long&intergenic&non=protein&coding&RNA&1094 100505702 0.846302829 9.20E=05
TCN1 transcobalamin&I&(vitamin&B12&binding&protein,&R&binder&family) 6947 0.84489527 0.000456539
STEAP4 STEAP&family&member&4 79689 0.842347511 3.63E=06
SPINK6 serine&peptidase&inhibitor,&Kazal&type&6 404203 0.839690606 5.32E=10
LLGL2 lethal&giant&larvae&homolog&2&(Drosophila) 3993 0.838619911 0.000113347
RAET1G retinoic&acid&early&transcript&1G 353091 0.838211367 1.68E=05
CARD18 caspase&recruitment&domain&family,&member&18 59082 0.837932774 7.72E=05
BLNK B=cell&linker 29760 0.83443718 0.000893153
TMEM185A transmembrane&protein&185A 84548 0.834237626 7.80E=05
CLDN4 claudin&4 1364 0.833399066 0.000121323
DSG1 desmoglein&1 1828 0.833231874 6.99E=07
ENOX1 ecto=NOX&disulfide=thiol&exchanger&1 55068 0.828910104 0.000586621
CDSN corneodesmosin 1041 0.825511689 1.73E=07
UNC5B unc=5&homolog&B&(C.&elegans) 219699 0.825315708 0.000340706
FAM63A family&with&sequence&similarity&63,&member&A 55793 0.823150914 2.76E=05
DMKN dermokine 93099 0.821390699 1.30E=09
ZNF185 zinc&finger&protein&185&(LIM&domain) 7739 0.821073225 7.45E=06
ELOVL4 ELOVL&fatty&acid&elongase&4 6785 0.813309514 1.93E=08
FCHSD1 FCH&and&double&SH3&domains&1 89848 0.812366712 0.0002495
KRT23 keratin&23&(histone&deacetylase&inducible) 25984 0.809366673 5.44E=06
IL1A interleukin&1,&alpha 3552 0.799515905 1.69E=09
HSPB8 heat&shock&22kDa&protein&8 26353 0.785965673 7.81E=06
MYO5B myosin&VB 4645 0.782024146 2.24E=08
 Gene$Symbol Gene$Name Gene$Id logFoldChange p"value
SCEL sciellin 8796 0.781454715 4.31E209
ABCG1 ATP2binding9cassette,9sub2family9G9(WHITE),9member91 9619 0.779374496 0.000839515
ENTPD3 ectonucleoside9triphosphate9diphosphohydrolase93 956 0.775120804 6.30E206
LINC00520 long9intergenic9non2protein9coding9RNA9520 645687 0.772576486 0.000373558
KIAA0513 KIAA0513 9764 0.769707267 0.000233753
TNFAIP8L3 tumor9necrosis9factor,9alpha2induced9protein982like93 388121 0.768158812 0.000466408
GAB2 GRB22associated9binding9protein92 9846 0.763408236 0.000573701
PCDH1 protocadherin91 5097 0.757678844 0.000204133
PLEKHG1
pleckstrin9homology9domain9containing,9family9G9(with9RhoGef9
domain)9member91 57480 0.75566912 0.000383588
GBP6 guanylate9binding9protein9family,9member96 163351 0.752695618 9.40E206
DUSP1 dual9specificity9phosphatase91 1843 0.741157473 5.07E206
AIF1L allograft9inflammatory9factor912like 83543 0.741032711 2.25E205
PLA2G4A phospholipase9A2,9group9IVA9(cytosolic,9calcium2dependent) 5321 0.740571422 2.64E208
MPZL3 myelin9protein9zero2like93 196264 0.737491542 1.09E205
MMP3 matrix9metallopeptidase939(stromelysin91,9progelatinase) 4314 0.736141673 6.39E205
TUBB2A tubulin,9beta92A9class9IIa 7280 0.735719915 4.60E206
CHL1 cell9adhesion9molecule9L12like 10752 0.732387052 0.000533014
ME1 malic9enzyme91,9NADP(+)2dependent,9cytosolic 4199 0.728408676 2.91E208
TXNRD1 thioredoxin9reductase91 7296 0.728317382 8.76E207
RAB11FIP1 RAB119family9interacting9protein919(class9I) 80223 0.718377816 1.82E208
SLC16A7 solute9carrier9family9169(monocarboxylate9transporter),9member97 9194 0.716798536 0.000188517
RBM3 RNA9binding9motif9(RNP1,9RRM)9protein93 5935 0.714698208 2.25E207
RASGEF1B RasGEF9domain9family,9member91B 153020 0.703810059 0.000975551
SAMD5 sterile9alpha9motif9domain9containing95 389432 0.699197201 7.79E206
CWH43 cell9wall9biogenesis9439C2terminal9homolog9(S.9cerevisiae) 80157 0.696418045 4.06E207
ZNF155 zinc9finger9protein9155 7711 0.673765253 0.000305606
KLK10 kallikrein2related9peptidase910 5655 0.670227731 8.07E205
PRDM1 PR9domain9containing91,9with9ZNF9domain 639 0.662883007 0.000180969
IL1RN interleukin919receptor9antagonist 3557 0.654963513 1.10E206
HBEGF heparin2binding9EGF2like9growth9factor 1839 0.653820109 2.39E207
ABCA12 ATP2binding9cassette,9sub2family9A9(ABC1),9member912 26154 0.652691679 2.46E205
NEBL nebulette 10529 0.651591281 0.00067357
PPL periplakin 5493 0.630664613 3.66E206
TRIM16L tripartite9motif9containing9162like 147166 0.630552762 0.000178966
CERS3 ceramide9synthase93 204219 0.627235896 1.19E205
HPSE heparanase 10855 0.614607444 1.93E205
BLMH bleomycin9hydrolase 642 0.608796829 1.07E205
SORT1 sortilin91 6272 0.6040748 0.000541769
RAET1E retinoic9acid9early9transcript91E 135250 0.602857258 5.27E205
CCDC71L coiled2coil9domain9containing9712like 168455 0.601921811 0.000677069
DENND2C DENN/MADD9domain9containing92C 163259 0.595747909 3.46E206
ERBB3 v2erb2b29avian9erythroblastic9leukemia9viral9oncogene9homolog93 2065 0.594678138 2.55E205
EPGN epithelial9mitogen 255324 0.580289164 6.97E206
LGALSL lectin,9galactoside2binding2like 29094 0.565072367 7.49E205
TRIM16 tripartite9motif9containing916 10626 0.56017902 6.87E206
POF1B premature9ovarian9failure,91B 79983 0.559528834 7.18E206
KRT6A keratin96A 3853 0.558093494 3.25E206
GCLC glutamate2cysteine9ligase,9catalytic9subunit 2729 0.556731771 4.43E205
KRT10 keratin910 3858 0.547446342 0.000205709
CTSV cathepsin9V 1515 0.542531481 7.31E205
TXNIP thioredoxin9interacting9protein 10628 0.534230543 0.000933179
CSTA cystatin9A9(stefin9A) 1475 0.533026887 6.16E206
ALS2CL ALS29C2terminal9like 259173 0.527702851 0.000352453
S100A7 S1009calcium9binding9protein9A7 6278 0.526735079 3.85E205
PRSS3 protease,9serine,93 5646 0.522825719 5.22E205
PIM1 pim219oncogene 5292 0.52218759 0.000422268
RNASE7 ribonuclease,9RNase9A9family,97 84659 0.52177469 0.000960772
PNLIPRP3 pancreatic9lipase2related9protein93 119548 0.51696723 4.07E205
UGCG UDP2glucose9ceramide9glucosyltransferase 7357 0.514565727 0.000134656
TM4SF1 transmembrane949L9six9family9member91 4071 0.51401384 0.000140326
TYRP1 tyrosinase2related9protein91 7306 0.506148578 0.000145469
PFKFB2 62phosphofructo222kinase/fructose22,62biphosphatase92 5208 0.505466957 3.73E205
ELOVL1 ELOVL9fatty9acid9elongase91 64834 0.494904976 0.00019366
XDH xanthine9dehydrogenase 7498 0.484398431 0.000449852
SLFN5 schlafen9family9member95 162394 0.479482968 0.000254372
KRT17 keratin917 3872 0.47104393 6.16E205
ABLIM1 actin9binding9LIM9protein91 3983 0.47020682 0.000693983
S100A6 S1009calcium9binding9protein9A6 6277 0.469521964 0.000297202
ALDH1A3 aldehyde9dehydrogenase919family,9member9A3 220 0.468740625 0.00042278
S100A2 S1009calcium9binding9protein9A2 6273 0.467752399 5.81E205
PERP PERP,9TP539apoptosis9effector 64065 0.464086308 0.000254144
ANXA1 annexin9A1 301 0.454622406 0.00012623
SPTLC3 serine9palmitoyltransferase,9long9chain9base9subunit93 55304 0.453687 0.00032003
FLG filaggrin 2312 0.44603286 0.000839223
SAT1 spermidine/spermine9N12acetyltransferase91 6303 0.434022765 0.000865196
YOD1 YOD19deubiquitinase 55432 0.428328583 0.000668375
NAA20 N(alpha)2acetyltransferase920,9NatB9catalytic9subunit 51126 0.419796567 0.000660683
SRXN1 sulfiredoxin91 140809 0.411483307 0.000805927
LDHA lactate9dehydrogenase9A 3939 20.389498542 0.000856763
HIST1H2BF histone9cluster91,9H2bf 8343 20.415375177 0.000668302
RNF213 ring9finger9protein9213 57674 20.424182629 0.000902412
EEA1 early9endosome9antigen91 8411 20.42435549 0.000776798
TGFBR2 transforming9growth9factor,9beta9receptor9II9(70/80kDa) 7048 20.426921291 0.000834577
 Gene$Symbol Gene$Name Gene$Id logFoldChange p"value
PHGDH phosphoglycerate-dehydrogenase 26227 30.430248357 0.000587962
JUN jun-proto3oncogene 3725 30.437432531 0.000552014
SLC2A1 solute-carrier-family-2-(facilitated-glucose-transporter),-member-1 6513 30.440789702 0.000553742
RAD50 RAD50-homolog-(S.-cerevisiae) 10111 30.441285067 0.000423987
PCDH7 protocadherin-7 5099 30.449983707 0.000469669
TNS4 tensin-4 84951 30.460189086 0.000690947
HIST1H2BM histone-cluster-1,-H2bm 8342 30.469382876 0.000664162
HIST2H2BF histone-cluster-2,-H2bf 440689 30.478560786 0.000135791
TRNP1 TMF13regulated-nuclear-protein-1 388610 30.483372382 0.000355033
CAMK2N1 calcium/calmodulin3dependent-protein-kinase-II-inhibitor-1 55450 30.486808511 0.000359338
BNIP3L BCL2/adenovirus-E1B-19kDa-interacting-protein-33like 665 30.487219035 0.000132167
SCD stearoyl3CoA-desaturase-(delta393desaturase) 6319 30.503714228 2.73E305
FLRT2 fibronectin-leucine-rich-transmembrane-protein-2 23768 30.53190633 8.42E305
PCBP2 poly(rC)-binding-protein-2 5094 30.535594428 0.000460856
HSPA1A heat-shock-70kDa-protein-1A 3303 30.541236919 6.16E305
TRIM2 tripartite-motif-containing-2 23321 30.548466456 0.0003985
PDS5B PDS5,-regulator-of-cohesion-maintenance,-homolog-B-(S.-cerevisiae) 23047 30.55544903 4.73E305
ZMYND8 zinc-finger,-MYND3type-containing-8 23613 30.562229366 1.78E305
FTH1 ferritin,-heavy-polypeptide-1 2495 30.568765527 9.32E305
MYBL1 v3myb-avian-myeloblastosis-viral-oncogene-homolog3like-1 4603 30.574652284 0.000944791
MAF v3maf-avian-musculoaponeurotic-fibrosarcoma-oncogene-homolog 4094 30.574942112 0.000416152
RUNX1 runt3related-transcription-factor-1 861 30.57944006 0.000578387
PMEPA1 prostate-transmembrane-protein,-androgen-induced-1 56937 30.58200948 9.61E305
MT1E metallothionein-1E 4493 30.5831001 3.71E306
ADNP activity3dependent-neuroprotector-homeobox 23394 30.586740852 0.00093153
PTMS parathymosin 5763 30.595786596 0.000122715
IGF1R insulin3like-growth-factor-1-receptor 3480 30.600961817 0.000157375
ASS1 argininosuccinate-synthase-1 445 30.601175763 5.23E306
NAV1 neuron-navigator-1 89796 30.605231196 0.000657827
LPCAT2 lysophosphatidylcholine-acyltransferase-2 54947 30.608103985 1.51E306
MT1X metallothionein-1X 4501 30.608325506 0.000531251
BNIP3 BCL2/adenovirus-E1B-19kDa-interacting-protein-3 664 30.609556476 5.95E306
MKI67 marker-of-proliferation-Ki367 4288 30.614199194 0.000935667
LTBP1 latent-transforming-growth-factor-beta-binding-protein-1 4052 30.618875544 0.000430246
NFAT5 nuclear-factor-of-activated-T3cells-5,-tonicity3responsive 10725 30.625179648 2.85E305
YLPM1 YLP-motif-containing-1 56252 30.629251145 0.000273439
APCDD1 adenomatosis-polyposis-coli-down3regulated-1 147495 30.657723904 0.000213987
VIM vimentin 7431 30.664117411 1.88E306
PABPC1 poly(A)-binding-protein,-cytoplasmic-1 26986 30.676972924 0.000609023
EP300 E1A-binding-protein-p300 2033 30.684044311 0.000939142
PIK3C2G
phosphatidylinositol343phosphate-33kinase,-catalytic-subunit-type-2-
gamma 5288 30.684266434 3.35E306
GPRC5A G-protein3coupled-receptor,-class-C,-group-5,-member-A 9052 30.705728846 0.000950481
POLR2A polymerase-(RNA)-II-(DNA-directed)-polypeptide-A,-220kDa 5430 30.706660086 8.94E305
TENM4 teneurin-transmembrane-protein-4 26011 30.714323375 0.000618587
HERC5 HECT-and-RLD-domain-containing-E3-ubiquitin-protein-ligase-5 51191 30.718486901 0.000904563
NR2F2 nuclear-receptor-subfamily-2,-group-F,-member-2 7026 30.727141196 0.000819322
FASN fatty-acid-synthase 2194 30.734431998 1.32E305
SPEN spen-family-transcriptional-repressor 23013 30.734643699 2.36E305
TSPAN1 tetraspanin-1 10103 30.737972118 6.38E306
KMT2A lysine-(K)3specific-methyltransferase-2A 4297 30.74155747 2.49E305
TGFBI transforming-growth-factor,-beta3induced,-68kDa 7045 30.744098949 1.63E308
NDRG1 N3myc-downstream-regulated-1 10397 30.745037581 2.96E309
KRT15 keratin-15 3866 30.755050271 6.28E306
GAS6 growth-arrest3specific-6 2621 30.756368099 5.46E305
ZDHHC2 zinc-finger,-DHHC3type-containing-2 51201 30.766009739 0.000167613
BTBD16 BTB-(POZ)-domain-containing-16 118663 30.789791084 0.000209092
DPYSL2 dihydropyrimidinase3like-2 1808 30.791377186 2.10E308
UBA7 ubiquitin3like-modifier-activating-enzyme-7 7318 30.791847894 0.000808044
RFX7 regulatory-factor-X,-7 64864 30.798058666 3.35E305
IL1R2 interleukin-1-receptor,-type-II 7850 30.798477513 8.28E307
IPW imprinted-in-Prader3Willi-syndrome-(non3protein-coding) 3653 30.806202678 0.000159751
GALM galactose-mutarotase-(aldose-13epimerase) 130589 30.817795704 0.000114808
PTPRS protein-tyrosine-phosphatase,-receptor-type,-S 5802 30.829733414 5.90E305
SAMHD1 SAM-domain-and-HD-domain-1 25939 30.834441707 0.00016479
COL4A2 collagen,-type-IV,-alpha-2 1284 30.846416908 3.94E309
METTL7A methyltransferase-like-7A 25840 30.847960628 0.000728231
KLF12 Kruppel3like-factor-12 11278 30.854001759 5.22E305
GDF11 growth-differentiation-factor-11 10220 30.865952275 4.21E305
BICC1 BicC-family-RNA-binding-protein-1 80114 30.868028858 0.000227829
MISP mitotic-spindle-positioning 126353 30.872410535 4.00E305
TPM2 tropomyosin-2-(beta) 7169 30.875421356 0.000142014
NUAK1 NUAK-family,-SNF13like-kinase,-1 9891 30.881193597 1.52E305
TSHZ3 teashirt-zinc-finger-homeobox-3 57616 30.882659654 0.000367308
HEG1 heart-development-protein-with-EGF3like-domains-1 57493 30.883706061 6.30E307
SDPR serum-deprivation-response 8436 30.892857825 0.000472074
NUP210 nucleoporin-210kDa 23225 30.894204276 0.000482158
CYP26B1 cytochrome-P450,-family-26,-subfamily-B,-polypeptide-1 56603 30.898379563 3.73E305
PCYT1B phosphate-cytidylyltransferase-1,-choline,-beta 9468 30.908175804 8.20E305
AXL AXL-receptor-tyrosine-kinase 558 30.913952801 1.58E307
FADS1 fatty-acid-desaturase-1 3992 30.922556225 4.67E310
REPS2 RALBP1-associated-Eps-domain-containing-2 9185 30.928301076 0.000245542
BEX1 brain-expressed,-X3linked-1 55859 30.941297413 0.000883945
TMEM200A transmembrane-protein-200A 114801 30.945006653 2.21E307
 Gene$Symbol Gene$Name Gene$Id logFoldChange p"value
SOX12 SRY$(sex$determining$region$Y)2box$12 6666 20.945635983 1.95E205
LGALS1 lectin,$galactoside2binding,$soluble,$1 3956 20.956698493 1.81E208
TRIML2 tripartite$motif$family2like$2 205860 20.961443064 9.79E206
TRIM47 tripartite$motif$containing$47 91107 20.978337446 7.23E205
MAP1B microtubule2associated$protein$1B 4131 20.981763965 1.16E207
OLFML3 olfactomedin2like$3 56944 20.99065176 0.00048993
COL4A1 collagen,$type$IV,$alpha$1 1282 21.006335111 1.10E211
LTBP2 latent$transforming$growth$factor$beta$binding$protein$2 4053 21.024590017 1.39E214
PRUNE2 prune$homolog$2$(Drosophila) 158471 21.041088048 1.65E206
TNS1 tensin$1 7145 21.044262485 9.23E206
PRKCQ protein$kinase$C,$theta 5588 21.056245334 1.56E206
MYH15 myosin,$heavy$chain$15 22989 21.07156524 5.80E205
SRRM2 serine/arginine$repetitive$matrix$2 23524 21.082766266 8.24E208
DNAH11 dynein,$axonemal,$heavy$chain$11 8701 21.084145753 5.78E206
FN1 fibronectin$1 2335 21.092729404 3.52E213
TIMP3 TIMP$metallopeptidase$inhibitor$3 7078 21.118259685 5.21E214
BEND6 BEN$domain$containing$6 221336 21.133088985 2.13E206
EGLN3 egl29$family$hypoxia2inducible$factor$3 112399 21.15356572 5.00E219
MAMDC2 MAM$domain$containing$2 256691 21.163380351 0.000455099
GJC1 gap$junction$protein,$gamma$1,$45kDa 10052 21.172907744 6.42E208
CMAHP
cytidine$monophospho2N2acetylneuraminic$acid$hydroxylase,$
pseudogene 8418 21.188647215 0.000118711
CDK18 cyclin2dependent$kinase$18 5129 21.192764271 0.000871896
BCAT1 branched$chain$amino2acid$transaminase$1,$cytosolic 586 21.198445755 4.46E213
TMEM158 transmembrane$protein$158$(gene/pseudogene) 25907 21.207310167 6.53E205
CMBL carboxymethylenebutenolidase$homolog$(Pseudomonas) 134147 21.214795705 8.93E208
PPAP2C phosphatidic$acid$phosphatase$type$2C 8612 21.224044745 4.42E206
STMN3 stathmin2like$3 50861 21.269962582 1.61E207
IGFBP2 insulin2like$growth$factor$binding$protein$2,$36kDa 3485 21.288520607 1.38E205
FHOD3 formin$homology$2$domain$containing$3 80206 21.295296849 2.64E208
LINC00704 long$intergenic$non2protein$coding$RNA$704 100216001 21.297552543 4.04E207
CCDC8 coiled2coil$domain$containing$8 83987 21.325521907 0.000368826
ADAM19 ADAM$metallopeptidase$domain$19 8728 21.368995301 1.08E205
XAF1 XIAP$associated$factor$1 54739 21.389980706 4.30E205
COL5A1 collagen,$type$V,$alpha$1 1289 21.418233479 0.000124987
FADS2 fatty$acid$desaturase$2 9415 21.490220437 1.33E231
MARCH4
membrane2associated$ring$finger$(C3HC4)$4,$E3$ubiquitin$protein$
ligase 57574 21.507145161 2.16E205
CASP14 caspase$14,$apoptosis2related$cysteine$peptidase 23581 21.516661048 3.28E215
L1TD1 LINE21$type$transposase$domain$containing$1 54596 21.537056056 1.53E205
MMP2
matrix$metallopeptidase$2$(gelatinase$A,$72kDa$gelatinase,$72kDa$
type$IV$collagenase) 4313 21.563442701 2.16E205
CCK cholecystokinin 885 21.615381653 1.80E205
VIT vitrin 5212 21.63485357 0.000510847
LOXL2 lysyl$oxidase2like$2 4017 21.689096678 8.34E212
ANO1 anoctamin$1,$calcium$activated$chloride$channel 55107 21.732405484 6.79E212
ZNF69 zinc$finger$protein$69 7620 21.928786078 3.83E205
SLC16A3 solute$carrier$family$16$(monocarboxylate$transporter),$member$3 9123 21.949409116 7.70E214
NDUFA4L2 NADH$dehydrogenase$(ubiquinone)$1$alpha$subcomplex,$42like$2 56901 21.977633957 2.67E216
SLC1A6
solute$carrier$family$1$(high$affinity$aspartate/glutamate$transporter),$
member$6 6511 22.032635575 8.37E212
KRT7 keratin$7 3855 22.046905395 3.58E210
PXDN peroxidasin$homolog$(Drosophila) 7837 22.055151662 2.11E209
FZD2 frizzled$class$receptor$2 2535 22.110319888 0.000567984
MXRA5 matrix2remodelling$associated$5 25878 22.186739087 3.43E222
SERPING1 serpin$peptidase$inhibitor,$clade$G$(C1$inhibitor),$member$1 710 22.201995943 2.91E208
NGFR nerve$growth$factor$receptor 4804 22.298826624 0.000736352
SARM1 sterile$alpha$and$TIR$motif$containing$1 23098 22.650233827 0.000807429
ISYNA1 inositol232phosphate$synthase$1 51477 22.754395923 0.00077216
STC1 stanniocalcin$1 6781 22.767489581 0.000315288
ANGPTL7 angiopoietin2like$7 10218 22.932032637 0.000643321
HCAR1 hydroxycarboxylic$acid$receptor$1 27198 23.06803103 0.000285676
LINC01347 long$intergenic$non2protein$coding$RNA$1347 731275 23.077218776 0.000979476
CA9 carbonic$anhydrase$IX 768 23.245921781 4.23E245
LOC148696 uncharacterized$LOC148696 148696 23.660376712 0.000210214
BZRAP1 benzodiazepine$receptor$(peripheral)$associated$protein$1 9256 23.825000973 4.48E205
CELF4 CUGBP,$Elav2like$family$member$4 56853 25.841905558 0.000716932
LOC100507156 uncharacterized$LOC100507156 100507156 26.322384544 0.000215135
THY1 Thy21$cell$surface$antigen 7070 26.521279336 5.26E205
FAM133CP family$with$sequence$similarity$133,$member$A$pseudogene 728640 26.951398819 8.26E207
Full list of clustering of related GO terms ranked in descending order of number of genes involved.  
 
	  
Cluster ID No. of GO Terms No. of Genes List of Genes GO ID GO Terms No. of Genes
GO:0032501 multicellular organismal process 180
GO:0032502 developmental process 162
GO:0048856 anatomical structure development 144
GO:0007275 multicellular organismal development 143
GO:0048731 system development 130
GO:0048869 cellular developmental process 108
GO:0030154 cell differentiation 106
GO:0048513 organ development 100
GO:0009888 tissue development 86
GO:0008544 epidermis development 50
GO:0060429 epithelium development 48
GO:0030855 epithelial cell differentiation 44
GO:0009913 epidermal cell differentiation 33
GO:0030216 keratinocyte differentiation 32
GO:0031424 keratinization 20
GO:0042221 response to chemical stimulus 99
GO:0010033 response to organic substance 77
GO:0070887 cellular response to chemical stimulus 68
GO:0009605 response to external stimulus 60
GO:0009719 response to endogenous stimulus 46
GO:0071310 cellular response to organic substance 46
GO:0009725 response to hormone stimulus 39
GO:0009991 response to extracellular stimulus 30
GO:0031667 response to nutrient levels 26
GO:0048545 response to steroid hormone stimulus 24
GO:0007584 response to nutrient 21
GO:0033273 response to vitamin 17
GO:0043627 response to estrogen stimulus 15
GO:0031960 response to corticosteroid stimulus 14
GO:0051384 response to glucocorticoid stimulus 13
GO:0007565 female pregnancy 12
GO:0032355 response to estradiol stimulus 11






























Cluster ID No. of GO Terms No. of Genes List of Genes GO ID GO Terms No. of Genes
GO:0005576 extracellular region 106
GO:0044421 extracellular region part 56
GO:0005615 extracellular space 44
GO:0002376 immune system process 63
GO:0006955 immune response 47
GO:0009611 response to wounding 45
GO:0006952 defense response 44
GO:0051704 multi-organism process 44
GO:0009607 response to biotic stimulus 29
GO:0051707 response to other organism 28
GO:0009617 response to bacterium 21
GO:0002237 response to molecule of bacterial origin 16
GO:0032496 response to lipopolysaccharide 16
GO:0009605 response to external stimulus 60
GO:0009719 response to endogenous stimulus 46
GO:0006629 lipid metabolic process 61
GO:0044255 cellular lipid metabolic process 44
GO:0008610 lipid biosynthetic process 32



































	  	  	  	  
Cluster ID No. of GO Terms No. of Genes List of Genes GO ID GO Terms No. of Genes
GO:0016491 oxidoreductase activity 38
GO:0006082 organic acid metabolic process 37
GO:0019752 carboxylic acid metabolic process 37
GO:0042180 cellular ketone metabolic process 37
GO:0043436 oxoacid metabolic process 37
GO:0032787 monocarboxylic acid metabolic process 25
GO:0060429 epithelium development 48
GO:0030855 epithelial cell differentiation 44
GO:0030216 keratinocyte differentiation 32
GO:0006508 proteolysis 39
GO:0004175 endopeptidase activity 21
GO:0017171 serine hydrolase activity 14
GO:0008236 serine-type peptidase activity 14
GO:0004252 serine-type endopeptidase activity 13
GO:0072358 cardiovascular system development 35
GO:0072359 circulatory system development 35
GO:0001944 vasculature development 31
GO:0001568 blood vessel development 30
GO:0048514 blood vessel morphogenesis 29
GO:0001525 angiogenesis 24
GO:0010035 response to inorganic substance 28
GO:0010038 response to metal ion 21
GO:0006979 response to oxidative stress 20
GO:0000302 response to reactive oxygen species 13
GO:0042542 response to hydrogen peroxide 11
GO:0034614 cellular response to reactive oxygen species 7
GO:0070301 cellular response to hydrogen peroxide 6





























	  	  	  
Cluster ID No. of GO Terms No. of Genes List of Genes GO ID GO Terms No. of Genes
GO:0004857 enzyme inhibitor activity 22
GO:0030414 peptidase inhibitor activity 19
GO:0061135 endopeptidase regulator activity 19
GO:0061134 peptidase regulator activity 19
GO:0004866 endopeptidase inhibitor activity 19
GO:0051346 negative regulation of hydrolase activity 15
GO:0052547 regulation of peptidase activity 15
GO:0004867 serine-type endopeptidase inhibitor activity 15
GO:0010466 negative regulation of peptidase activity 12
GO:0010951 negative regulation of endopeptidase activity 10
GO:0031667 response to nutrient levels 26
GO:0007584 response to nutrient 21
GO:0033273 response to vitamin 17
GO:0044283 small molecule biosynthetic process 19
GO:0016053 organic acid biosynthetic process 16
GO:0046394 carboxylic acid biosynthetic process 16
GO:0006633 fatty acid biosynthetic process 11
GO:0033559 unsaturated fatty acid metabolic process 11
GO:0006690 icosanoid metabolic process 10
GO:0006693 prostaglandin metabolic process 7
GO:0006636 unsaturated fatty acid biosynthetic process 7
GO:0006692 prostanoid metabolic process 7
GO:0046456 icosanoid biosynthetic process 6
GO:0001516 prostaglandin biosynthetic process 4
GO:0046457 prostanoid biosynthetic process 4
GO:0031394 positive regulation of prostaglandin biosynthetic process 3
GO:0031392 regulation of prostaglandin biosynthetic process 3
GO:2001279 regulation of unsaturated fatty acid biosynthetic process 3
GO:2001280 positive regulation of unsaturated fatty acid biosynthetic process 3




Cluster 13 3 26 PTGS2,TIMP3,TRIM16,ALDH3A1,MAP1B,CCK,IL1A,IL1B,ASS1,AKR1C3,FZD2,LCN2,JUN,CYP26B1,DUSP1,IGF1R,IGFBP2,FADS1,PLA2G4A,EP300,CTSV,ARG1,HMOX1,SLC2A1,STC1,GAS6
Cluster 14 16 23 ANXA1,PTGS2,ISYNA1,BBOX1,BCAT1,GGT6,PHGDH,FADS1,PLA2G4A,FADS2,ASS1,PLA2G4F,AKR1C2,AKR1C3,ACER1,DHRS9,SCD,GCLC,HPGD,ELOVL4,FASN,ELOVL1,CYP4F3
	  	  	  
Cluster ID No. of GO Terms No. of Genes List of Genes GO ID GO Terms No. of Genes
GO:0016705
oxidoreductase activity, acting on paired 
donors, with incorporation or reduction of 
molecular oxygen
16
GO:0005506 iron ion binding 16
GO:0046906 tetrapyrrole binding 11
GO:0020037 heme binding 10
GO:0004497 monooxygenase activity 9
GO:0031012 extracellular matrix 22
GO:0005578 proteinaceous extracellular matrix 21
GO:0002526 acute inflammatory response 12
GO:0006953 acute-phase response 8
GO:0001659 temperature homeostasis 6
GO:0002673 regulation of acute inflammatory response 6
GO:0030728 ovulation 5
GO:0001893 maternal placenta development 5
GO:0031649 heat generation 5
GO:0001660 fever generation 5
GO:0033280 response to vitamin D 5
GO:0031620 regulation of fever generation 4
GO:0010573 vascular endothelial growth factor production 4
GO:0031622 positive regulation of fever generation 4
GO:0010575 positive regulation vascular endothelial growth factor production 4
GO:0031652 positive regulation of heat generation 4
GO:0046697 decidualization 4
GO:0031650 regulation of heat generation 4
GO:0010574 regulation of vascular endothelial growth factor production 4
GO:0045111 intermediate filament cytoskeleton 18
GO:0005882 intermediate filament 17
GO:0045095 keratin filament 11
GO:0051384 response to glucocorticoid stimulus 13
GO:0007565 female pregnancy 12
GO:0016746 transferase activity, transferring acyl groups 18
GO:0016747 transferase activity, transferring acyl groups other than amino-acyl groups 14
Cluster 18 3 KRT75,KRT23,KRT10,KRT78,KRT1,TCHH,KRT7,KRT4,FLG,KRT80,VIM,KRT17,KRT16,KRT15,KRT6B,KRT6C,KRT6A,CASP1418
ANXA1,PTGS2,ALDH3A1,IGFBP2,IL1B,EP300,ASS1,PLA2G4A,CTSV,IL1RN,CLDN4,ARG1,MMP2,HPGD,ENDOU,STC1,DUSP1,MMP3
SAT1,TGM3,TGM5,TGM1,ZDHHC2,GGT6,EP300,AWAT1,SPTSSB,NAA20,CERS3,DGAT2,ELOVL4,LPCAT2,SPTLC3,ELOVL1,FASN,AGPAT9
Cluster 17 17 20 ANXA1,PTGS2,S100A8,DEFB1,SERPING1,IL1A,IL1B,ASS1,HPGD,CTSV,CIDEA,PLA2G4A,IL1RN,FZD2,FN1,PTGER3,PRDM1,STC1,HPSE,EREG
22
Cluster 15 5 22 PTGS2,FLVCR2,BBOX1,TCN1,FADS1,CMAHP,FADS2,AKR1C1,AKR1C2,AKR1C3,EGLN3,CYP4F22,CYP4F3,SCD,LCN2,HMOX1,XDH,CYP26B1,CYP2C18,TYRP1,FTH1,PXDN





	  	  	  
Cluster ID No. of GO Terms No. of Genes List of Genes GO ID GO Terms No. of Genes
GO:0042445 hormone metabolic process 12
GO:0006766 vitamin metabolic process 11
GO:0034754 cellular hormone metabolic process 9
GO:0006775 fat-soluble vitamin metabolic process 7
GO:0006776 vitamin A metabolic process 7
GO:0006721 terpenoid metabolic process 7
GO:0001523 retinoid metabolic process 7
GO:0016101 diterpenoid metabolic process 7
GO:0042573 retinoic acid metabolic process 5
GO:0071496 cellular response to external stimulus 16
GO:0031668 cellular response to extracellular stimulus 14
GO:0070482 response to oxygen levels 15
GO:0036293 response to decreased oxygen levels 15
GO:0001666 response to hypoxia 15
GO:0016616 oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor 13
GO:0016614 oxidoreductase activity, acting on CH-OH group of donors 13
GO:0000302 response to reactive oxygen species 13
GO:0042542 response to hydrogen peroxide 11
Cluster 26 3 13 ANXA1,LCN2,JUN,TXNIP,PLA2G4A,EP300,BNIP3,ARG1,HMOX1,S100A7,AKR1C3,DUSP1,PXDNGO:0034614 cellular response to reactive oxygen species 7
GO:0043062 extracellular structure organization 12
GO:0030198 extracellular matrix organization 12
GO:0060090 binding, bridging 11
GO:0030674 protein binding, bridging 10
GO:0044259 multicellular organismal macromolecule metabolic process 9
GO:0044236 multicellular organismal metabolic process 9
GO:0032963 collagen metabolic process 8
GO:0030574 collagen catabolic process 5
GO:0044243 multicellular organismal catabolic process 5
GO:0045834 positive regulation of lipid metabolic process 9




Cluster 22 2 16 ADNP,LCN2,HMOX1,FADS1,IL1B,AXL,AKR1C3,FZD2,JUN,SLC2A1,LDHA,CYP26B1,CTSV,BNIP3,MMP3,GAS6
Cluster 23 3 15 PTGS2,ALDH3A1,NDRG1,PRKCQ,IL1A,IL1B,EP300,BNIP3,EGLN3,LOXL2,HMOX1,SCNN1G,STC1,MMP2,MMP3
Cluster 29 5 9 MMP10,MMP1,ARG1,COL5A1,KLK6,EP300,MMP2,MMP3,AKR1C3
Cluster 27 2 12 MMP10,COL5A1,COL4A2,LOXL2,MPZL3,TGFBI,SPINK5,MMP1,MMP2,MMP3,PXDN,GAS6
ANXA1,ADAP2,IVL,CSTA,GAB2,FLRT2,RAD50,SPRR1A,SPRR1B,BLNK,GAS6112Cluster 28
Cluster 30 2 9 ANXA1,PTGS2,IGF1R,ABCG1,FGF2,NOD2,IL1A,PLA2G4A,IL1B
	  	  	  
Cluster ID No. of GO Terms No. of Genes List of Genes GO ID GO Terms No. of Genes
GO:0071241 cellular response to inorganic substance 9
GO:0071248 cellular response to metal ion 8
GO:0008106 alcohol dehydrogenase (NADP+) activity 4
GO:0004033 aldo-keto reductase (NADP) activity 4
GO:0033764
steroid dehydrogenase activity, acting on the 
CH-OH group of donors, NAD or NADP as 
acceptor
4
GO:0042448 progesterone metabolic process 4
GO:0016628 oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor 4
GO:0042574 retinal metabolic process 3
GO:0047023 androsterone dehydrogenase activity 3
GO:0047086 ketosteroid monooxygenase activity 3
GO:0004032 alditol:NADP+ 1-oxidoreductase activity 3
GO:0030647 aminoglycoside antibiotic metabolic process 3
GO:0009753 response to jasmonic acid stimulus 3
GO:0044597 daunorubicin metabolic process 3
GO:0043288 apocarotenoid metabolic process 3
GO:0018636 phenanthrene 9,10-monooxygenase activity 3
GO:0047115 trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity 3
GO:0071395 cellular response to jasmonic acid stimulus 3
GO:0044598 doxorubicin metabolic process 3
GO:0002138 retinoic acid biosynthetic process 2
GO:0047718 indanol dehydrogenase activity 2
GO:0047026 androsterone dehydrogenase (A-specific) activity 2
GO:0004958 prostaglandin F receptor activity 2
GO:0006693 prostaglandin metabolic process 7
GO:0006692 prostanoid metabolic process 7
GO:0030148 sphingolipid biosynthetic process 7
GO:0046467 membrane lipid biosynthetic process 7
GO:0046686 response to cadmium ion 5
GO:0071276 cellular response to cadmium ion 4
GO:0001893 maternal placenta development 5
GO:0046697 decidualization 4
Cluster 32 21 7 DHRS9,ALDH3A1,FASN,ALDH1A3,AKR1C1,AKR1C2,AKR1C3
Cluster 33 2 7 ANXA1,PTGS2,PLA2G4F,PLA2G4A,HPGD,AKR1C2,AKR1C3
Cluster 31 2 9 ACER1,MT1X,JUN,HMOX1,KRT10,MT1E,BNIP3,ASS1,AKR1C3
Cluster 36 2 5 PTGS2,PRDM1,STC1,PLA2G4A,CTSV
Cluster 34 2 7 UGCG,ACER1,PPAP2C,CERS3,SPTLC3,ELOVL1,SPTSSB
Cluster 35 2 5 MT1X,ARG1,HMOX1,MT1E,AKR1C3
	  Cluster ID No. of GO Terms No. of Genes List of Genes GO ID GO Terms No. of Genes
GO:0001516 prostaglandin biosynthetic process 4
GO:0046457 prostanoid biosynthetic process 4
GO:2001279 regulation of unsaturated fatty acid biosynthetic process 3
GO:0031392 regulation of prostaglandin biosynthetic process 3
GO:0031394 positive regulation of prostaglandin biosynthetic process 3
GO:2001280 positive regulation of unsaturated fatty acid biosynthetic process 3
GO:0010573 vascular endothelial growth factor production 4
GO:0010574 regulation of vascular endothelial growth factor production 4
GO:0016755 transferase activity, transferring amino-acyl groups 4
GO:0003810 protein-glutamine gamma-glutamyltransferase activity 3
GO:0045229 external encapsulating structure organization 2
GO:0043163 cell envelope organization 2
GO:0004955 prostaglandin receptor activity 4
GO:0004954 prostanoid receptor activity 4
GO:0004953 icosanoid receptor activity 4
GO:0005152 interleukin-1 receptor antagonist activity 4
GO:0030547 receptor inhibitor activity 4
GO:0048019 receptor antagonist activity 4
GO:0016717
oxidoreductase activity, acting on paired 
donors, with oxidation of a pair of donors 
resulting in the reduction of molecular oxygen 
to two molecules of water
3
GO:0016215 acyl-CoA desaturase activity 2
GO:0004768 stearoyl-CoA 9-desaturase activity 2
GO:0046113 nucleobase catabolic process 3
GO:0006145 purine nucleobase catabolic process 2
GO:0015172 acidic amino acid transmembrane transporter activity 3
GO:0015183 L-aspartate transmembrane transporter activity 2
ANXA1,PTGS2,PLA2G4A,PLA2G4F46Cluster 37
Cluster 40 3 4 PTGER3,HPGD,AKR1C2,AKR1C3
Cluster 41 3 4 IL1RN,IL36RN,PXDN,IL36G
Cluster 38 2 4 HPSE,PTGS2,IL1A,IL1B
Cluster 39 4 4 TGM1,TGM3,GGT6,TGM5
SLC1A6,SLC13A3,SLC7A1132Cluster 44
FADS1,SCD,FADS233Cluster 42
GDA,DPYSL2,XDH32Cluster 43
